id	sid	tid	token	lemma	pos
fnp-4365	1	1	post	post	ADJ
fnp-4365	1	2	-	-	ADJ
fnp-4365	1	3	mortem	mortem	ADJ
fnp-4365	1	4	neuropathologic	neuropathologic	ADJ
fnp-4365	1	5	examination	examination	NOUN
fnp-4365	1	6	of	of	ADP
fnp-4365	1	7	a	a	DET
fnp-4365	1	8	6	6	NUM
fnp-4365	1	9	-	-	PUNCT
fnp-4365	1	10	case	case	NOUN
fnp-4365	1	11	series	series	NOUN
fnp-4365	1	12	of	of	ADP
fnp-4365	1	13	car	car	NOUN
fnp-4365	1	14	t	t	PROPN
fnp-4365	1	15	-	-	PUNCT
fnp-4365	1	16	cell	cell	NOUN
fnp-4365	1	17	treated	treat	VERB
fnp-4365	1	18	patients	patient	NOUN
fnp-4365	1	19	feel	feel	VERB
fnp-4365	1	20	free	free	ADJ
fnp-4365	1	21	to	to	PART
fnp-4365	1	22	add	add	VERB
fnp-4365	1	23	comments	comment	NOUN
fnp-4365	1	24	by	by	ADP
fnp-4365	1	25	clicking	click	VERB
fnp-4365	1	26	these	these	DET
fnp-4365	1	27	icons	icon	NOUN
fnp-4365	1	28	on	on	ADP
fnp-4365	1	29	the	the	DET
fnp-4365	1	30	sidebar	sidebar	NOUN
fnp-4365	1	31	free	free	ADJ
fnp-4365	1	32	neuropathology	neuropathology	NOUN
fnp-4365	1	33	3:23	3:23	NUM
fnp-4365	1	34	(	(	PUNCT
fnp-4365	1	35	2022	2022	NUM
fnp-4365	1	36	)	)	PUNCT
fnp-4365	1	37	original	original	ADJ
fnp-4365	1	38	paper	paper	NOUN
fnp-4365	1	39	post	post	ADJ
fnp-4365	1	40	-	-	ADJ
fnp-4365	1	41	mortem	mortem	ADJ
fnp-4365	1	42	neuropathologic	neuropathologic	ADJ
fnp-4365	1	43	examination	examination	NOUN
fnp-4365	1	44	of	of	ADP
fnp-4365	1	45	a	a	DET
fnp-4365	1	46	6	6	NUM
fnp-4365	1	47	-	-	PUNCT
fnp-4365	1	48	case	case	NOUN
fnp-4365	1	49	series	series	NOUN
fnp-4365	1	50	of	of	ADP
fnp-4365	1	51	car	car	NOUN
fnp-4365	1	52	t	t	PROPN
fnp-4365	1	53	-	-	PUNCT
fnp-4365	1	54	cell	cell	NOUN
fnp-4365	1	55	treated	treat	VERB
fnp-4365	1	56	patients	patient	NOUN
fnp-4365	1	57	nuria	nuria	PROPN
fnp-4365	1	58	vidal	vidal	PROPN
fnp-4365	1	59	-	-	PUNCT
fnp-4365	1	60	robau1	robau1	NOUN
fnp-4365	1	61	*	*	NOUN
fnp-4365	1	62	,	,	PUNCT
fnp-4365	1	63	gabriela	gabriela	PROPN
fnp-4365	1	64	caballero1	caballero1	PROPN
fnp-4365	1	65	*	*	PROPN
fnp-4365	1	66	,	,	PUNCT
fnp-4365	1	67	ivan	ivan	PROPN
fnp-4365	1	68	archilla1	archilla1	PROPN
fnp-4365	1	69	,	,	PUNCT
fnp-4365	1	70	andrea	andrea	PROPN
fnp-4365	1	71	ladino2	ladino2	PROPN
fnp-4365	1	72	,	,	PUNCT
fnp-4365	1	73	sara	sara	PROPN
fnp-4365	1	74	fernández2	fernández2	PROPN
fnp-4365	1	75	,	,	PUNCT
fnp-4365	1	76	valentín	valentín	PROPN
fnp-4365	1	77	ortiz	ortiz	PROPN
fnp-4365	1	78	-	-	PUNCT
fnp-4365	1	79	maldonado3	maldonado3	PROPN
fnp-4365	1	80	,	,	PUNCT
fnp-4365	1	81	montserrat	montserrat	PROPN
fnp-4365	1	82	rovira3	rovira3	PROPN
fnp-4365	1	83	,	,	PUNCT
fnp-4365	1	84	marta	marta	PROPN
fnp-4365	1	85	gómez	gómez	PROPN
fnp-4365	1	86	-	-	PUNCT
fnp-4365	1	87	hernando3	hernando3	NOUN
fnp-4365	1	88	,	,	PUNCT
fnp-4365	1	89	julio	julio	PROPN
fnp-4365	1	90	delgado3	delgado3	PROPN
fnp-4365	1	91	,	,	PUNCT
fnp-4365	1	92	maría	maría	PROPN
fnp-4365	1	93	suárez	suárez	NOUN
fnp-4365	1	94	-	-	PUNCT
fnp-4365	1	95	lledó3	lledó3	VERB
fnp-4365	1	96	,	,	PUNCT
fnp-4365	1	97	carlos	carlos	PROPN
fnp-4365	1	98	fernández	fernández	PROPN
fnp-4365	1	99	de	de	PROPN
fnp-4365	1	100	larrea3,8	larrea3,8	PROPN
fnp-4365	1	101	,	,	PUNCT
fnp-4365	1	102	olga	olga	PROPN
fnp-4365	1	103	balagué1	balagué1	PROPN
fnp-4365	1	104	,	,	PUNCT
fnp-4365	1	105	gerard	gerard	PROPN
fnp-4365	1	106	frigola1	frigola1	PROPN
fnp-4365	1	107	,	,	PUNCT
fnp-4365	1	108	abel	abel	PROPN
fnp-4365	1	109	muñoz1	muñoz1	PROPN
fnp-4365	1	110	,	,	PUNCT
fnp-4365	1	111	estrella	estrella	PROPN
fnp-4365	1	112	ortiz1	ortiz1	PROPN
fnp-4365	1	113	,	,	PUNCT
fnp-4365	1	114	teresa	teresa	PROPN
fnp-4365	1	115	ribalta1	ribalta1	PROPN
fnp-4365	1	116	,	,	PUNCT
fnp-4365	1	117	miguel	miguel	PROPN
fnp-4365	1	118	j.	j.	PROPN
fnp-4365	1	119	martinez5,6	martinez5,6	PROPN
fnp-4365	1	120	,	,	PUNCT
fnp-4365	1	121	maria	maria	PROPN
fnp-4365	1	122	angeles	angeles	PROPN
fnp-4365	1	123	-	-	PUNCT
fnp-4365	1	124	marcos5	marcos5	PROPN
fnp-4365	1	125	,	,	PUNCT
fnp-4365	1	126	marta	marta	PROPN
fnp-4365	1	127	español	español	PROPN
fnp-4365	1	128	-	-	PUNCT
fnp-4365	1	129	rego7	rego7	NOUN
fnp-4365	1	130	,	,	PUNCT
fnp-4365	1	131	azucena	azucena	PROPN
fnp-4365	1	132	gonzález7	gonzález7	PROPN
fnp-4365	1	133	,	,	PUNCT
fnp-4365	1	134	daniel	daniel	PROPN
fnp-4365	1	135	benitez	benitez	PROPN
fnp-4365	1	136	-	-	PUNCT
fnp-4365	1	137	ribas7	ribas7	PROPN
fnp-4365	1	138	,	,	PUNCT
fnp-4365	1	139	eugenia	eugenia	PROPN
fnp-4365	1	140	martinez	martinez	PROPN
fnp-4365	1	141	-	-	PUNCT
fnp-4365	1	142	hernandez4	hernandez4	PROPN
fnp-4365	1	143	,	,	PUNCT
fnp-4365	1	144	pedro	pedro	PROPN
fnp-4365	1	145	castro2,8	castro2,8	PROPN
fnp-4365	1	146	,	,	PUNCT
fnp-4365	1	147	iban	iban	NOUN
fnp-4365	1	148	aldecoa1,9	aldecoa1,9	PROPN
fnp-4365	1	149	1	1	NUM
fnp-4365	1	150	pathology	pathology	NOUN
fnp-4365	1	151	department	department	NOUN
fnp-4365	1	152	,	,	PUNCT
fnp-4365	1	153	biomedical	biomedical	ADJ
fnp-4365	1	154	diagnostic	diagnostic	ADJ
fnp-4365	1	155	centre	centre	NOUN
fnp-4365	1	156	(	(	PUNCT
fnp-4365	1	157	cdb	cdb	PROPN
fnp-4365	1	158	)	)	PUNCT
fnp-4365	1	159	,	,	PUNCT
fnp-4365	1	160	hospital	hospital	NOUN
fnp-4365	1	161	clinic	clinic	NOUN
fnp-4365	1	162	of	of	ADP
fnp-4365	1	163	barcelona	barcelona	PROPN
fnp-4365	1	164	–	–	PUNCT
fnp-4365	1	165	university	university	PROPN
fnp-4365	1	166	of	of	ADP
fnp-4365	1	167	barcelona	barcelona	PROPN
fnp-4365	1	168	,	,	PUNCT
fnp-4365	1	169	barcelona	barcelona	PROPN
fnp-4365	1	170	,	,	PUNCT
fnp-4365	1	171	spain	spain	PROPN
fnp-4365	1	172	2	2	NUM
fnp-4365	1	173	medical	medical	ADJ
fnp-4365	1	174	intensive	intensive	ADJ
fnp-4365	1	175	care	care	NOUN
fnp-4365	1	176	unit	unit	NOUN
fnp-4365	1	177	,	,	PUNCT
fnp-4365	1	178	hospital	hospital	NOUN
fnp-4365	1	179	clinic	clinic	NOUN
fnp-4365	1	180	of	of	ADP
fnp-4365	1	181	barcelona	barcelona	PROPN
fnp-4365	1	182	–	–	PUNCT
fnp-4365	1	183	university	university	PROPN
fnp-4365	1	184	of	of	ADP
fnp-4365	1	185	barcelona	barcelona	PROPN
fnp-4365	1	186	,	,	PUNCT
fnp-4365	1	187	barcelona	barcelona	PROPN
fnp-4365	1	188	,	,	PUNCT
fnp-4365	1	189	spain	spain	PROPN
fnp-4365	1	190	3	3	NUM
fnp-4365	1	191	haematology	haematology	PROPN
fnp-4365	1	192	department	department	NOUN
fnp-4365	1	193	,	,	PUNCT
fnp-4365	1	194	hospital	hospital	NOUN
fnp-4365	1	195	clinic	clinic	NOUN
fnp-4365	1	196	of	of	ADP
fnp-4365	1	197	barcelona	barcelona	PROPN
fnp-4365	1	198	–	–	PUNCT
fnp-4365	1	199	university	university	PROPN
fnp-4365	1	200	of	of	ADP
fnp-4365	1	201	barcelona	barcelona	PROPN
fnp-4365	1	202	,	,	PUNCT
fnp-4365	1	203	barcelona	barcelona	PROPN
fnp-4365	1	204	,	,	PUNCT
fnp-4365	1	205	spain	spain	PROPN
fnp-4365	1	206	4	4	NUM
fnp-4365	1	207	neurology	neurology	NOUN
fnp-4365	1	208	department	department	NOUN
fnp-4365	1	209	,	,	PUNCT
fnp-4365	1	210	hospital	hospital	NOUN
fnp-4365	1	211	clinic	clinic	NOUN
fnp-4365	1	212	of	of	ADP
fnp-4365	1	213	barcelona	barcelona	PROPN
fnp-4365	1	214	–	–	PUNCT
fnp-4365	1	215	university	university	PROPN
fnp-4365	1	216	of	of	ADP
fnp-4365	1	217	barcelona	barcelona	PROPN
fnp-4365	1	218	,	,	PUNCT
fnp-4365	1	219	barcelona	barcelona	PROPN
fnp-4365	1	220	,	,	PUNCT
fnp-4365	1	221	spain	spain	PROPN
fnp-4365	1	222	5	5	NUM
fnp-4365	1	223	microbiology	microbiology	NOUN
fnp-4365	1	224	department	department	NOUN
fnp-4365	1	225	,	,	PUNCT
fnp-4365	1	226	biomedical	biomedical	ADJ
fnp-4365	1	227	diagnostic	diagnostic	ADJ
fnp-4365	1	228	centre	centre	NOUN
fnp-4365	1	229	(	(	PUNCT
fnp-4365	1	230	cdb	cdb	PROPN
fnp-4365	1	231	)	)	PUNCT
fnp-4365	1	232	,	,	PUNCT
fnp-4365	1	233	hospital	hospital	NOUN
fnp-4365	1	234	clinic	clinic	NOUN
fnp-4365	1	235	of	of	ADP
fnp-4365	1	236	barcelona	barcelona	PROPN
fnp-4365	1	237	–	–	PUNCT
fnp-4365	1	238	university	university	PROPN
fnp-4365	1	239	of	of	ADP
fnp-4365	1	240	barcelona	barcelona	PROPN
fnp-4365	1	241	,	,	PUNCT
fnp-4365	1	242	barcelona	barcelona	PROPN
fnp-4365	1	243	,	,	PUNCT
fnp-4365	1	244	spain	spain	PROPN
fnp-4365	1	245	6	6	NUM
fnp-4365	1	246	barcelona	barcelona	PROPN
fnp-4365	1	247	institute	institute	PROPN
fnp-4365	1	248	for	for	ADP
fnp-4365	1	249	global	global	ADJ
fnp-4365	1	250	health	health	PROPN
fnp-4365	1	251	(	(	PUNCT
fnp-4365	1	252	isglobal	isglobal	PROPN
fnp-4365	1	253	)	)	PUNCT
fnp-4365	1	254	,	,	PUNCT
fnp-4365	1	255	hospital	hospital	NOUN
fnp-4365	1	256	clinic	clinic	NOUN
fnp-4365	1	257	of	of	ADP
fnp-4365	1	258	barcelona	barcelona	PROPN
fnp-4365	1	259	–	–	PUNCT
fnp-4365	1	260	university	university	PROPN
fnp-4365	1	261	of	of	ADP
fnp-4365	1	262	barcelona	barcelona	PROPN
fnp-4365	1	263	,	,	PUNCT
fnp-4365	1	264	barcelona	barcelona	PROPN
fnp-4365	1	265	,	,	PUNCT
fnp-4365	1	266	spain	spain	PROPN
fnp-4365	1	267	7	7	NUM
fnp-4365	1	268	immunology	immunology	NOUN
fnp-4365	1	269	department	department	NOUN
fnp-4365	1	270	,	,	PUNCT
fnp-4365	1	271	biomedical	biomedical	ADJ
fnp-4365	1	272	diagnostic	diagnostic	ADJ
fnp-4365	1	273	centre	centre	NOUN
fnp-4365	1	274	(	(	PUNCT
fnp-4365	1	275	cdb	cdb	PROPN
fnp-4365	1	276	)	)	PUNCT
fnp-4365	1	277	,	,	PUNCT
fnp-4365	1	278	hospital	hospital	NOUN
fnp-4365	1	279	clinic	clinic	NOUN
fnp-4365	1	280	of	of	ADP
fnp-4365	1	281	barcelona	barcelona	PROPN
fnp-4365	1	282	–	–	PUNCT
fnp-4365	1	283	university	university	PROPN
fnp-4365	1	284	of	of	ADP
fnp-4365	1	285	barcelona	barcelona	PROPN
fnp-4365	1	286	,	,	PUNCT
fnp-4365	1	287	barcelona	barcelona	PROPN
fnp-4365	1	288	,	,	PUNCT
fnp-4365	1	289	spain	spain	PROPN
fnp-4365	1	290	8	8	NUM
fnp-4365	1	291	august	august	PROPN
fnp-4365	1	292	pi	pi	PROPN
fnp-4365	1	293	sunyer	sunyer	PROPN
fnp-4365	1	294	biomedical	biomedical	PROPN
fnp-4365	1	295	research	research	PROPN
fnp-4365	1	296	institute	institute	PROPN
fnp-4365	1	297	(	(	PUNCT
fnp-4365	1	298	idibaps	idibap	NOUN
fnp-4365	1	299	)	)	PUNCT
fnp-4365	1	300	–	–	PUNCT
fnp-4365	1	301	university	university	NOUN
fnp-4365	1	302	of	of	ADP
fnp-4365	1	303	barcelona	barcelona	PROPN
fnp-4365	1	304	,	,	PUNCT
fnp-4365	1	305	barcelona	barcelona	PROPN
fnp-4365	1	306	,	,	PUNCT
fnp-4365	1	307	spain	spain	PROPN
fnp-4365	1	308	9	9	NUM
fnp-4365	1	309	neurological	neurological	ADJ
fnp-4365	1	310	tissue	tissue	NOUN
fnp-4365	1	311	bank	bank	NOUN
fnp-4365	1	312	,	,	PUNCT
fnp-4365	1	313	biobank	biobank	NOUN
fnp-4365	1	314	of	of	ADP
fnp-4365	1	315	hospital	hospital	NOUN
fnp-4365	1	316	clinic	clinic	NOUN
fnp-4365	1	317	of	of	ADP
fnp-4365	1	318	barcelona	barcelona	PROPN
fnp-4365	1	319	–	–	PUNCT
fnp-4365	1	320	idibaps	idibap	NOUN
fnp-4365	1	321	,	,	PUNCT
fnp-4365	1	322	barcelona	barcelona	PROPN
fnp-4365	1	323	,	,	PUNCT
fnp-4365	1	324	spain	spain	PROPN
fnp-4365	1	325	  	  	SPACE
fnp-4365	1	326	*	*	PUNCT
fnp-4365	2	1	these	these	DET
fnp-4365	2	2	authors	author	NOUN
fnp-4365	2	3	contributed	contribute	VERB
fnp-4365	2	4	equally	equally	ADV
fnp-4365	2	5	corresponding	corresponding	ADJ
fnp-4365	2	6	author	author	NOUN
fnp-4365	2	7	:	:	PUNCT
fnp-4365	2	8	iban	iban	PROPN
fnp-4365	2	9	aldecoa	aldecoa	PROPN
fnp-4365	2	10	ansorregui	ansorregui	PROPN
fnp-4365	2	11	·	·	PUNCT
fnp-4365	2	12	pathology	pathology	PROPN
fnp-4365	2	13	department	department	NOUN
fnp-4365	2	14	.	.	PUNCT
fnp-4365	3	1	3rd	3rd	ADJ
fnp-4365	3	2	stair	stair	NOUN
fnp-4365	3	3	,	,	PUNCT
fnp-4365	3	4	5th	5th	ADJ
fnp-4365	3	5	floor	floor	NOUN
fnp-4365	3	6	·	·	PUNCT
fnp-4365	3	7	hospital	hospital	NOUN
fnp-4365	3	8	clinic	clinic	NOUN
fnp-4365	3	9	of	of	ADP
fnp-4365	3	10	barcelona	barcelona	PROPN
fnp-4365	3	11	·	·	PUNCT
fnp-4365	3	12	st	st	PROPN
fnp-4365	3	13	.	.	PROPN
fnp-4365	3	14	villaroel	villaroel	PROPN
fnp-4365	3	15	170	170	NUM
fnp-4365	3	16	·	·	SYM
fnp-4365	3	17	08036	08036	NUM
fnp-4365	3	18	barcelona	barcelona	PROPN
fnp-4365	3	19	·	·	PUNCT
fnp-4365	4	1	spain	spain	PROPN
fnp-4365	4	2	ialdecoa@clinic.cat	ialdecoa@clinic.cat	PROPN
fnp-4365	4	3	submitted	submit	VERB
fnp-4365	4	4	:	:	PUNCT
fnp-4365	4	5	04	04	NUM
fnp-4365	4	6	august	august	PROPN
fnp-4365	4	7	2022	2022	NUM
fnp-4365	4	8	accepted	accept	VERB
fnp-4365	4	9	:	:	PUNCT
fnp-4365	4	10	20	20	NUM
fnp-4365	4	11	october	october	NOUN
fnp-4365	4	12	2022	2022	NUM
fnp-4365	4	13	copyedited	copyedit	VERB
fnp-4365	4	14	by	by	ADP
fnp-4365	4	15	:	:	PUNCT
fnp-4365	4	16	alessia	alessia	PROPN
fnp-4365	4	17	sciortino	sciortino	PROPN
fnp-4365	4	18	published	publish	VERB
fnp-4365	4	19	:	:	PUNCT
fnp-4365	4	20	27	27	NUM
fnp-4365	4	21	october	october	NOUN
fnp-4365	4	22	2022	2022	NUM
fnp-4365	4	23	https://doi.org/10.17879/freeneuropathology-2022-4365	https://doi.org/10.17879/freeneuropathology-2022-4365	PROPN
fnp-4365	4	24	keywords	keyword	NOUN
fnp-4365	4	25	:	:	PUNCT
fnp-4365	4	26	hematologic	hematologic	NOUN
fnp-4365	4	27	malignancies	malignancy	NOUN
fnp-4365	4	28	,	,	PUNCT
fnp-4365	4	29	chimeric	chimeric	ADJ
fnp-4365	4	30	antigen	antigen	ADJ
fnp-4365	4	31	receptor	receptor	NOUN
fnp-4365	4	32	(	(	PUNCT
fnp-4365	4	33	car	car	NOUN
fnp-4365	4	34	)	)	PUNCT
fnp-4365	4	35	t	t	NOUN
fnp-4365	4	36	-	-	PUNCT
fnp-4365	4	37	cell	cell	NOUN
fnp-4365	4	38	,	,	PUNCT
fnp-4365	4	39	cytokine	cytokine	ADJ
fnp-4365	4	40	release	release	NOUN
fnp-4365	4	41	syndrome	syndrome	NOUN
fnp-4365	4	42	(	(	PUNCT
fnp-4365	4	43	crs	crs	PROPN
fnp-4365	4	44	)	)	PUNCT
fnp-4365	4	45	,	,	PUNCT
fnp-4365	4	46	neurotoxicity	neurotoxicity	NOUN
fnp-4365	4	47	,	,	PUNCT
fnp-4365	4	48	neuropathology	neuropathology	NOUN
fnp-4365	4	49	,	,	PUNCT
fnp-4365	4	50	immunohistochemical	immunohistochemical	ADJ
fnp-4365	4	51	stains	stain	NOUN
fnp-4365	4	52	abstract	abstract	ADJ
fnp-4365	4	53	introduction	introduction	NOUN
fnp-4365	4	54	:	:	PUNCT
fnp-4365	4	55	chimeric	chimeric	ADJ
fnp-4365	4	56	antigen	antigen	ADJ
fnp-4365	4	57	receptor	receptor	NOUN
fnp-4365	4	58	(	(	PUNCT
fnp-4365	4	59	car	car	NOUN
fnp-4365	4	60	)	)	PUNCT
fnp-4365	4	61	t	t	NOUN
fnp-4365	4	62	-	-	PUNCT
fnp-4365	4	63	cell	cell	NOUN
fnp-4365	4	64	therapy	therapy	NOUN
fnp-4365	4	65	is	be	AUX
fnp-4365	4	66	a	a	DET
fnp-4365	4	67	promising	promising	ADJ
fnp-4365	4	68	immunotherapy	immunotherapy	NOUN
fnp-4365	4	69	for	for	ADP
fnp-4365	4	70	the	the	DET
fnp-4365	4	71	treatment	treatment	NOUN
fnp-4365	4	72	of	of	ADP
fnp-4365	4	73	refractory	refractory	NOUN
fnp-4365	4	74	hematopoietic	hematopoietic	ADJ
fnp-4365	4	75	malignancies	malignancy	NOUN
fnp-4365	4	76	.	.	PUNCT
fnp-4365	5	1	adverse	adverse	ADJ
fnp-4365	5	2	events	event	NOUN
fnp-4365	5	3	are	be	AUX
fnp-4365	5	4	common	common	ADJ
fnp-4365	5	5	,	,	PUNCT
fnp-4365	5	6	and	and	CCONJ
fnp-4365	5	7	neurotoxicity	neurotoxicity	NOUN
fnp-4365	5	8	is	be	AUX
fnp-4365	5	9	one	one	NUM
fnp-4365	5	10	of	of	ADP
fnp-4365	5	11	the	the	DET
fnp-4365	5	12	most	most	ADV
fnp-4365	5	13	important	important	ADJ
fnp-4365	5	14	.	.	PUNCT
fnp-4365	6	1	however	however	ADV
fnp-4365	6	2	,	,	PUNCT
fnp-4365	6	3	the	the	DET
fnp-4365	6	4	physiopathology	physiopathology	NOUN
fnp-4365	6	5	is	be	AUX
fnp-4365	6	6	unknown	unknown	ADJ
fnp-4365	6	7	and	and	CCONJ
fnp-4365	6	8	neuropathologic	neuropathologic	ADJ
fnp-4365	6	9	information	information	NOUN
fnp-4365	6	10	is	be	AUX
fnp-4365	6	11	scarce	scarce	ADJ
fnp-4365	6	12	.	.	PUNCT
fnp-4365	7	1	materials	material	NOUN
fnp-4365	7	2	and	and	CCONJ
fnp-4365	7	3	methods	method	NOUN
fnp-4365	7	4	:	:	PUNCT
fnp-4365	7	5	post	post	ADJ
fnp-4365	7	6	-	-	ADJ
fnp-4365	7	7	mortem	mortem	ADJ
fnp-4365	7	8	examination	examination	NOUN
fnp-4365	7	9	of	of	ADP
fnp-4365	7	10	6	6	NUM
fnp-4365	7	11	brains	brain	NOUN
fnp-4365	7	12	from	from	ADP
fnp-4365	7	13	patients	patient	NOUN
fnp-4365	7	14	that	that	PRON
fnp-4365	7	15	underwent	undergo	VERB
fnp-4365	7	16	car	car	NOUN
fnp-4365	7	17	t	t	NOUN
fnp-4365	7	18	-	-	PUNCT
fnp-4365	7	19	cell	cell	NOUN
fnp-4365	7	20	therapy	therapy	NOUN
fnp-4365	7	21	from	from	ADP
fnp-4365	7	22	2017	2017	NUM
fnp-4365	7	23	to	to	ADP
fnp-4365	7	24	2022	2022	NUM
fnp-4365	7	25	.	.	PUNCT
fnp-4365	8	1	in	in	ADP
fnp-4365	8	2	all	all	DET
fnp-4365	8	3	cases	case	NOUN
fnp-4365	8	4	,	,	PUNCT
fnp-4365	8	5	polymerase	polymerase	NOUN
fnp-4365	8	6	chain	chain	NOUN
fnp-4365	8	7	reaction	reaction	NOUN
fnp-4365	8	8	(	(	PUNCT
fnp-4365	8	9	pcr	pcr	NOUN
fnp-4365	8	10	)	)	PUNCT
fnp-4365	8	11	in	in	ADP
fnp-4365	8	12	paraffin	paraffin	NOUN
fnp-4365	8	13	blocks	block	NOUN
fnp-4365	8	14	for	for	ADP
fnp-4365	8	15	the	the	DET
fnp-4365	8	16	detection	detection	NOUN
fnp-4365	8	17	of	of	ADP
fnp-4365	8	18	car	car	NOUN
fnp-4365	8	19	t	t	NOUN
fnp-4365	8	20	cells	cell	NOUN
fnp-4365	8	21	was	be	AUX
fnp-4365	8	22	performed	perform	VERB
fnp-4365	8	23	.	.	PUNCT
fnp-4365	9	1	results	result	NOUN
fnp-4365	9	2	:	:	PUNCT
fnp-4365	9	3	two	two	NUM
fnp-4365	9	4	patients	patient	NOUN
fnp-4365	9	5	died	die	VERB
fnp-4365	9	6	of	of	ADP
fnp-4365	9	7	hematologic	hematologic	NOUN
fnp-4365	9	8	progression	progression	NOUN
fnp-4365	9	9	,	,	PUNCT
fnp-4365	9	10	while	while	SCONJ
fnp-4365	9	11	the	the	DET
fnp-4365	9	12	others	other	NOUN
fnp-4365	9	13	died	die	VERB
fnp-4365	9	14	of	of	ADP
fnp-4365	9	15	cytokine	cytokine	ADJ
fnp-4365	9	16	release	release	NOUN
fnp-4365	9	17	syndrome	syndrome	NOUN
fnp-4365	9	18	,	,	PUNCT
fnp-4365	9	19	lung	lung	NOUN
fnp-4365	9	20	infection	infection	NOUN
fnp-4365	9	21	,	,	PUNCT
fnp-4365	9	22	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	9	23	,	,	PUNCT
fnp-4365	9	24	and	and	CCONJ
fnp-4365	9	25	acute	acute	ADJ
fnp-4365	9	26	liver	liver	NOUN
fnp-4365	9	27	failure	failure	NOUN
fnp-4365	9	28	.	.	PUNCT
fnp-4365	10	1	two	two	NUM
fnp-4365	10	2	out	out	ADP
fnp-4365	10	3	of	of	ADP
fnp-4365	10	4	6	6	NUM
fnp-4365	10	5	presented	present	VERB
fnp-4365	10	6	neurological	neurological	ADJ
fnp-4365	10	7	symptoms	symptom	NOUN
fnp-4365	10	8	,	,	PUNCT
fnp-4365	10	9	one	one	NUM
fnp-4365	10	10	with	with	ADP
fnp-4365	10	11	extracranial	extracranial	ADJ
fnp-4365	10	12	malignancy	malignancy	NOUN
fnp-4365	10	13	progression	progression	NOUN
fnp-4365	10	14	and	and	CCONJ
fnp-4365	10	15	the	the	DET
fnp-4365	10	16	other	other	ADJ
fnp-4365	10	17	with	with	ADP
fnp-4365	10	18	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	10	19	.	.	PUNCT
fnp-4365	11	1	the	the	DET
fnp-4365	11	2	neuropathology	neuropathology	NOUN
fnp-4365	11	3	of	of	ADP
fnp-4365	11	4	the	the	DET
fnp-4365	11	5	latter	latter	ADJ
fnp-4365	11	6	showed	show	VERB
fnp-4365	11	7	severe	severe	ADJ
fnp-4365	11	8	perivascular	perivascular	ADJ
fnp-4365	11	9	and	and	CCONJ
fnp-4365	11	10	interstitial	interstitial	ADJ
fnp-4365	11	11	lymphocytic	lymphocytic	ADJ
fnp-4365	11	12	infiltration	infiltration	NOUN
fnp-4365	11	13	,	,	PUNCT
fnp-4365	11	14	predominantly	predominantly	ADV
fnp-4365	11	15	cd8	cd8	PROPN
fnp-4365	11	16	+	+	PROPN
fnp-4365	11	17	,	,	PUNCT
fnp-4365	11	18	together	together	ADV
fnp-4365	11	19	with	with	ADP
fnp-4365	11	20	a	a	DET
fnp-4365	11	21	diffuse	diffuse	ADJ
fnp-4365	11	22	interstitial	interstitial	ADJ
fnp-4365	11	23	histiocytic	histiocytic	ADJ
fnp-4365	11	24	infiltration	infiltration	NOUN
fnp-4365	11	25	,	,	PUNCT
fnp-4365	11	26	affecting	affect	VERB
fnp-4365	11	27	mainly	mainly	ADV
fnp-4365	11	28	the	the	DET
fnp-4365	11	29	spinal	spinal	ADJ
fnp-4365	11	30	cord	cord	NOUN
fnp-4365	11	31	,	,	PUNCT
fnp-4365	11	32	midbrain	midbrain	NOUN
fnp-4365	11	33	,	,	PUNCT
fnp-4365	11	34	and	and	CCONJ
fnp-4365	11	35	hippocampus	hippocampus	NOUN
fnp-4365	11	36	,	,	PUNCT
fnp-4365	11	37	and	and	CCONJ
fnp-4365	11	38	a	a	DET
fnp-4365	11	39	diffuse	diffuse	ADJ
fnp-4365	11	40	gliosis	gliosis	NOUN
fnp-4365	11	41	of	of	ADP
fnp-4365	11	42	basal	basal	ADJ
fnp-4365	11	43	ganglia	ganglia	NOUN
fnp-4365	11	44	,	,	PUNCT
fnp-4365	11	45	hippocampus	hippocampus	NOUN
fnp-4365	11	46	,	,	PUNCT
fnp-4365	11	47	and	and	CCONJ
fnp-4365	11	48	brainstem	brainstem	NOUN
fnp-4365	11	49	.	.	PUNCT
fnp-4365	12	1	microbiological	microbiological	ADJ
fnp-4365	12	2	studies	study	NOUN
fnp-4365	12	3	were	be	AUX
fnp-4365	12	4	negative	negative	ADJ
fnp-4365	12	5	for	for	ADP
fnp-4365	12	6	neurotropic	neurotropic	ADJ
fnp-4365	12	7	viruses	virus	NOUN
fnp-4365	12	8	,	,	PUNCT
fnp-4365	12	9	and	and	CCONJ
fnp-4365	12	10	pcr	pcr	PROPN
fnp-4365	12	11	failed	fail	VERB
fnp-4365	12	12	to	to	PART
fnp-4365	12	13	detect	detect	VERB
fnp-4365	12	14	car	car	NOUN
fnp-4365	12	15	t	t	NOUN
fnp-4365	12	16	-cells	-cell	NOUN
fnp-4365	12	17	.	.	PUNCT
fnp-4365	13	1	another	another	DET
fnp-4365	13	2	case	case	NOUN
fnp-4365	13	3	without	without	ADP
fnp-4365	13	4	detectable	detectable	ADJ
fnp-4365	13	5	neurological	neurological	ADJ
fnp-4365	13	6	signs	sign	NOUN
fnp-4365	13	7	showed	show	VERB
fnp-4365	13	8	cortical	cortical	ADJ
fnp-4365	13	9	and	and	CCONJ
fnp-4365	13	10	subcortical	subcortical	ADJ
fnp-4365	13	11	gliosis	gliosis	NOUN
fnp-4365	13	12	due	due	ADP
fnp-4365	13	13	to	to	ADP
fnp-4365	13	14	acute	acute	VERB
fnp-4365	13	15	hypoxic	hypoxic	ADJ
fnp-4365	13	16	-	-	PUNCT
fnp-4365	13	17	ischemic	ischemic	ADJ
fnp-4365	13	18	damage	damage	NOUN
fnp-4365	13	19	.	.	PUNCT
fnp-4365	14	1	the	the	DET
fnp-4365	14	2	remaining	remain	VERB
fnp-4365	14	3	4	4	NUM
fnp-4365	14	4	cases	case	NOUN
fnp-4365	14	5	only	only	ADV
fnp-4365	14	6	showed	show	VERB
fnp-4365	14	7	a	a	DET
fnp-4365	14	8	mild	mild	ADJ
fnp-4365	14	9	patchy	patchy	ADJ
fnp-4365	14	10	gliosis	gliosis	NOUN
fnp-4365	14	11	and	and	CCONJ
fnp-4365	14	12	microglial	microglial	ADJ
fnp-4365	14	13	activation	activation	NOUN
fnp-4365	14	14	,	,	PUNCT
fnp-4365	14	15	and	and	CCONJ
fnp-4365	14	16	car	car	NOUN
fnp-4365	14	17	t	t	NOUN
fnp-4365	14	18	cells	cell	NOUN
fnp-4365	14	19	were	be	AUX
fnp-4365	14	20	detected	detect	VERB
fnp-4365	14	21	by	by	ADP
fnp-4365	14	22	pcr	pcr	NOUN
fnp-4365	14	23	only	only	ADV
fnp-4365	14	24	in	in	ADP
fnp-4365	14	25	one	one	NUM
fnp-4365	14	26	of	of	ADP
fnp-4365	14	27	them	they	PRON
fnp-4365	14	28	.	.	PUNCT
fnp-4365	15	1	conclusions	conclusion	NOUN
fnp-4365	15	2	:	:	PUNCT
fnp-4365	15	3	in	in	ADP
fnp-4365	15	4	this	this	DET
fnp-4365	15	5	series	series	NOUN
fnp-4365	15	6	of	of	ADP
fnp-4365	15	7	patients	patient	NOUN
fnp-4365	15	8	that	that	PRON
fnp-4365	15	9	died	die	VERB
fnp-4365	15	10	after	after	ADP
fnp-4365	15	11	car	car	NOUN
fnp-4365	15	12	t	t	NOUN
fnp-4365	15	13	-	-	PUNCT
fnp-4365	15	14	cell	cell	NOUN
fnp-4365	15	15	therapy	therapy	NOUN
fnp-4365	15	16	,	,	PUNCT
fnp-4365	15	17	we	we	PRON
fnp-4365	15	18	predominantly	predominantly	ADV
fnp-4365	15	19	found	find	VERB
fnp-4365	15	20	non	non	ADJ
fnp-4365	15	21	-	-	ADJ
fnp-4365	15	22	specific	specific	ADJ
fnp-4365	15	23	or	or	CCONJ
fnp-4365	15	24	minimal	minimal	ADJ
fnp-4365	15	25	neuropathological	neuropathological	ADJ
fnp-4365	15	26	changes	change	NOUN
fnp-4365	15	27	.	.	PUNCT
fnp-4365	16	1	car	car	NOUN
fnp-4365	16	2	t	t	NOUN
fnp-4365	16	3	-	-	PUNCT
fnp-4365	16	4	cell	cell	NOUN
fnp-4365	16	5	related	relate	VERB
fnp-4365	16	6	toxicity	toxicity	NOUN
fnp-4365	16	7	may	may	AUX
fnp-4365	16	8	not	not	PART
fnp-4365	16	9	be	be	AUX
fnp-4365	16	10	the	the	DET
fnp-4365	16	11	only	only	ADJ
fnp-4365	16	12	cause	cause	NOUN
fnp-4365	16	13	of	of	ADP
fnp-4365	16	14	neurological	neurological	ADJ
fnp-4365	16	15	symptoms	symptom	NOUN
fnp-4365	16	16	,	,	PUNCT
fnp-4365	16	17	and	and	CCONJ
fnp-4365	16	18	the	the	DET
fnp-4365	16	19	autopsy	autopsy	NOUN
fnp-4365	16	20	could	could	AUX
fnp-4365	16	21	detect	detect	VERB
fnp-4365	16	22	additional	additional	ADJ
fnp-4365	16	23	pathological	pathological	ADJ
fnp-4365	16	24	findings	finding	NOUN
fnp-4365	16	25	.	.	PUNCT
fnp-4365	17	1	introduction	introduction	NOUN
fnp-4365	17	2	chimeric	chimeric	ADJ
fnp-4365	17	3	antigen	antigen	ADJ
fnp-4365	17	4	receptor	receptor	NOUN
fnp-4365	17	5	(	(	PUNCT
fnp-4365	17	6	car	car	NOUN
fnp-4365	17	7	)	)	PUNCT
fnp-4365	17	8	t	t	NOUN
fnp-4365	17	9	-	-	PUNCT
fnp-4365	17	10	cell	cell	NOUN
fnp-4365	17	11	therapy	therapy	NOUN
fnp-4365	17	12	is	be	AUX
fnp-4365	17	13	a	a	DET
fnp-4365	17	14	promising	promising	ADJ
fnp-4365	17	15	immunotherapy	immunotherapy	NOUN
fnp-4365	17	16	for	for	ADP
fnp-4365	17	17	the	the	DET
fnp-4365	17	18	treatment	treatment	NOUN
fnp-4365	17	19	of	of	ADP
fnp-4365	17	20	refractory	refractory	NOUN
fnp-4365	17	21	hematopoietic	hematopoietic	ADJ
fnp-4365	17	22	malignancies	malignancy	NOUN
fnp-4365	17	23	.	.	PUNCT
fnp-4365	18	1	normal	normal	ADJ
fnp-4365	18	2	and	and	CCONJ
fnp-4365	18	3	malignant	malignant	ADJ
fnp-4365	18	4	b	b	NOUN
fnp-4365	18	5	-	-	PUNCT
fnp-4365	18	6	cells	cell	NOUN
fnp-4365	18	7	express	express	VERB
fnp-4365	18	8	the	the	DET
fnp-4365	18	9	cd19	cd19	PROPN
fnp-4365	18	10	protein	protein	NOUN
fnp-4365	18	11	in	in	ADP
fnp-4365	18	12	the	the	DET
fnp-4365	18	13	cell	cell	NOUN
fnp-4365	18	14	membrane	membrane	NOUN
fnp-4365	18	15	.	.	PUNCT
fnp-4365	19	1	lymphodepletion	lymphodepletion	NOUN
fnp-4365	19	2	followed	follow	VERB
fnp-4365	19	3	by	by	ADP
fnp-4365	19	4	transfer	transfer	NOUN
fnp-4365	19	5	of	of	ADP
fnp-4365	19	6	autologous	autologous	ADJ
fnp-4365	19	7	t	t	PROPN
fnp-4365	19	8	-	-	PUNCT
fnp-4365	19	9	cells	cell	NOUN
fnp-4365	19	10	that	that	PRON
fnp-4365	19	11	have	have	AUX
fnp-4365	19	12	been	be	AUX
fnp-4365	19	13	genetically	genetically	ADV
fnp-4365	19	14	modified	modify	VERB
fnp-4365	19	15	to	to	PART
fnp-4365	19	16	express	express	VERB
fnp-4365	19	17	a	a	DET
fnp-4365	19	18	car	car	NOUN
fnp-4365	19	19	targeting	target	VERB
fnp-4365	19	20	cd19	cd19	PROPN
fnp-4365	19	21	have	have	AUX
fnp-4365	19	22	been	be	AUX
fnp-4365	19	23	effective	effective	ADJ
fnp-4365	19	24	in	in	ADP
fnp-4365	19	25	clinical	clinical	ADJ
fnp-4365	19	26	trials	trial	NOUN
fnp-4365	19	27	,	,	PUNCT
fnp-4365	19	28	producing	produce	VERB
fnp-4365	19	29	remission	remission	NOUN
fnp-4365	19	30	of	of	ADP
fnp-4365	19	31	refractory	refractory	NOUN
fnp-4365	19	32	or	or	CCONJ
fnp-4365	19	33	relapsed	relapse	VERB
fnp-4365	19	34	acute	acute	ADJ
fnp-4365	19	35	lymphoblastic	lymphoblastic	ADJ
fnp-4365	19	36	leukemia	leukemia	NOUN
fnp-4365	19	37	(	(	PUNCT
fnp-4365	19	38	all	all	ADV
fnp-4365	19	39	)	)	PUNCT
fnp-4365	19	40	,	,	PUNCT
fnp-4365	19	41	chronic	chronic	ADJ
fnp-4365	19	42	lymphocytic	lymphocytic	ADJ
fnp-4365	19	43	leukemia	leukemia	NOUN
fnp-4365	19	44	and	and	CCONJ
fnp-4365	19	45	non	non	ADJ
fnp-4365	19	46	-	-	ADJ
fnp-4365	19	47	hodgkin	hodgkin	ADJ
fnp-4365	19	48	’s	’s	PART
fnp-4365	19	49	lymphoma	lymphoma	NOUN
fnp-4365	19	50	(	(	PUNCT
fnp-4365	19	51	nhl)1–5	nhl)1–5	PROPN
fnp-4365	19	52	.	.	PUNCT
fnp-4365	20	1	recently	recently	ADV
fnp-4365	20	2	,	,	PUNCT
fnp-4365	20	3	bcma	bcma	PROPN
fnp-4365	20	4	targeted	target	VERB
fnp-4365	20	5	cars	car	NOUN
fnp-4365	20	6	have	have	AUX
fnp-4365	20	7	been	be	AUX
fnp-4365	20	8	used	use	VERB
fnp-4365	20	9	to	to	PART
fnp-4365	20	10	treat	treat	VERB
fnp-4365	20	11	multiple	multiple	ADJ
fnp-4365	20	12	myeloma6	myeloma6	NOUN
fnp-4365	20	13	.	.	PUNCT
fnp-4365	21	1	among	among	ADP
fnp-4365	21	2	toxic	toxic	ADJ
fnp-4365	21	3	effects	effect	NOUN
fnp-4365	21	4	expected	expect	VERB
fnp-4365	21	5	after	after	ADP
fnp-4365	21	6	lymphodepletion	lymphodepletion	NOUN
fnp-4365	21	7	and	and	CCONJ
fnp-4365	21	8	anti	anti	ADJ
fnp-4365	21	9	-	-	ADJ
fnp-4365	21	10	cd19	cd19	PROPN
fnp-4365	21	11	car	car	NOUN
fnp-4365	21	12	t	t	NOUN
fnp-4365	21	13	-	-	PUNCT
fnp-4365	21	14	cell	cell	NOUN
fnp-4365	21	15	infusion	infusion	NOUN
fnp-4365	21	16	,	,	PUNCT
fnp-4365	21	17	cytokine	cytokine	ADJ
fnp-4365	21	18	release	release	NOUN
fnp-4365	21	19	syndrome	syndrome	NOUN
fnp-4365	21	20	(	(	PUNCT
fnp-4365	21	21	crs	crs	PROPN
fnp-4365	21	22	)	)	PUNCT
fnp-4365	21	23	and	and	CCONJ
fnp-4365	21	24	neurotoxicity	neurotoxicity	NOUN
fnp-4365	21	25	are	be	AUX
fnp-4365	21	26	the	the	DET
fnp-4365	21	27	most	most	ADV
fnp-4365	21	28	relevant	relevant	ADJ
fnp-4365	21	29	but	but	CCONJ
fnp-4365	21	30	,	,	PUNCT
fnp-4365	21	31	unlike	unlike	ADP
fnp-4365	21	32	crs	crs	PROPN
fnp-4365	21	33	,	,	PUNCT
fnp-4365	21	34	the	the	DET
fnp-4365	21	35	physiopathology	physiopathology	NOUN
fnp-4365	21	36	of	of	ADP
fnp-4365	21	37	neurological	neurological	ADJ
fnp-4365	21	38	events	event	NOUN
fnp-4365	21	39	is	be	AUX
fnp-4365	21	40	less	less	ADV
fnp-4365	21	41	known	known	ADJ
fnp-4365	21	42	and	and	CCONJ
fnp-4365	21	43	neuropathologic	neuropathologic	ADJ
fnp-4365	21	44	information	information	NOUN
fnp-4365	21	45	is	be	AUX
fnp-4365	21	46	scarce7	scarce7	PROPN
fnp-4365	21	47	.	.	PUNCT
fnp-4365	22	1	clinical	clinical	ADJ
fnp-4365	22	2	presentation	presentation	NOUN
fnp-4365	22	3	develops	develop	VERB
fnp-4365	22	4	mostly	mostly	ADV
fnp-4365	22	5	as	as	ADP
fnp-4365	22	6	non	non	ADJ
fnp-4365	22	7	-	-	ADJ
fnp-4365	22	8	specific	specific	ADJ
fnp-4365	22	9	brain	brain	NOUN
fnp-4365	22	10	dysfunction	dysfunction	NOUN
fnp-4365	22	11	without	without	ADP
fnp-4365	22	12	focal	focal	ADJ
fnp-4365	22	13	signs	sign	NOUN
fnp-4365	22	14	,	,	PUNCT
fnp-4365	22	15	most	most	ADJ
fnp-4365	22	16	of	of	ADP
fnp-4365	22	17	them	they	PRON
fnp-4365	22	18	being	be	AUX
fnp-4365	22	19	mild	mild	ADJ
fnp-4365	22	20	and	and	CCONJ
fnp-4365	22	21	transient	transient	NOUN
fnp-4365	22	22	.	.	PUNCT
fnp-4365	23	1	nevertheless	nevertheless	ADV
fnp-4365	23	2	,	,	PUNCT
fnp-4365	23	3	focal	focal	ADJ
fnp-4365	23	4	symptoms	symptom	NOUN
fnp-4365	23	5	such	such	ADJ
fnp-4365	23	6	as	as	ADP
fnp-4365	23	7	seizures	seizure	NOUN
fnp-4365	23	8	and	and	CCONJ
fnp-4365	23	9	fatal	fatal	ADJ
fnp-4365	23	10	cerebral	cerebral	ADJ
fnp-4365	23	11	oedema	oedema	NOUN
fnp-4365	23	12	have	have	AUX
fnp-4365	23	13	been	be	AUX
fnp-4365	23	14	described	describe	VERB
fnp-4365	23	15	.	.	PUNCT
fnp-4365	24	1	neurotoxicity	neurotoxicity	NOUN
fnp-4365	24	2	can	can	AUX
fnp-4365	24	3	occur	occur	VERB
fnp-4365	24	4	in	in	ADP
fnp-4365	24	5	the	the	DET
fnp-4365	24	6	context	context	NOUN
fnp-4365	24	7	of	of	ADP
fnp-4365	24	8	severe	severe	ADJ
fnp-4365	24	9	crs	crs	PROPN
fnp-4365	24	10	,	,	PUNCT
fnp-4365	24	11	where	where	SCONJ
fnp-4365	24	12	disruption	disruption	NOUN
fnp-4365	24	13	of	of	ADP
fnp-4365	24	14	the	the	DET
fnp-4365	24	15	blood	blood	NOUN
fnp-4365	24	16	-	-	PUNCT
fnp-4365	24	17	brain	brain	NOUN
fnp-4365	24	18	barrier	barrier	NOUN
fnp-4365	24	19	(	(	PUNCT
fnp-4365	24	20	bbb	bbb	NOUN
fnp-4365	24	21	)	)	PUNCT
fnp-4365	24	22	by	by	ADP
fnp-4365	24	23	cytokine	cytokine	ADJ
fnp-4365	24	24	production	production	NOUN
fnp-4365	24	25	and	and	CCONJ
fnp-4365	24	26	subsequent	subsequent	ADJ
fnp-4365	24	27	endothelial	endothelial	ADJ
fnp-4365	24	28	activation	activation	NOUN
fnp-4365	24	29	leads	lead	VERB
fnp-4365	24	30	to	to	ADP
fnp-4365	24	31	an	an	DET
fnp-4365	24	32	increase	increase	NOUN
fnp-4365	24	33	in	in	ADP
fnp-4365	24	34	proinflammatory	proinflammatory	ADJ
fnp-4365	24	35	cytokine	cytokine	NOUN
fnp-4365	24	36	levels	level	NOUN
fnp-4365	24	37	in	in	ADP
fnp-4365	24	38	cerebrospinal	cerebrospinal	ADJ
fnp-4365	24	39	fluid	fluid	NOUN
fnp-4365	24	40	(	(	PUNCT
fnp-4365	24	41	csf)7–10	csf)7–10	NOUN
fnp-4365	24	42	.	.	PUNCT
fnp-4365	25	1	however	however	ADV
fnp-4365	25	2	,	,	PUNCT
fnp-4365	25	3	neurotoxicity	neurotoxicity	NOUN
fnp-4365	25	4	is	be	AUX
fnp-4365	25	5	also	also	ADV
fnp-4365	25	6	associated	associate	VERB
fnp-4365	25	7	with	with	ADP
fnp-4365	25	8	expansion	expansion	NOUN
fnp-4365	25	9	and	and	CCONJ
fnp-4365	25	10	activation	activation	NOUN
fnp-4365	25	11	of	of	ADP
fnp-4365	25	12	car	car	NOUN
fnp-4365	25	13	t	t	NOUN
fnp-4365	25	14	-	-	PUNCT
fnp-4365	25	15	cells	cell	NOUN
fnp-4365	25	16	that	that	PRON
fnp-4365	25	17	lead	lead	VERB
fnp-4365	25	18	to	to	ADP
fnp-4365	25	19	a	a	DET
fnp-4365	25	20	direct	direct	ADJ
fnp-4365	25	21	parenchymal	parenchymal	ADJ
fnp-4365	25	22	car	car	NOUN
fnp-4365	25	23	t	t	NOUN
fnp-4365	25	24	-	-	PUNCT
fnp-4365	25	25	cell	cell	NOUN
fnp-4365	25	26	infiltration	infiltration	NOUN
fnp-4365	25	27	.	.	PUNCT
fnp-4365	26	1	in	in	ADP
fnp-4365	26	2	addition	addition	NOUN
fnp-4365	26	3	to	to	ADP
fnp-4365	26	4	crs	crs	PROPN
fnp-4365	26	5	following	follow	VERB
fnp-4365	26	6	car	car	NOUN
fnp-4365	26	7	t	t	NOUN
fnp-4365	26	8	-	-	PUNCT
fnp-4365	26	9	cell	cell	NOUN
fnp-4365	26	10	infusion	infusion	NOUN
fnp-4365	26	11	,	,	PUNCT
fnp-4365	26	12	factors	factor	NOUN
fnp-4365	26	13	that	that	PRON
fnp-4365	26	14	favor	favor	VERB
fnp-4365	26	15	car	car	NOUN
fnp-4365	26	16	t	t	NOUN
fnp-4365	26	17	-	-	PUNCT
fnp-4365	26	18	cell	cell	NOUN
fnp-4365	26	19	proliferation	proliferation	NOUN
fnp-4365	26	20	in	in	ADP
fnp-4365	26	21	blood	blood	NOUN
fnp-4365	26	22	,	,	PUNCT
fnp-4365	26	23	such	such	ADJ
fnp-4365	26	24	as	as	ADP
fnp-4365	26	25	the	the	DET
fnp-4365	26	26	addition	addition	NOUN
fnp-4365	26	27	of	of	ADP
fnp-4365	26	28	fludarabine	fludarabine	NOUN
fnp-4365	26	29	to	to	PART
fnp-4365	26	30	cyclophosphamide	cyclophosphamide	VERB
fnp-4365	26	31	lymphodepletion	lymphodepletion	PROPN
fnp-4365	26	32	chemotherapy9	chemotherapy9	PROPN
fnp-4365	26	33	,	,	PUNCT
fnp-4365	26	34	are	be	AUX
fnp-4365	26	35	also	also	ADV
fnp-4365	26	36	associated	associate	VERB
fnp-4365	26	37	with	with	ADP
fnp-4365	26	38	an	an	DET
fnp-4365	26	39	increased	increase	VERB
fnp-4365	26	40	risk	risk	NOUN
fnp-4365	26	41	of	of	ADP
fnp-4365	26	42	neurotoxicity	neurotoxicity	NOUN
fnp-4365	26	43	.	.	PUNCT
fnp-4365	27	1	fludarabine	fludarabine	PROPN
fnp-4365	27	2	is	be	AUX
fnp-4365	27	3	a	a	DET
fnp-4365	27	4	antineoplastic	antineoplastic	ADJ
fnp-4365	27	5	agent	agent	NOUN
fnp-4365	27	6	that	that	PRON
fnp-4365	27	7	added	add	VERB
fnp-4365	27	8	to	to	ADP
fnp-4365	27	9	the	the	DET
fnp-4365	27	10	conditioning	conditioning	NOUN
fnp-4365	27	11	regimens	regimen	NOUN
fnp-4365	27	12	improves	improve	VERB
fnp-4365	27	13	the	the	DET
fnp-4365	27	14	expansion	expansion	NOUN
fnp-4365	27	15	and	and	CCONJ
fnp-4365	27	16	persistence	persistence	NOUN
fnp-4365	27	17	of	of	ADP
fnp-4365	27	18	car	car	NOUN
fnp-4365	27	19	t	t	NOUN
fnp-4365	27	20	-	-	PUNCT
fnp-4365	27	21	cells	cell	NOUN
fnp-4365	27	22	,	,	PUNCT
fnp-4365	27	23	as	as	ADV
fnp-4365	27	24	well	well	ADV
fnp-4365	27	25	as	as	ADP
fnp-4365	27	26	duration	duration	NOUN
fnp-4365	27	27	of	of	ADP
fnp-4365	27	28	remission	remission	NOUN
fnp-4365	27	29	and	and	CCONJ
fnp-4365	27	30	disease	disease	NOUN
fnp-4365	27	31	-	-	PUNCT
fnp-4365	27	32	free	free	ADJ
fnp-4365	27	33	survival2,4,5	survival2,4,5	NOUN
fnp-4365	27	34	.	.	PUNCT
fnp-4365	28	1	its	its	PRON
fnp-4365	28	2	contribution	contribution	NOUN
fnp-4365	28	3	to	to	ADP
fnp-4365	28	4	neurotoxicity	neurotoxicity	NOUN
fnp-4365	28	5	may	may	AUX
fnp-4365	28	6	be	be	AUX
fnp-4365	28	7	driven	drive	VERB
fnp-4365	28	8	by	by	ADP
fnp-4365	28	9	different	different	ADJ
fnp-4365	28	10	mechanisms	mechanism	NOUN
fnp-4365	28	11	,	,	PUNCT
fnp-4365	28	12	and	and	CCONJ
fnp-4365	28	13	is	be	AUX
fnp-4365	28	14	yet	yet	ADV
fnp-4365	28	15	to	to	PART
fnp-4365	28	16	be	be	AUX
fnp-4365	28	17	elucidated	elucidate	VERB
fnp-4365	28	18	.	.	PUNCT
fnp-4365	29	1	however	however	ADV
fnp-4365	29	2	,	,	PUNCT
fnp-4365	29	3	fludarabine	fludarabine	NOUN
fnp-4365	29	4	-	-	PUNCT
fnp-4365	29	5	associated	associate	VERB
fnp-4365	29	6	neurotoxicity	neurotoxicity	NOUN
fnp-4365	29	7	has	have	VERB
fnp-4365	29	8	a	a	DET
fnp-4365	29	9	later	later	ADJ
fnp-4365	29	10	onset	onset	NOUN
fnp-4365	29	11	,	,	PUNCT
fnp-4365	29	12	and	and	CCONJ
fnp-4365	29	13	cerebral	cerebral	ADJ
fnp-4365	29	14	oedema	oedema	NOUN
fnp-4365	29	15	is	be	AUX
fnp-4365	29	16	not	not	PART
fnp-4365	29	17	usually	usually	ADV
fnp-4365	29	18	reported11	reported11	NOUN
fnp-4365	29	19	.	.	PUNCT
fnp-4365	30	1	reports	report	NOUN
fnp-4365	30	2	of	of	ADP
fnp-4365	30	3	neuropathological	neuropathological	ADJ
fnp-4365	30	4	findings	finding	NOUN
fnp-4365	30	5	after	after	SCONJ
fnp-4365	30	6	car	car	NOUN
fnp-4365	30	7	t	t	NOUN
fnp-4365	30	8	-	-	PUNCT
fnp-4365	30	9	cell	cell	NOUN
fnp-4365	30	10	therapy	therapy	NOUN
fnp-4365	30	11	are	be	AUX
fnp-4365	30	12	scarce	scarce	ADJ
fnp-4365	30	13	,	,	PUNCT
fnp-4365	30	14	independent	independent	ADJ
fnp-4365	30	15	of	of	ADP
fnp-4365	30	16	the	the	DET
fnp-4365	30	17	presence	presence	NOUN
fnp-4365	30	18	or	or	CCONJ
fnp-4365	30	19	absence	absence	NOUN
fnp-4365	30	20	of	of	ADP
fnp-4365	30	21	neurological	neurological	ADJ
fnp-4365	30	22	symptoms	symptom	NOUN
fnp-4365	30	23	prior	prior	ADV
fnp-4365	30	24	to	to	ADP
fnp-4365	30	25	death	death	NOUN
fnp-4365	30	26	.	.	PUNCT
fnp-4365	31	1	we	we	PRON
fnp-4365	31	2	only	only	ADV
fnp-4365	31	3	found	find	VERB
fnp-4365	31	4	4	4	NUM
fnp-4365	31	5	cases	case	NOUN
fnp-4365	31	6	described	describe	VERB
fnp-4365	31	7	in	in	ADP
fnp-4365	31	8	the	the	DET
fnp-4365	31	9	literature	literature	NOUN
fnp-4365	31	10	,	,	PUNCT
fnp-4365	31	11	which	which	PRON
fnp-4365	31	12	showed	show	VERB
fnp-4365	31	13	variable	variable	ADJ
fnp-4365	31	14	and	and	CCONJ
fnp-4365	31	15	non	non	ADJ
fnp-4365	31	16	-	-	ADJ
fnp-4365	31	17	specific	specific	ADJ
fnp-4365	31	18	neuropathological	neuropathological	ADJ
fnp-4365	31	19	changes7–10	changes7–10	NOUN
fnp-4365	31	20	.	.	PUNCT
fnp-4365	32	1	here	here	ADV
fnp-4365	32	2	,	,	PUNCT
fnp-4365	32	3	we	we	PRON
fnp-4365	32	4	report	report	VERB
fnp-4365	32	5	detailed	detailed	ADJ
fnp-4365	32	6	neuropathological	neuropathological	ADJ
fnp-4365	32	7	findings	finding	NOUN
fnp-4365	32	8	of	of	ADP
fnp-4365	32	9	6	6	NUM
fnp-4365	32	10	patients	patient	NOUN
fnp-4365	32	11	who	who	PRON
fnp-4365	32	12	died	die	VERB
fnp-4365	32	13	after	after	ADP
fnp-4365	32	14	car	car	NOUN
fnp-4365	32	15	t	t	NOUN
fnp-4365	32	16	-	-	PUNCT
fnp-4365	32	17	cell	cell	NOUN
fnp-4365	32	18	therapy12	therapy12	NOUN
fnp-4365	32	19	.	.	PUNCT
fnp-4365	33	1	materials	material	NOUN
fnp-4365	33	2	and	and	CCONJ
fnp-4365	33	3	methods	method	NOUN
fnp-4365	33	4	six	six	NUM
fnp-4365	33	5	brains	brain	NOUN
fnp-4365	33	6	from	from	ADP
fnp-4365	33	7	patients	patient	NOUN
fnp-4365	33	8	that	that	PRON
fnp-4365	33	9	underwent	undergo	VERB
fnp-4365	33	10	car	car	NOUN
fnp-4365	33	11	t	t	NOUN
fnp-4365	33	12	-	-	PUNCT
fnp-4365	33	13	cell	cell	NOUN
fnp-4365	33	14	therapy	therapy	NOUN
fnp-4365	33	15	from	from	ADP
fnp-4365	33	16	2017	2017	NUM
fnp-4365	33	17	to	to	ADP
fnp-4365	33	18	2022	2022	NUM
fnp-4365	33	19	in	in	ADP
fnp-4365	33	20	a	a	DET
fnp-4365	33	21	tertiary	tertiary	ADJ
fnp-4365	33	22	university	university	NOUN
fnp-4365	33	23	hospital	hospital	NOUN
fnp-4365	33	24	were	be	AUX
fnp-4365	33	25	examined	examine	VERB
fnp-4365	33	26	.	.	PUNCT
fnp-4365	34	1	we	we	PRON
fnp-4365	34	2	selected	select	VERB
fnp-4365	34	3	all	all	DET
fnp-4365	34	4	cases	case	NOUN
fnp-4365	34	5	with	with	ADP
fnp-4365	34	6	car	car	NOUN
fnp-4365	34	7	t	t	NOUN
fnp-4365	34	8	-	-	PUNCT
fnp-4365	34	9	cell	cell	NOUN
fnp-4365	34	10	therapy	therapy	NOUN
fnp-4365	34	11	from	from	ADP
fnp-4365	34	12	requested	request	VERB
fnp-4365	34	13	medical	medical	ADJ
fnp-4365	34	14	autopsies	autopsy	NOUN
fnp-4365	34	15	at	at	ADP
fnp-4365	34	16	the	the	DET
fnp-4365	34	17	pathology	pathology	PROPN
fnp-4365	34	18	department	department	NOUN
fnp-4365	34	19	during	during	ADP
fnp-4365	34	20	this	this	DET
fnp-4365	34	21	period	period	NOUN
fnp-4365	34	22	.	.	PUNCT
fnp-4365	35	1	patients	patient	NOUN
fnp-4365	35	2	received	receive	VERB
fnp-4365	35	3	ari-0001	ari-0001	NOUN
fnp-4365	35	4	(	(	PUNCT
fnp-4365	35	5	anti	anti	ADJ
fnp-4365	35	6	-	-	ADJ
fnp-4365	35	7	cd19	cd19	PROPN
fnp-4365	35	8	)	)	PUNCT
fnp-4365	35	9	and	and	CCONJ
fnp-4365	35	10	ari-0002h	ari-0002h	NUM
fnp-4365	35	11	(	(	PUNCT
fnp-4365	35	12	anti	anti	ADJ
fnp-4365	35	13	-	-	ADJ
fnp-4365	35	14	bcma	bcma	ADJ
fnp-4365	35	15	,	,	PUNCT
fnp-4365	35	16	for	for	ADP
fnp-4365	35	17	patients	patient	NOUN
fnp-4365	35	18	with	with	ADP
fnp-4365	35	19	multiple	multiple	ADJ
fnp-4365	35	20	myeloma	myeloma	NOUN
fnp-4365	35	21	)	)	PUNCT
fnp-4365	35	22	based	base	VERB
fnp-4365	35	23	car	car	NOUN
fnp-4365	35	24	t	t	NOUN
fnp-4365	35	25	treatment	treatment	NOUN
fnp-4365	35	26	.	.	PUNCT
fnp-4365	36	1	for	for	ADP
fnp-4365	36	2	ari-0001	ari-0001	NOUN
fnp-4365	36	3	,	,	PUNCT
fnp-4365	36	4	the	the	DET
fnp-4365	36	5	planned	plan	VERB
fnp-4365	36	6	target	target	NOUN
fnp-4365	36	7	cell	cell	NOUN
fnp-4365	36	8	dose	dose	VERB
fnp-4365	36	9	varied	varied	ADJ
fnp-4365	36	10	depending	depend	VERB
fnp-4365	36	11	on	on	ADP
fnp-4365	36	12	the	the	DET
fnp-4365	36	13	patient	patient	NOUN
fnp-4365	36	14	's	's	PART
fnp-4365	36	15	disease	disease	NOUN
fnp-4365	36	16	:	:	PUNCT
fnp-4365	36	17	typically	typically	ADV
fnp-4365	36	18	,	,	PUNCT
fnp-4365	36	19	1	1	NUM
fnp-4365	36	20	×	×	NOUN
fnp-4365	36	21	106	106	NUM
fnp-4365	36	22	ari-0001	ari-0001	NOUN
fnp-4365	36	23	cells	cell	NOUN
fnp-4365	36	24	/	/	SYM
fnp-4365	36	25	kg	kg	PROPN
fnp-4365	36	26	for	for	ADP
fnp-4365	36	27	patients	patient	NOUN
fnp-4365	36	28	with	with	ADP
fnp-4365	36	29	acute	acute	ADJ
fnp-4365	36	30	lymphoblastic	lymphoblastic	ADJ
fnp-4365	36	31	leukemia	leukemia	NOUN
fnp-4365	36	32	and	and	CCONJ
fnp-4365	36	33	chronic	chronic	ADJ
fnp-4365	36	34	lymphocytic	lymphocytic	ADJ
fnp-4365	36	35	leukemia	leukemia	NOUN
fnp-4365	36	36	;	;	PUNCT
fnp-4365	36	37	and	and	CCONJ
fnp-4365	36	38	5	5	NUM
fnp-4365	36	39	×	×	NOUN
fnp-4365	36	40	106	106	NUM
fnp-4365	36	41	ari-0001	ari-0001	NOUN
fnp-4365	36	42	cells	cell	NOUN
fnp-4365	36	43	/	/	SYM
fnp-4365	36	44	kg	kg	PROPN
fnp-4365	36	45	for	for	ADP
fnp-4365	36	46	non	non	ADJ
fnp-4365	36	47	-	-	ADJ
fnp-4365	36	48	hodgkin	hodgkin	ADJ
fnp-4365	36	49	lymphoma	lymphoma	NOUN
fnp-4365	36	50	patients	patient	NOUN
fnp-4365	36	51	.	.	PUNCT
fnp-4365	37	1	full	full	ADJ
fnp-4365	37	2	details	detail	NOUN
fnp-4365	37	3	of	of	ADP
fnp-4365	37	4	ari-0001	ari-0001	NOUN
fnp-4365	37	5	and	and	CCONJ
fnp-4365	37	6	ari-0002h	ari-0002h	NOUN
fnp-4365	37	7	cell	cell	NOUN
fnp-4365	37	8	production	production	NOUN
fnp-4365	37	9	and	and	CCONJ
fnp-4365	37	10	a	a	DET
fnp-4365	37	11	phenotypic	phenotypic	ADJ
fnp-4365	37	12	characterization	characterization	NOUN
fnp-4365	37	13	of	of	ADP
fnp-4365	37	14	these	these	DET
fnp-4365	37	15	cells	cell	NOUN
fnp-4365	37	16	can	can	AUX
fnp-4365	37	17	be	be	AUX
fnp-4365	37	18	found	find	VERB
fnp-4365	37	19	elsewhere6,12–14	elsewhere6,12–14	PROPN
fnp-4365	37	20	.	.	PUNCT
fnp-4365	38	1	clinical	clinical	ADJ
fnp-4365	38	2	data	datum	NOUN
fnp-4365	38	3	was	be	AUX
fnp-4365	38	4	retrospectively	retrospectively	ADV
fnp-4365	38	5	retrieved	retrieve	VERB
fnp-4365	38	6	from	from	ADP
fnp-4365	38	7	the	the	DET
fnp-4365	38	8	electronic	electronic	ADJ
fnp-4365	38	9	medical	medical	ADJ
fnp-4365	38	10	records	record	NOUN
fnp-4365	38	11	.	.	PUNCT
fnp-4365	39	1	formalin	formalin	NOUN
fnp-4365	39	2	-	-	PUNCT
fnp-4365	39	3	fixed	fix	VERB
fnp-4365	39	4	and	and	CCONJ
fnp-4365	39	5	paraffin	paraffin	NOUN
fnp-4365	39	6	-	-	PUNCT
fnp-4365	39	7	embedded	embed	VERB
fnp-4365	39	8	tissue	tissue	NOUN
fnp-4365	39	9	sections	section	NOUN
fnp-4365	39	10	from	from	ADP
fnp-4365	39	11	the	the	DET
fnp-4365	39	12	frontal	frontal	ADJ
fnp-4365	39	13	cortex	cortex	NOUN
fnp-4365	39	14	,	,	PUNCT
fnp-4365	39	15	visual	visual	ADJ
fnp-4365	39	16	cortex	cortex	NOUN
fnp-4365	39	17	,	,	PUNCT
fnp-4365	39	18	cingulate	cingulate	NOUN
fnp-4365	39	19	,	,	PUNCT
fnp-4365	39	20	hippocampus	hippocampus	NOUN
fnp-4365	39	21	,	,	PUNCT
fnp-4365	39	22	amygdala	amygdala	NOUN
fnp-4365	39	23	,	,	PUNCT
fnp-4365	39	24	thalamus	thalamus	NOUN
fnp-4365	39	25	,	,	PUNCT
fnp-4365	39	26	basal	basal	ADJ
fnp-4365	39	27	ganglia	ganglia	NOUN
fnp-4365	39	28	,	,	PUNCT
fnp-4365	39	29	white	white	ADJ
fnp-4365	39	30	matter	matter	NOUN
fnp-4365	39	31	,	,	PUNCT
fnp-4365	39	32	midbrain	midbrain	NOUN
fnp-4365	39	33	,	,	PUNCT
fnp-4365	39	34	pons	pon	NOUN
fnp-4365	39	35	,	,	PUNCT
fnp-4365	39	36	medulla	medulla	NOUN
fnp-4365	39	37	oblongata	oblongata	NOUN
fnp-4365	39	38	,	,	PUNCT
fnp-4365	39	39	spinal	spinal	ADJ
fnp-4365	39	40	cord	cord	NOUN
fnp-4365	39	41	and	and	CCONJ
fnp-4365	39	42	cerebellum	cerebellum	NOUN
fnp-4365	39	43	that	that	PRON
fnp-4365	39	44	had	have	AUX
fnp-4365	39	45	been	be	AUX
fnp-4365	39	46	stained	stain	VERB
fnp-4365	39	47	with	with	ADP
fnp-4365	39	48	hematoxylin	hematoxylin	NOUN
fnp-4365	39	49	-	-	PUNCT
fnp-4365	39	50	eosin	eosin	NOUN
fnp-4365	39	51	(	(	PUNCT
fnp-4365	39	52	he	he	PRON
fnp-4365	39	53	)	)	PUNCT
fnp-4365	39	54	were	be	AUX
fnp-4365	39	55	histologically	histologically	ADV
fnp-4365	39	56	assessed	assess	VERB
fnp-4365	39	57	using	use	VERB
fnp-4365	39	58	light	light	ADJ
fnp-4365	39	59	microscopy	microscopy	NOUN
fnp-4365	39	60	.	.	PUNCT
fnp-4365	40	1	in	in	ADP
fnp-4365	40	2	some	some	PRON
fnp-4365	40	3	of	of	ADP
fnp-4365	40	4	the	the	DET
fnp-4365	40	5	cases	case	NOUN
fnp-4365	40	6	the	the	DET
fnp-4365	40	7	study	study	NOUN
fnp-4365	40	8	was	be	AUX
fnp-4365	40	9	extended	extend	VERB
fnp-4365	40	10	with	with	ADP
fnp-4365	40	11	immunohistochemistry	immunohistochemistry	NOUN
fnp-4365	40	12	(	(	PUNCT
fnp-4365	40	13	ihc	ihc	PROPN
fnp-4365	40	14	)	)	PUNCT
fnp-4365	40	15	.	.	PUNCT
fnp-4365	41	1	ihc	ihc	PROPN
fnp-4365	41	2	was	be	AUX
fnp-4365	41	3	performed	perform	VERB
fnp-4365	41	4	on	on	ADP
fnp-4365	41	5	5-µm	5-µm	NUM
fnp-4365	41	6	formalin	formalin	NOUN
fnp-4365	41	7	-	-	PUNCT
fnp-4365	41	8	fixed	fix	VERB
fnp-4365	41	9	,	,	PUNCT
fnp-4365	41	10	paraffin	paraffin	NOUN
fnp-4365	41	11	-	-	PUNCT
fnp-4365	41	12	embedded	embed	VERB
fnp-4365	41	13	(	(	PUNCT
fnp-4365	41	14	ffpe	ffpe	NOUN
fnp-4365	41	15	)	)	PUNCT
fnp-4365	41	16	sections	section	NOUN
fnp-4365	41	17	using	use	VERB
fnp-4365	41	18	the	the	DET
fnp-4365	41	19	roche	roche	PROPN
fnp-4365	41	20	benchmark	benchmark	NOUN
fnp-4365	41	21	ultra	ultra	ADJ
fnp-4365	41	22	platform	platform	NOUN
fnp-4365	41	23	with	with	ADP
fnp-4365	41	24	usual	usual	ADJ
fnp-4365	41	25	antigen	antigen	ADJ
fnp-4365	41	26	retrieval	retrieval	NOUN
fnp-4365	41	27	protocols	protocol	NOUN
fnp-4365	41	28	.	.	PUNCT
fnp-4365	42	1	the	the	DET
fnp-4365	42	2	primary	primary	ADJ
fnp-4365	42	3	antibodies	antibody	NOUN
fnp-4365	42	4	used	use	VERB
fnp-4365	42	5	were	be	AUX
fnp-4365	42	6	cd3	cd3	VERB
fnp-4365	42	7	(	(	PUNCT
fnp-4365	42	8	2gv6	2gv6	NUM
fnp-4365	42	9	,	,	PUNCT
fnp-4365	42	10	roche	roche	NOUN
fnp-4365	42	11	)	)	PUNCT
fnp-4365	42	12	,	,	PUNCT
fnp-4365	43	1	cd20	cd20	PROPN
fnp-4365	43	2	(	(	PUNCT
fnp-4365	43	3	l26	l26	PROPN
fnp-4365	43	4	,	,	PUNCT
fnp-4365	43	5	roche	roche	NOUN
fnp-4365	43	6	)	)	PUNCT
fnp-4365	43	7	,	,	PUNCT
fnp-4365	43	8	cd4	cd4	PROPN
fnp-4365	43	9	(	(	PUNCT
fnp-4365	43	10	sp35	sp35	PROPN
fnp-4365	43	11	,	,	PUNCT
fnp-4365	43	12	roche	roche	NOUN
fnp-4365	43	13	)	)	PUNCT
fnp-4365	43	14	,	,	PUNCT
fnp-4365	43	15	cd68	cd68	PROPN
fnp-4365	43	16	(	(	PUNCT
fnp-4365	43	17	kp-1	kp-1	PROPN
fnp-4365	43	18	,	,	PUNCT
fnp-4365	43	19	roche	roche	NOUN
fnp-4365	43	20	)	)	PUNCT
fnp-4365	43	21	,	,	PUNCT
fnp-4365	43	22	glial	glial	ADJ
fnp-4365	43	23	fibrillary	fibrillary	ADJ
fnp-4365	43	24	acidic	acidic	ADJ
fnp-4365	43	25	protein	protein	NOUN
fnp-4365	43	26	(	(	PUNCT
fnp-4365	43	27	gfap	gfap	ADJ
fnp-4365	43	28	)	)	PUNCT
fnp-4365	43	29	(	(	PUNCT
fnp-4365	43	30	ep672y	ep672y	PROPN
fnp-4365	43	31	,	,	PUNCT
fnp-4365	43	32	roche	roche	NOUN
fnp-4365	43	33	)	)	PUNCT
fnp-4365	43	34	,	,	PUNCT
fnp-4365	43	35	terminal	terminal	ADJ
fnp-4365	43	36	deoxynucleotidyl	deoxynucleotidyl	NOUN
fnp-4365	43	37	transferase	transferase	NOUN
fnp-4365	43	38	(	(	PUNCT
fnp-4365	43	39	tdt	tdt	PROPN
fnp-4365	43	40	)	)	PUNCT
fnp-4365	43	41	(	(	PUNCT
fnp-4365	43	42	roche	roche	NOUN
fnp-4365	43	43	)	)	PUNCT
fnp-4365	43	44	,	,	PUNCT
fnp-4365	43	45	beta	beta	NOUN
fnp-4365	43	46	amyloid	amyloid	NOUN
fnp-4365	43	47	(	(	PUNCT
fnp-4365	43	48	de2b4	de2b4	NOUN
fnp-4365	43	49	,	,	PUNCT
fnp-4365	43	50	roche	roche	NOUN
fnp-4365	43	51	)	)	PUNCT
fnp-4365	43	52	,	,	PUNCT
fnp-4365	43	53	tau	tau	PROPN
fnp-4365	43	54	(	(	PUNCT
fnp-4365	43	55	at8	at8	PROPN
fnp-4365	43	56	,	,	PUNCT
fnp-4365	43	57	thermo	thermo	NOUN
fnp-4365	43	58	-	-	PUNCT
fnp-4365	43	59	fisher	fisher	PROPN
fnp-4365	43	60	scientific	scientific	NOUN
fnp-4365	43	61	)	)	PUNCT
fnp-4365	43	62	,	,	PUNCT
fnp-4365	43	63	neurofilament	neurofilament	NOUN
fnp-4365	43	64	(	(	PUNCT
fnp-4365	43	65	2f11	2f11	NOUN
fnp-4365	43	66	,	,	PUNCT
fnp-4365	43	67	roche	roche	NOUN
fnp-4365	43	68	)	)	PUNCT
fnp-4365	43	69	,	,	PUNCT
fnp-4365	43	70	herpes	herpe	NOUN
fnp-4365	43	71	simplex	simplex	NOUN
fnp-4365	43	72	virus	virus	NOUN
fnp-4365	43	73	(	(	PUNCT
fnp-4365	43	74	hsv)-1	hsv)-1	NOUN
fnp-4365	43	75	(	(	PUNCT
fnp-4365	43	76	10a3	10a3	NUM
fnp-4365	43	77	,	,	PUNCT
fnp-4365	43	78	roche	roche	NOUN
fnp-4365	43	79	)	)	PUNCT
fnp-4365	43	80	,	,	PUNCT
fnp-4365	43	81	hsv2	hsv2	PROPN
fnp-4365	43	82	(	(	PUNCT
fnp-4365	43	83	dbm15.69	dbm15.69	NOUN
fnp-4365	43	84	,	,	PUNCT
fnp-4365	43	85	sanbio	sanbio	NOUN
fnp-4365	43	86	)	)	PUNCT
fnp-4365	43	87	,	,	PUNCT
fnp-4365	43	88	human	human	ADJ
fnp-4365	43	89	herpes	herpe	NOUN
fnp-4365	43	90	virus	virus	NOUN
fnp-4365	43	91	(	(	PUNCT
fnp-4365	43	92	hhv)-6	hhv)-6	NOUN
fnp-4365	43	93	(	(	PUNCT
fnp-4365	43	94	a	a	PRON
fnp-4365	43	95	&	&	CCONJ
fnp-4365	43	96	b	b	NOUN
fnp-4365	43	97	,	,	PUNCT
fnp-4365	43	98	gp	gp	NOUN
fnp-4365	43	99	60/110	60/110	NUM
fnp-4365	43	100	,	,	PUNCT
fnp-4365	43	101	millipore	millipore	PROPN
fnp-4365	43	102	)	)	PUNCT
fnp-4365	43	103	,	,	PUNCT
fnp-4365	43	104	hhv-8	hhv-8	PUNCT
fnp-4365	43	105	(	(	PUNCT
fnp-4365	43	106	13b10	13b10	NUM
fnp-4365	43	107	,	,	PUNCT
fnp-4365	43	108	roche	roche	NOUN
fnp-4365	43	109	)	)	PUNCT
fnp-4365	43	110	,	,	PUNCT
fnp-4365	43	111	cytomegalovirus	cytomegalovirus	NOUN
fnp-4365	43	112	(	(	PUNCT
fnp-4365	43	113	cmv	cmv	PROPN
fnp-4365	43	114	)	)	PUNCT
fnp-4365	43	115	(	(	PUNCT
fnp-4365	43	116	8b1.2	8b1.2	NUM
fnp-4365	43	117	,	,	PUNCT
fnp-4365	43	118	1g5.2	1g5.2	NUM
fnp-4365	43	119	,	,	PUNCT
fnp-4365	43	120	and	and	CCONJ
fnp-4365	43	121	2d4.2	2d4.2	NUM
fnp-4365	43	122	,	,	PUNCT
fnp-4365	43	123	roche	roche	NOUN
fnp-4365	43	124	)	)	PUNCT
fnp-4365	43	125	,	,	PUNCT
fnp-4365	43	126	epstein	epstein	PROPN
fnp-4365	43	127	-	-	PUNCT
fnp-4365	43	128	barr	barr	PROPN
fnp-4365	43	129	virus	virus	PROPN
fnp-4365	43	130	(	(	PUNCT
fnp-4365	43	131	ebv	ebv	NOUN
fnp-4365	43	132	)	)	PUNCT
fnp-4365	43	133	latent	latent	NOUN
fnp-4365	43	134	membrane	membrane	NOUN
fnp-4365	43	135	protein	protein	NOUN
fnp-4365	43	136	(	(	PUNCT
fnp-4365	43	137	lmp)-1	lmp)-1	ADJ
fnp-4365	43	138	(	(	PUNCT
fnp-4365	43	139	cs1	cs1	NOUN
fnp-4365	43	140	-	-	PUNCT
fnp-4365	43	141	4	4	NUM
fnp-4365	43	142	,	,	PUNCT
fnp-4365	43	143	roche	roche	NOUN
fnp-4365	43	144	)	)	PUNCT
fnp-4365	43	145	,	,	PUNCT
fnp-4365	43	146	epstein	epstein	PROPN
fnp-4365	43	147	-	-	PUNCT
fnp-4365	43	148	barr	barr	PROPN
fnp-4365	43	149	virus	virus	PROPN
fnp-4365	43	150	(	(	PUNCT
fnp-4365	43	151	ebv)-encoded	ebv)-encode	VERB
fnp-4365	43	152	small	small	ADJ
fnp-4365	43	153	rnas	rna	NOUN
fnp-4365	43	154	(	(	PUNCT
fnp-4365	43	155	eber	eber	PROPN
fnp-4365	43	156	)	)	PUNCT
fnp-4365	43	157	(	(	PUNCT
fnp-4365	43	158	roche	roche	NOUN
fnp-4365	43	159	)	)	PUNCT
fnp-4365	43	160	,	,	PUNCT
fnp-4365	43	161	and	and	CCONJ
fnp-4365	43	162	polyomavirus	polyomavirus	NOUN
fnp-4365	43	163	(	(	PUNCT
fnp-4365	43	164	mrq-4	mrq-4	X
fnp-4365	43	165	,	,	PUNCT
fnp-4365	43	166	roche	roche	NOUN
fnp-4365	43	167	)	)	PUNCT
fnp-4365	43	168	.	.	PUNCT
fnp-4365	44	1	ihc	ihc	PROPN
fnp-4365	44	2	studies	study	NOUN
fnp-4365	44	3	were	be	AUX
fnp-4365	44	4	performed	perform	VERB
fnp-4365	44	5	in	in	ADP
fnp-4365	44	6	the	the	DET
fnp-4365	44	7	initial	initial	ADJ
fnp-4365	44	8	diagnostic	diagnostic	ADJ
fnp-4365	44	9	workup	workup	NOUN
fnp-4365	44	10	when	when	SCONJ
fnp-4365	44	11	clinical	clinical	ADJ
fnp-4365	44	12	suspicion	suspicion	NOUN
fnp-4365	44	13	or	or	CCONJ
fnp-4365	44	14	neuropathological	neuropathological	ADJ
fnp-4365	44	15	evidence	evidence	NOUN
fnp-4365	44	16	of	of	ADP
fnp-4365	44	17	any	any	DET
fnp-4365	44	18	pathologic	pathologic	ADJ
fnp-4365	44	19	process	process	NOUN
fnp-4365	44	20	was	be	AUX
fnp-4365	44	21	observed	observe	VERB
fnp-4365	44	22	.	.	PUNCT
fnp-4365	45	1	in	in	ADP
fnp-4365	45	2	addition	addition	NOUN
fnp-4365	45	3	,	,	PUNCT
fnp-4365	45	4	a	a	DET
fnp-4365	45	5	systematic	systematic	ADJ
fnp-4365	45	6	retrospective	retrospective	ADJ
fnp-4365	45	7	analysis	analysis	NOUN
fnp-4365	45	8	was	be	AUX
fnp-4365	45	9	performed	perform	VERB
fnp-4365	45	10	:	:	PUNCT
fnp-4365	45	11	cd3	cd3	PROPN
fnp-4365	45	12	and	and	CCONJ
fnp-4365	45	13	cd20	cd20	PROPN
fnp-4365	45	14	were	be	AUX
fnp-4365	45	15	screened	screen	VERB
fnp-4365	45	16	on	on	ADP
fnp-4365	45	17	hippocampal	hippocampal	NOUN
fnp-4365	45	18	and	and	CCONJ
fnp-4365	45	19	midbrain	midbrain	NOUN
fnp-4365	45	20	sections	section	NOUN
fnp-4365	45	21	in	in	ADP
fnp-4365	45	22	all	all	DET
fnp-4365	45	23	cases	case	NOUN
fnp-4365	45	24	,	,	PUNCT
fnp-4365	45	25	on	on	ADP
fnp-4365	45	26	spinal	spinal	ADJ
fnp-4365	45	27	cord	cord	NOUN
fnp-4365	45	28	sections	section	NOUN
fnp-4365	45	29	in	in	ADP
fnp-4365	45	30	all	all	DET
fnp-4365	45	31	cases	case	NOUN
fnp-4365	45	32	except	except	SCONJ
fnp-4365	45	33	case	case	NOUN
fnp-4365	45	34	1	1	NUM
fnp-4365	45	35	,	,	PUNCT
fnp-4365	45	36	on	on	ADP
fnp-4365	45	37	frontal	frontal	ADJ
fnp-4365	45	38	cortex	cortex	NOUN
fnp-4365	45	39	in	in	ADP
fnp-4365	45	40	all	all	DET
fnp-4365	45	41	cases	case	NOUN
fnp-4365	45	42	except	except	SCONJ
fnp-4365	45	43	cases	case	NOUN
fnp-4365	45	44	2	2	NUM
fnp-4365	45	45	and	and	CCONJ
fnp-4365	45	46	3	3	NUM
fnp-4365	45	47	,	,	PUNCT
fnp-4365	45	48	and	and	CCONJ
fnp-4365	45	49	on	on	ADP
fnp-4365	45	50	basal	basal	ADJ
fnp-4365	45	51	ganglia	ganglia	NOUN
fnp-4365	45	52	only	only	ADV
fnp-4365	45	53	in	in	ADP
fnp-4365	45	54	cases	case	NOUN
fnp-4365	45	55	4	4	NUM
fnp-4365	45	56	and	and	CCONJ
fnp-4365	45	57	6	6	NUM
fnp-4365	45	58	.	.	X
fnp-4365	46	1	gfap	gfap	ADJ
fnp-4365	46	2	ihc	ihc	PROPN
fnp-4365	46	3	was	be	AUX
fnp-4365	46	4	performed	perform	VERB
fnp-4365	46	5	on	on	ADP
fnp-4365	46	6	frontal	frontal	ADJ
fnp-4365	46	7	sections	section	NOUN
fnp-4365	46	8	in	in	ADP
fnp-4365	46	9	all	all	DET
fnp-4365	46	10	cases	case	NOUN
fnp-4365	46	11	,	,	PUNCT
fnp-4365	46	12	on	on	ADP
fnp-4365	46	13	basal	basal	ADJ
fnp-4365	46	14	ganglia	ganglia	NOUN
fnp-4365	46	15	in	in	ADP
fnp-4365	46	16	all	all	DET
fnp-4365	46	17	cases	case	NOUN
fnp-4365	46	18	except	except	SCONJ
fnp-4365	46	19	case	case	NOUN
fnp-4365	46	20	3	3	NUM
fnp-4365	46	21	,	,	PUNCT
fnp-4365	46	22	on	on	ADP
fnp-4365	46	23	hippocampus	hippocampus	NOUN
fnp-4365	46	24	in	in	ADP
fnp-4365	46	25	all	all	DET
fnp-4365	46	26	cases	case	NOUN
fnp-4365	46	27	except	except	SCONJ
fnp-4365	46	28	case	case	NOUN
fnp-4365	46	29	1	1	NUM
fnp-4365	46	30	,	,	PUNCT
fnp-4365	46	31	and	and	CCONJ
fnp-4365	46	32	on	on	ADP
fnp-4365	46	33	midbrain	midbrain	NOUN
fnp-4365	46	34	only	only	ADV
fnp-4365	46	35	in	in	ADP
fnp-4365	46	36	case	case	NOUN
fnp-4365	46	37	4	4	NUM
fnp-4365	46	38	.	.	PUNCT
fnp-4365	46	39	polymerase	polymerase	NOUN
fnp-4365	46	40	chain	chain	NOUN
fnp-4365	46	41	reaction	reaction	NOUN
fnp-4365	46	42	(	(	PUNCT
fnp-4365	46	43	pcr	pcr	NOUN
fnp-4365	46	44	)	)	PUNCT
fnp-4365	46	45	in	in	ADP
fnp-4365	46	46	paraffin	paraffin	NOUN
fnp-4365	46	47	blocks	block	NOUN
fnp-4365	46	48	was	be	AUX
fnp-4365	46	49	performed	perform	VERB
fnp-4365	46	50	in	in	ADP
fnp-4365	46	51	case	case	NOUN
fnp-4365	46	52	5	5	NUM
fnp-4365	46	53	for	for	ADP
fnp-4365	46	54	the	the	DET
fnp-4365	46	55	detection	detection	NOUN
fnp-4365	46	56	of	of	ADP
fnp-4365	46	57	hhv-6	hhv-6	NOUN
fnp-4365	46	58	,	,	PUNCT
fnp-4365	46	59	west	west	PROPN
fnp-4365	46	60	nile	nile	PROPN
fnp-4365	46	61	virus	virus	PROPN
fnp-4365	46	62	,	,	PUNCT
fnp-4365	46	63	adenovirus	adenovirus	NOUN
fnp-4365	46	64	,	,	PUNCT
fnp-4365	46	65	enterovirus	enterovirus	NOUN
fnp-4365	46	66	,	,	PUNCT
fnp-4365	46	67	measles	measle	NOUN
fnp-4365	46	68	,	,	PUNCT
fnp-4365	46	69	mumps	mump	NOUN
fnp-4365	46	70	and	and	CCONJ
fnp-4365	46	71	lymphocytic	lymphocytic	ADJ
fnp-4365	46	72	choriomeningitis	choriomeningitis	NOUN
fnp-4365	46	73	.	.	PUNCT
fnp-4365	47	1	samples	sample	NOUN
fnp-4365	47	2	of	of	ADP
fnp-4365	47	3	all	all	DET
fnp-4365	47	4	cases	case	NOUN
fnp-4365	47	5	from	from	ADP
fnp-4365	47	6	hippocampus	hippocampus	NOUN
fnp-4365	47	7	,	,	PUNCT
fnp-4365	47	8	midbrain	midbrain	NOUN
fnp-4365	47	9	,	,	PUNCT
fnp-4365	47	10	and	and	CCONJ
fnp-4365	47	11	spinal	spinal	ADJ
fnp-4365	47	12	cord	cord	NOUN
fnp-4365	47	13	(	(	PUNCT
fnp-4365	47	14	only	only	ADV
fnp-4365	47	15	in	in	ADP
fnp-4365	47	16	cases	case	NOUN
fnp-4365	47	17	2	2	NUM
fnp-4365	47	18	to	to	PART
fnp-4365	47	19	6	6	NUM
fnp-4365	47	20	)	)	PUNCT
fnp-4365	47	21	were	be	AUX
fnp-4365	47	22	used	use	VERB
fnp-4365	47	23	for	for	ADP
fnp-4365	47	24	car	car	NOUN
fnp-4365	47	25	t	t	NOUN
fnp-4365	47	26	-	-	PUNCT
fnp-4365	47	27	cell	cell	NOUN
fnp-4365	47	28	detection	detection	NOUN
fnp-4365	47	29	by	by	ADP
fnp-4365	47	30	pcr	pcr	PROPN
fnp-4365	47	31	.	.	PUNCT
fnp-4365	48	1	five	five	NUM
fnp-4365	48	2	micrometer	micrometer	NOUN
fnp-4365	48	3	sections	section	NOUN
fnp-4365	48	4	were	be	AUX
fnp-4365	48	5	obtained	obtain	VERB
fnp-4365	48	6	from	from	ADP
fnp-4365	48	7	paraffin	paraffin	NOUN
fnp-4365	48	8	blocks	block	NOUN
fnp-4365	48	9	,	,	PUNCT
fnp-4365	48	10	and	and	CCONJ
fnp-4365	48	11	dna	dna	NOUN
fnp-4365	48	12	was	be	AUX
fnp-4365	48	13	extracted	extract	VERB
fnp-4365	48	14	using	use	VERB
fnp-4365	48	15	qia	qia	PROPN
fnp-4365	48	16	amp	amp	PROPN
fnp-4365	48	17	dna	dna	PROPN
fnp-4365	48	18	ffpe	ffpe	NOUN
fnp-4365	48	19	tissue	tissue	NOUN
fnp-4365	48	20	kit	kit	NOUN
fnp-4365	48	21	(	(	PUNCT
fnp-4365	48	22	qiagen	qiagen	PROPN
fnp-4365	48	23	,	,	PUNCT
fnp-4365	48	24	hilden	hilden	PROPN
fnp-4365	48	25	,	,	PUNCT
fnp-4365	48	26	germany	germany	PROPN
fnp-4365	48	27	)	)	PUNCT
fnp-4365	48	28	.	.	PUNCT
fnp-4365	49	1	real	real	ADJ
fnp-4365	49	2	-	-	PUNCT
fnp-4365	49	3	time	time	NOUN
fnp-4365	49	4	pcr	pcr	NOUN
fnp-4365	49	5	was	be	AUX
fnp-4365	49	6	used	use	VERB
fnp-4365	49	7	to	to	PART
fnp-4365	49	8	measure	measure	VERB
fnp-4365	49	9	number	number	NOUN
fnp-4365	49	10	of	of	ADP
fnp-4365	49	11	copies	copy	NOUN
fnp-4365	49	12	/	/	SYM
fnp-4365	49	13	cell	cell	NOUN
fnp-4365	49	14	.	.	PUNCT
fnp-4365	50	1	genomic	genomic	ADJ
fnp-4365	50	2	dna	dna	PROPN
fnp-4365	50	3	was	be	AUX
fnp-4365	50	4	amplified	amplify	VERB
fnp-4365	50	5	as	as	ADP
fnp-4365	50	6	previously	previously	ADV
fnp-4365	50	7	described13	described13	ADJ
fnp-4365	50	8	.	.	PUNCT
fnp-4365	51	1	amplification	amplification	NOUN
fnp-4365	51	2	reactions	reaction	NOUN
fnp-4365	51	3	were	be	AUX
fnp-4365	51	4	performed	perform	VERB
fnp-4365	51	5	in	in	ADP
fnp-4365	51	6	triplicate	triplicate	NOUN
fnp-4365	51	7	.	.	PUNCT
fnp-4365	52	1	an	an	DET
fnp-4365	52	2	eight	eight	NUM
fnp-4365	52	3	-	-	PUNCT
fnp-4365	52	4	point	point	NOUN
fnp-4365	52	5	standard	standard	ADJ
fnp-4365	52	6	curve	curve	NOUN
fnp-4365	52	7	was	be	AUX
fnp-4365	52	8	generated	generate	VERB
fnp-4365	52	9	using	use	VERB
fnp-4365	52	10	a	a	DET
fnp-4365	52	11	sequence	sequence	NOUN
fnp-4365	52	12	close	close	ADV
fnp-4365	52	13	to	to	ADP
fnp-4365	52	14	the	the	DET
fnp-4365	52	15	cdkn1a	cdkn1a	NOUN
fnp-4365	52	16	gene	gene	NOUN
fnp-4365	52	17	(	(	PUNCT
fnp-4365	52	18	genebank	genebank	NOUN
fnp-4365	52	19	:	:	PUNCT
fnp-4365	52	20	z86995	z86995	NUM
fnp-4365	52	21	)	)	PUNCT
fnp-4365	52	22	as	as	ADP
fnp-4365	52	23	comparator	comparator	NOUN
fnp-4365	52	24	.	.	PUNCT
fnp-4365	53	1	the	the	DET
fnp-4365	53	2	test	test	NOUN
fnp-4365	53	3	was	be	AUX
fnp-4365	53	4	calibrated	calibrate	VERB
fnp-4365	53	5	to	to	PART
fnp-4365	53	6	detect	detect	VERB
fnp-4365	53	7	a	a	DET
fnp-4365	53	8	number	number	NOUN
fnp-4365	53	9	of	of	ADP
fnp-4365	53	10	copies	copy	NOUN
fnp-4365	53	11	ranging	range	VERB
fnp-4365	53	12	from	from	ADP
fnp-4365	53	13	5	5	NUM
fnp-4365	53	14	to	to	PART
fnp-4365	53	15	106	106	NUM
fnp-4365	53	16	per	per	ADP
fnp-4365	53	17	500	500	NUM
fnp-4365	53	18	ng	ng	PROPN
fnp-4365	53	19	of	of	ADP
fnp-4365	53	20	genomic	genomic	PROPN
fnp-4365	53	21	dna	dna	PROPN
fnp-4365	53	22	.	.	PUNCT
fnp-4365	54	1	results	result	NOUN
fnp-4365	54	2	see	see	VERB
fnp-4365	54	3	table	table	NOUN
fnp-4365	54	4	1	1	NUM
fnp-4365	54	5	for	for	ADP
fnp-4365	54	6	a	a	DET
fnp-4365	54	7	summary	summary	NOUN
fnp-4365	54	8	of	of	ADP
fnp-4365	54	9	the	the	DET
fnp-4365	54	10	cases	case	NOUN
fnp-4365	54	11	here	here	ADV
fnp-4365	54	12	presented	present	VERB
fnp-4365	54	13	and	and	CCONJ
fnp-4365	54	14	the	the	DET
fnp-4365	54	15	other	other	ADJ
fnp-4365	54	16	cases	case	NOUN
fnp-4365	54	17	reported	report	VERB
fnp-4365	54	18	in	in	ADP
fnp-4365	54	19	the	the	DET
fnp-4365	54	20	literature	literature	NOUN
fnp-4365	54	21	,	,	PUNCT
fnp-4365	54	22	and	and	CCONJ
fnp-4365	54	23	figure	figure	VERB
fnp-4365	54	24	1	1	NUM
fnp-4365	54	25	for	for	ADP
fnp-4365	54	26	the	the	DET
fnp-4365	54	27	comparison	comparison	NOUN
fnp-4365	54	28	of	of	ADP
fnp-4365	54	29	gliosis	gliosis	NOUN
fnp-4365	54	30	and	and	CCONJ
fnp-4365	54	31	t	t	NOUN
fnp-4365	54	32	-	-	PUNCT
fnp-4365	54	33	cell	cell	NOUN
fnp-4365	54	34	infiltrates	infiltrate	NOUN
fnp-4365	54	35	of	of	ADP
fnp-4365	54	36	the	the	DET
fnp-4365	54	37	cases	case	NOUN
fnp-4365	54	38	.	.	PUNCT
fnp-4365	55	1	table	table	NOUN
fnp-4365	55	2	1	1	NUM
fnp-4365	55	3	.	.	PUNCT
fnp-4365	56	1	clinical	clinical	ADJ
fnp-4365	56	2	data	datum	NOUN
fnp-4365	56	3	and	and	CCONJ
fnp-4365	56	4	histopathologic	histopathologic	NOUN
fnp-4365	56	5	findings	finding	NOUN
fnp-4365	56	6	of	of	ADP
fnp-4365	56	7	our	our	PRON
fnp-4365	56	8	cases	case	NOUN
fnp-4365	56	9	and	and	CCONJ
fnp-4365	56	10	previously	previously	ADV
fnp-4365	56	11	described	describe	VERB
fnp-4365	56	12	cases	case	NOUN
fnp-4365	56	13	(	(	PUNCT
fnp-4365	56	14	modified	modify	VERB
fnp-4365	56	15	from7	from7	NOUN
fnp-4365	56	16	)	)	PUNCT
fnp-4365	56	17	m	m	PRON
fnp-4365	56	18	:	:	PUNCT
fnp-4365	56	19	male	male	ADJ
fnp-4365	56	20	;	;	PUNCT
fnp-4365	56	21	f	f	X
fnp-4365	56	22	:	:	PUNCT
fnp-4365	56	23	female	female	ADJ
fnp-4365	56	24	;	;	PUNCT
fnp-4365	56	25	n	n	CCONJ
fnp-4365	56	26	/	/	SYM
fnp-4365	56	27	a	a	PRON
fnp-4365	56	28	:	:	PUNCT
fnp-4365	56	29	not	not	PART
fnp-4365	56	30	applicable	applicable	ADJ
fnp-4365	56	31	.	.	PUNCT
fnp-4365	57	1	ffpe	ffpe	NOUN
fnp-4365	57	2	:	:	PUNCT
fnp-4365	57	3	formalin	formalin	NOUN
fnp-4365	57	4	fixed	fix	VERB
fnp-4365	57	5	paraffin	paraffin	NOUN
fnp-4365	57	6	embedded	embed	VERB
fnp-4365	57	7	.	.	PUNCT
fnp-4365	58	1	figure	figure	NOUN
fnp-4365	58	2	1	1	NUM
fnp-4365	58	3	.	.	PUNCT
fnp-4365	58	4	figures	figure	NOUN
fnp-4365	58	5	co	co	VERB
fnp-4365	58	6	to	to	ADP
fnp-4365	58	7	f1	f1	VERB
fnp-4365	58	8	:	:	PUNCT
fnp-4365	58	9	gfap	gfap	ADJ
fnp-4365	58	10	immunohistochemistry	immunohistochemistry	NOUN
fnp-4365	58	11	of	of	ADP
fnp-4365	58	12	hippocampus	hippocampus	NOUN
fnp-4365	58	13	(	(	PUNCT
fnp-4365	58	14	upper	upper	ADJ
fnp-4365	58	15	third	third	ADJ
fnp-4365	58	16	ca1	ca1	NOUN
fnp-4365	58	17	sector	sector	NOUN
fnp-4365	58	18	-right	-right	NOUN
fnp-4365	58	19	sideand	sideand	NOUN
fnp-4365	58	20	subiculum	subiculum	NOUN
fnp-4365	58	21	–	–	PUNCT
fnp-4365	58	22	left	leave	VERB
fnp-4365	58	23	side-	side-	NOUN
fnp-4365	58	24	)	)	PUNCT
fnp-4365	58	25	and	and	CCONJ
fnp-4365	58	26	parahippocampal	parahippocampal	ADJ
fnp-4365	58	27	area	area	NOUN
fnp-4365	58	28	(	(	PUNCT
fnp-4365	58	29	lower	low	ADJ
fnp-4365	58	30	third	third	ADJ
fnp-4365	58	31	,	,	PUNCT
fnp-4365	58	32	transenthorinal	transenthorinal	ADJ
fnp-4365	58	33	cortex	cortex	NOUN
fnp-4365	58	34	)	)	PUNCT
fnp-4365	58	35	of	of	ADP
fnp-4365	58	36	a	a	DET
fnp-4365	58	37	control	control	NOUN
fnp-4365	58	38	(	(	PUNCT
fnp-4365	58	39	co	co	NOUN
fnp-4365	58	40	)	)	PUNCT
fnp-4365	58	41	and	and	CCONJ
fnp-4365	58	42	cases	case	NOUN
fnp-4365	58	43	2	2	NUM
fnp-4365	58	44	(	(	PUNCT
fnp-4365	58	45	b1	b1	NOUN
fnp-4365	58	46	)	)	PUNCT
fnp-4365	58	47	,	,	PUNCT
fnp-4365	58	48	3	3	NUM
fnp-4365	58	49	(	(	PUNCT
fnp-4365	58	50	c1	c1	PROPN
fnp-4365	58	51	)	)	PUNCT
fnp-4365	58	52	,	,	PUNCT
fnp-4365	58	53	4	4	NUM
fnp-4365	58	54	(	(	PUNCT
fnp-4365	58	55	d1	d1	PROPN
fnp-4365	58	56	)	)	PUNCT
fnp-4365	58	57	,	,	PUNCT
fnp-4365	58	58	5	5	NUM
fnp-4365	58	59	(	(	PUNCT
fnp-4365	58	60	e1	e1	PROPN
fnp-4365	58	61	)	)	PUNCT
fnp-4365	58	62	and	and	CCONJ
fnp-4365	58	63	6	6	NUM
fnp-4365	58	64	(	(	PUNCT
fnp-4365	58	65	f1	f1	NOUN
fnp-4365	58	66	)	)	PUNCT
fnp-4365	58	67	.	.	PUNCT
fnp-4365	59	1	the	the	DET
fnp-4365	59	2	control	control	NOUN
fnp-4365	59	3	was	be	AUX
fnp-4365	59	4	a	a	DET
fnp-4365	59	5	52	52	NUM
fnp-4365	59	6	-	-	PUNCT
fnp-4365	59	7	year	year	NOUN
fnp-4365	59	8	-	-	PUNCT
fnp-4365	59	9	old	old	ADJ
fnp-4365	59	10	male	male	NOUN
fnp-4365	59	11	who	who	PRON
fnp-4365	59	12	died	die	VERB
fnp-4365	59	13	due	due	ADP
fnp-4365	59	14	to	to	ADP
fnp-4365	59	15	an	an	DET
fnp-4365	59	16	acute	acute	ADJ
fnp-4365	59	17	bilateral	bilateral	ADJ
fnp-4365	59	18	adrenal	adrenal	ADJ
fnp-4365	59	19	hemorrhage	hemorrhage	NOUN
fnp-4365	59	20	with	with	ADP
fnp-4365	59	21	extensive	extensive	ADJ
fnp-4365	59	22	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	59	23	(	(	PUNCT
fnp-4365	59	24	insets	inset	NOUN
fnp-4365	59	25	,	,	PUNCT
fnp-4365	59	26	parahippocampal	parahippocampal	ADJ
fnp-4365	59	27	white	white	ADJ
fnp-4365	59	28	matter	matter	NOUN
fnp-4365	59	29	,	,	PUNCT
fnp-4365	59	30	400x	400x	NUM
fnp-4365	59	31	)	)	PUNCT
fnp-4365	59	32	.	.	PUNCT
fnp-4365	60	1	the	the	DET
fnp-4365	60	2	cases	case	NOUN
fnp-4365	60	3	showed	show	VERB
fnp-4365	60	4	variable	variable	ADJ
fnp-4365	60	5	gliosis	gliosis	NOUN
fnp-4365	60	6	,	,	PUNCT
fnp-4365	60	7	predominantly	predominantly	ADV
fnp-4365	60	8	mild	mild	ADJ
fnp-4365	60	9	,	,	PUNCT
fnp-4365	60	10	higher	high	ADJ
fnp-4365	60	11	in	in	ADP
fnp-4365	60	12	case	case	NOUN
fnp-4365	60	13	5	5	NUM
fnp-4365	60	14	(	(	PUNCT
fnp-4365	60	15	e1	e1	PROPN
fnp-4365	60	16	)	)	PUNCT
fnp-4365	60	17	who	who	PRON
fnp-4365	60	18	had	have	VERB
fnp-4365	60	19	an	an	DET
fnp-4365	60	20	encephalitis	encephalitis	NOUN
fnp-4365	60	21	,	,	PUNCT
fnp-4365	60	22	and	and	CCONJ
fnp-4365	60	23	case	case	NOUN
fnp-4365	60	24	4	4	NUM
fnp-4365	60	25	(	(	PUNCT
fnp-4365	60	26	d1	d1	NOUN
fnp-4365	60	27	)	)	PUNCT
fnp-4365	60	28	who	who	PRON
fnp-4365	60	29	died	die	VERB
fnp-4365	60	30	with	with	ADP
fnp-4365	60	31	an	an	DET
fnp-4365	60	32	extensive	extensive	ADJ
fnp-4365	60	33	acute	acute	ADJ
fnp-4365	60	34	pneumonia	pneumonia	NOUN
fnp-4365	60	35	.	.	PUNCT
fnp-4365	61	1	both	both	PRON
fnp-4365	61	2	had	have	VERB
fnp-4365	61	3	mild	mild	ADJ
fnp-4365	61	4	and	and	CCONJ
fnp-4365	61	5	isolated	isolated	ADJ
fnp-4365	61	6	clasmatodendritic	clasmatodendritic	ADJ
fnp-4365	61	7	changes	change	NOUN
fnp-4365	61	8	in	in	ADP
fnp-4365	61	9	white	white	ADJ
fnp-4365	61	10	matter	matter	NOUN
fnp-4365	61	11	(	(	PUNCT
fnp-4365	61	12	see	see	VERB
fnp-4365	61	13	insets	inset	NOUN
fnp-4365	61	14	)	)	PUNCT
fnp-4365	61	15	.	.	PUNCT
fnp-4365	62	1	row	row	NOUN
fnp-4365	62	2	3	3	NUM
fnp-4365	62	3	and	and	CCONJ
fnp-4365	62	4	4	4	NUM
fnp-4365	62	5	show	show	VERB
fnp-4365	62	6	t	t	NOUN
fnp-4365	62	7	-	-	PUNCT
fnp-4365	62	8	cell	cell	NOUN
fnp-4365	62	9	infiltrates	infiltrate	NOUN
fnp-4365	62	10	(	(	PUNCT
fnp-4365	62	11	cd3	cd3	VERB
fnp-4365	62	12	+	+	NOUN
fnp-4365	62	13	)	)	PUNCT
fnp-4365	62	14	in	in	ADP
fnp-4365	62	15	parahippocampal	parahippocampal	ADJ
fnp-4365	62	16	cortex	cortex	NOUN
fnp-4365	62	17	(	(	PUNCT
fnp-4365	62	18	left	leave	VERB
fnp-4365	62	19	half	half	NOUN
fnp-4365	62	20	)	)	PUNCT
fnp-4365	62	21	and	and	CCONJ
fnp-4365	62	22	substantia	substantia	PROPN
fnp-4365	62	23	nigra	nigra	PROPN
fnp-4365	62	24	pars	par	NOUN
fnp-4365	62	25	compacta	compacta	NOUN
fnp-4365	62	26	(	(	PUNCT
fnp-4365	62	27	right	right	ADJ
fnp-4365	62	28	half	half	NOUN
fnp-4365	62	29	)	)	PUNCT
fnp-4365	62	30	,	,	PUNCT
fnp-4365	62	31	in	in	ADP
fnp-4365	62	32	cases	case	NOUN
fnp-4365	62	33	1	1	NUM
fnp-4365	62	34	(	(	PUNCT
fnp-4365	62	35	a2	a2	PROPN
fnp-4365	62	36	)	)	PUNCT
fnp-4365	62	37	,	,	PUNCT
fnp-4365	62	38	2	2	NUM
fnp-4365	62	39	(	(	PUNCT
fnp-4365	62	40	b2	b2	NOUN
fnp-4365	62	41	)	)	PUNCT
fnp-4365	62	42	,	,	PUNCT
fnp-4365	62	43	3	3	NUM
fnp-4365	62	44	(	(	PUNCT
fnp-4365	62	45	c2	c2	PROPN
fnp-4365	62	46	)	)	PUNCT
fnp-4365	62	47	,	,	PUNCT
fnp-4365	62	48	4	4	NUM
fnp-4365	62	49	(	(	PUNCT
fnp-4365	62	50	d2	d2	PROPN
fnp-4365	62	51	)	)	PUNCT
fnp-4365	62	52	,	,	PUNCT
fnp-4365	62	53	5	5	NUM
fnp-4365	62	54	(	(	PUNCT
fnp-4365	62	55	e2	e2	PROPN
fnp-4365	62	56	)	)	PUNCT
fnp-4365	62	57	and	and	CCONJ
fnp-4365	62	58	6	6	NUM
fnp-4365	62	59	(	(	PUNCT
fnp-4365	62	60	f2	f2	PROPN
fnp-4365	62	61	)	)	PUNCT
fnp-4365	62	62	.	.	PUNCT
fnp-4365	63	1	only	only	ADV
fnp-4365	63	2	case	case	NOUN
fnp-4365	63	3	5	5	NUM
fnp-4365	63	4	(	(	PUNCT
fnp-4365	63	5	e2	e2	PROPN
fnp-4365	63	6	)	)	PUNCT
fnp-4365	63	7	presented	present	VERB
fnp-4365	63	8	marked	mark	VERB
fnp-4365	63	9	infiltrates	infiltrate	NOUN
fnp-4365	63	10	,	,	PUNCT
fnp-4365	63	11	while	while	SCONJ
fnp-4365	63	12	other	other	ADJ
fnp-4365	63	13	cases	case	NOUN
fnp-4365	63	14	has	have	AUX
fnp-4365	63	15	only	only	ADV
fnp-4365	63	16	scattered	scatter	VERB
fnp-4365	63	17	to	to	AUX
fnp-4365	63	18	isolated	isolate	VERB
fnp-4365	63	19	perivascular	perivascular	ADJ
fnp-4365	63	20	t	t	PROPN
fnp-4365	63	21	-	-	PUNCT
fnp-4365	63	22	cells	cell	NOUN
fnp-4365	63	23	.	.	PUNCT
fnp-4365	64	1	case	case	NOUN
fnp-4365	64	2	2	2	NUM
fnp-4365	64	3	(	(	PUNCT
fnp-4365	64	4	b2	b2	NOUN
fnp-4365	64	5	)	)	PUNCT
fnp-4365	64	6	,	,	PUNCT
fnp-4365	64	7	which	which	PRON
fnp-4365	64	8	was	be	AUX
fnp-4365	64	9	positive	positive	ADJ
fnp-4365	64	10	for	for	ADP
fnp-4365	64	11	cart	cart	NOUN
fnp-4365	64	12	pcr	pcr	NOUN
fnp-4365	64	13	in	in	ADP
fnp-4365	64	14	brain	brain	NOUN
fnp-4365	64	15	tissue	tissue	NOUN
fnp-4365	64	16	,	,	PUNCT
fnp-4365	64	17	did	do	AUX
fnp-4365	64	18	not	not	PART
fnp-4365	64	19	have	have	VERB
fnp-4365	64	20	significantly	significantly	ADV
fnp-4365	64	21	higher	high	ADJ
fnp-4365	64	22	t	t	NOUN
fnp-4365	64	23	-	-	PUNCT
fnp-4365	64	24	cell	cell	NOUN
fnp-4365	64	25	infiltrates	infiltrate	NOUN
fnp-4365	64	26	(	(	PUNCT
fnp-4365	64	27	figures	figure	NOUN
fnp-4365	64	28	co	co	VERB
fnp-4365	64	29	,	,	PUNCT
fnp-4365	64	30	b1	b1	VERB
fnp-4365	64	31	to	to	ADP
fnp-4365	64	32	f1	f1	NOUN
fnp-4365	65	1	20x	20x	NOUN
fnp-4365	65	2	scale	scale	NOUN
fnp-4365	65	3	bar	bar	NOUN
fnp-4365	65	4	500	500	NUM
fnp-4365	65	5	µm	µm	NOUN
fnp-4365	65	6	;	;	PUNCT
fnp-4365	65	7	insets	inset	NOUN
fnp-4365	65	8	400x	400x	NUM
fnp-4365	65	9	,	,	PUNCT
fnp-4365	65	10	scale	scale	NOUN
fnp-4365	65	11	bar	bar	NOUN
fnp-4365	65	12	20	20	NUM
fnp-4365	65	13	µm	µm	NOUN
fnp-4365	65	14	.	.	PUNCT
fnp-4365	65	15	figures	figure	NOUN
fnp-4365	65	16	a2	a2	PROPN
fnp-4365	65	17	to	to	ADP
fnp-4365	65	18	f2	f2	PROPN
fnp-4365	65	19	200x	200x	PROPN
fnp-4365	65	20	,	,	PUNCT
fnp-4365	65	21	scale	scale	NOUN
fnp-4365	65	22	bar	bar	NOUN
fnp-4365	65	23	50	50	NUM
fnp-4365	65	24	µm	µm	NOUN
fnp-4365	65	25	)	)	PUNCT
fnp-4365	65	26	.	.	PUNCT
fnp-4365	66	1	case	case	NOUN
fnp-4365	66	2	1	1	NUM
fnp-4365	66	3	a	a	DET
fnp-4365	66	4	44	44	NUM
fnp-4365	66	5	-	-	PUNCT
fnp-4365	66	6	year	year	NOUN
fnp-4365	66	7	-	-	PUNCT
fnp-4365	66	8	old	old	ADJ
fnp-4365	66	9	woman	woman	NOUN
fnp-4365	66	10	with	with	ADP
fnp-4365	66	11	acute	acute	PROPN
fnp-4365	66	12	b	b	NOUN
fnp-4365	66	13	-	-	PUNCT
fnp-4365	66	14	cell	cell	NOUN
fnp-4365	66	15	lymphoblastic	lymphoblastic	ADJ
fnp-4365	66	16	leukemia	leukemia	NOUN
fnp-4365	66	17	presented	present	VERB
fnp-4365	66	18	to	to	ADP
fnp-4365	66	19	an	an	DET
fnp-4365	66	20	outside	outside	ADJ
fnp-4365	66	21	hospital	hospital	NOUN
fnp-4365	66	22	with	with	ADP
fnp-4365	66	23	central	central	ADJ
fnp-4365	66	24	nervous	nervous	ADJ
fnp-4365	66	25	system	system	NOUN
fnp-4365	66	26	(	(	PUNCT
fnp-4365	66	27	cns	cns	NOUN
fnp-4365	66	28	)	)	PUNCT
fnp-4365	66	29	involvement	involvement	NOUN
fnp-4365	66	30	and	and	CCONJ
fnp-4365	66	31	a	a	DET
fnp-4365	66	32	paravertebral	paravertebral	ADJ
fnp-4365	66	33	mass	mass	NOUN
fnp-4365	66	34	(	(	PUNCT
fnp-4365	66	35	d8	d8	PROPN
fnp-4365	66	36	-	-	PUNCT
fnp-4365	66	37	d10	d10	PROPN
fnp-4365	66	38	)	)	PUNCT
fnp-4365	66	39	without	without	ADP
fnp-4365	66	40	spinal	spinal	ADJ
fnp-4365	66	41	compression	compression	NOUN
fnp-4365	66	42	.	.	PUNCT
fnp-4365	67	1	at	at	ADP
fnp-4365	67	2	disease	disease	NOUN
fnp-4365	67	3	onset	onset	VERB
fnp-4365	67	4	,	,	PUNCT
fnp-4365	67	5	she	she	PRON
fnp-4365	67	6	had	have	VERB
fnp-4365	67	7	lymph	lymph	NOUN
fnp-4365	67	8	node	node	NOUN
fnp-4365	67	9	involvement	involvement	NOUN
fnp-4365	67	10	and	and	CCONJ
fnp-4365	67	11	leukocytosis	leukocytosis	NOUN
fnp-4365	67	12	and	and	CCONJ
fnp-4365	67	13	was	be	AUX
fnp-4365	67	14	refractory	refractory	NOUN
fnp-4365	67	15	to	to	ADP
fnp-4365	67	16	five	five	NUM
fnp-4365	67	17	lines	line	NOUN
fnp-4365	67	18	of	of	ADP
fnp-4365	67	19	treatment	treatment	NOUN
fnp-4365	67	20	.	.	PUNCT
fnp-4365	68	1	at	at	ADP
fnp-4365	68	2	her	her	PRON
fnp-4365	68	3	first	first	ADJ
fnp-4365	68	4	consultation	consultation	NOUN
fnp-4365	68	5	in	in	ADP
fnp-4365	68	6	our	our	PRON
fnp-4365	68	7	center	center	NOUN
fnp-4365	68	8	she	she	PRON
fnp-4365	68	9	did	do	AUX
fnp-4365	68	10	not	not	PART
fnp-4365	68	11	present	present	VERB
fnp-4365	68	12	any	any	DET
fnp-4365	68	13	neurological	neurological	ADJ
fnp-4365	68	14	symptoms	symptom	NOUN
fnp-4365	68	15	.	.	PUNCT
fnp-4365	69	1	basal	basal	PROPN
fnp-4365	69	2	brain	brain	NOUN
fnp-4365	69	3	magnetic	magnetic	ADJ
fnp-4365	69	4	resonance	resonance	NOUN
fnp-4365	69	5	imaging	imaging	NOUN
fnp-4365	69	6	(	(	PUNCT
fnp-4365	69	7	mri	mri	NOUN
fnp-4365	69	8	)	)	PUNCT
fnp-4365	69	9	showed	show	VERB
fnp-4365	69	10	a	a	DET
fnp-4365	69	11	nonspecific	nonspecific	ADJ
fnp-4365	69	12	lacunar	lacunar	NOUN
fnp-4365	69	13	lesion	lesion	NOUN
fnp-4365	69	14	in	in	ADP
fnp-4365	69	15	the	the	DET
fnp-4365	69	16	left	left	ADJ
fnp-4365	69	17	frontal	frontal	ADJ
fnp-4365	69	18	white	white	ADJ
fnp-4365	69	19	matter	matter	NOUN
fnp-4365	69	20	and	and	CCONJ
fnp-4365	69	21	discrete	discrete	VERB
fnp-4365	69	22	homogeneous	homogeneous	ADJ
fnp-4365	69	23	dural	dural	ADJ
fnp-4365	69	24	enhancement	enhancement	NOUN
fnp-4365	69	25	in	in	ADP
fnp-4365	69	26	cerebral	cerebral	ADJ
fnp-4365	69	27	convexity	convexity	NOUN
fnp-4365	69	28	;	;	PUNCT
fnp-4365	69	29	the	the	DET
fnp-4365	69	30	cerebrospinal	cerebrospinal	ADJ
fnp-4365	69	31	fluid	fluid	NOUN
fnp-4365	69	32	(	(	PUNCT
fnp-4365	69	33	csf	csf	NOUN
fnp-4365	69	34	)	)	PUNCT
fnp-4365	69	35	study	study	NOUN
fnp-4365	69	36	was	be	AUX
fnp-4365	69	37	normal	normal	ADJ
fnp-4365	69	38	.	.	PUNCT
fnp-4365	70	1	after	after	ADP
fnp-4365	70	2	the	the	DET
fnp-4365	70	3	conditioning	conditioning	NOUN
fnp-4365	70	4	with	with	ADP
fnp-4365	70	5	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	70	6	and	and	CCONJ
fnp-4365	70	7	fludarabine	fludarabine	PROPN
fnp-4365	70	8	,	,	PUNCT
fnp-4365	70	9	she	she	PRON
fnp-4365	70	10	received	receive	VERB
fnp-4365	70	11	car	car	NOUN
fnp-4365	70	12	-	-	PUNCT
fnp-4365	70	13	cd19	cd19	PROPN
fnp-4365	70	14	treatment	treatment	NOUN
fnp-4365	70	15	.	.	PUNCT
fnp-4365	71	1	three	three	NUM
fnp-4365	71	2	days	day	NOUN
fnp-4365	71	3	after	after	ADP
fnp-4365	71	4	the	the	DET
fnp-4365	71	5	infusion	infusion	NOUN
fnp-4365	71	6	she	she	PRON
fnp-4365	71	7	developed	develop	VERB
fnp-4365	71	8	fever	fever	NOUN
fnp-4365	71	9	,	,	PUNCT
fnp-4365	71	10	pulmonary	pulmonary	ADJ
fnp-4365	71	11	interstitial	interstitial	ADJ
fnp-4365	71	12	infiltrates	infiltrate	NOUN
fnp-4365	71	13	,	,	PUNCT
fnp-4365	71	14	and	and	CCONJ
fnp-4365	71	15	pleural	pleural	ADJ
fnp-4365	71	16	effusion	effusion	NOUN
fnp-4365	71	17	.	.	PUNCT
fnp-4365	72	1	the	the	DET
fnp-4365	72	2	radiology	radiology	NOUN
fnp-4365	72	3	was	be	AUX
fnp-4365	72	4	suggestive	suggestive	ADJ
fnp-4365	72	5	of	of	ADP
fnp-4365	72	6	non	non	ADJ
fnp-4365	72	7	-	-	ADJ
fnp-4365	72	8	cardiogenic	cardiogenic	ADJ
fnp-4365	72	9	oedema	oedema	NOUN
fnp-4365	72	10	,	,	PUNCT
fnp-4365	72	11	with	with	ADP
fnp-4365	72	12	isolated	isolated	ADJ
fnp-4365	72	13	colonies	colony	NOUN
fnp-4365	72	14	of	of	ADP
fnp-4365	72	15	staphylococcus	staphylococcus	NOUN
fnp-4365	72	16	haemolyticus	haemolyticus	NOUN
fnp-4365	72	17	in	in	ADP
fnp-4365	72	18	respiratory	respiratory	ADJ
fnp-4365	72	19	samples	sample	NOUN
fnp-4365	72	20	culture	culture	NOUN
fnp-4365	72	21	.	.	PUNCT
fnp-4365	73	1	she	she	PRON
fnp-4365	73	2	received	receive	VERB
fnp-4365	73	3	antimicrobial	antimicrobial	ADJ
fnp-4365	73	4	therapy	therapy	NOUN
fnp-4365	73	5	,	,	PUNCT
fnp-4365	73	6	depletive	depletive	ADJ
fnp-4365	73	7	treatment	treatment	NOUN
fnp-4365	73	8	,	,	PUNCT
fnp-4365	73	9	pleural	pleural	ADJ
fnp-4365	73	10	drainage	drainage	NOUN
fnp-4365	73	11	,	,	PUNCT
fnp-4365	73	12	and	and	CCONJ
fnp-4365	73	13	non	non	ADJ
fnp-4365	73	14	-	-	ADJ
fnp-4365	73	15	invasive	invasive	ADJ
fnp-4365	73	16	mechanical	mechanical	ADJ
fnp-4365	73	17	ventilation	ventilation	NOUN
fnp-4365	73	18	,	,	PUNCT
fnp-4365	73	19	as	as	ADV
fnp-4365	73	20	well	well	ADV
fnp-4365	73	21	as	as	ADP
fnp-4365	73	22	tocilizumab	tocilizumab	NOUN
fnp-4365	73	23	,	,	PUNCT
fnp-4365	73	24	as	as	SCONJ
fnp-4365	73	25	a	a	DET
fnp-4365	73	26	crs	crs	NOUN
fnp-4365	73	27	could	could	AUX
fnp-4365	73	28	not	not	PART
fnp-4365	73	29	be	be	AUX
fnp-4365	73	30	ruled	rule	VERB
fnp-4365	73	31	out	out	ADP
fnp-4365	73	32	.	.	PUNCT
fnp-4365	74	1	her	her	PRON
fnp-4365	74	2	clinical	clinical	ADJ
fnp-4365	74	3	status	status	NOUN
fnp-4365	74	4	improved	improve	VERB
fnp-4365	74	5	,	,	PUNCT
fnp-4365	74	6	although	although	SCONJ
fnp-4365	74	7	she	she	PRON
fnp-4365	74	8	had	have	VERB
fnp-4365	74	9	persistent	persistent	ADJ
fnp-4365	74	10	fever	fever	NOUN
fnp-4365	74	11	with	with	ADP
fnp-4365	74	12	negative	negative	ADJ
fnp-4365	74	13	microbiological	microbiological	ADJ
fnp-4365	74	14	culture	culture	NOUN
fnp-4365	74	15	.	.	PUNCT
fnp-4365	75	1	fourteen	fourteen	NUM
fnp-4365	75	2	days	day	NOUN
fnp-4365	75	3	after	after	ADP
fnp-4365	75	4	the	the	DET
fnp-4365	75	5	infusion	infusion	NOUN
fnp-4365	75	6	she	she	PRON
fnp-4365	75	7	progressed	progress	VERB
fnp-4365	75	8	with	with	ADP
fnp-4365	75	9	fever	fever	NOUN
fnp-4365	75	10	,	,	PUNCT
fnp-4365	75	11	hemodynamic	hemodynamic	ADJ
fnp-4365	75	12	instability	instability	NOUN
fnp-4365	75	13	and	and	CCONJ
fnp-4365	75	14	multi	multi	ADJ
fnp-4365	75	15	organ	organ	NOUN
fnp-4365	75	16	failure	failure	NOUN
fnp-4365	75	17	,	,	PUNCT
fnp-4365	75	18	as	as	ADV
fnp-4365	75	19	well	well	ADV
fnp-4365	75	20	as	as	ADP
fnp-4365	75	21	car	car	NOUN
fnp-4365	75	22	t	t	NOUN
fnp-4365	75	23	-	-	PUNCT
fnp-4365	75	24	cells	cell	NOUN
fnp-4365	75	25	amplification	amplification	NOUN
fnp-4365	75	26	in	in	ADP
fnp-4365	75	27	peripheral	peripheral	ADJ
fnp-4365	75	28	blood	blood	NOUN
fnp-4365	75	29	.	.	PUNCT
fnp-4365	76	1	with	with	ADP
fnp-4365	76	2	the	the	DET
fnp-4365	76	3	diagnosis	diagnosis	NOUN
fnp-4365	76	4	of	of	ADP
fnp-4365	76	5	crs	crs	PROPN
fnp-4365	76	6	,	,	PUNCT
fnp-4365	76	7	a	a	DET
fnp-4365	76	8	second	second	ADJ
fnp-4365	76	9	dose	dose	NOUN
fnp-4365	76	10	of	of	ADP
fnp-4365	76	11	tocilizumab	tocilizumab	NOUN
fnp-4365	76	12	was	be	AUX
fnp-4365	76	13	administered	administer	VERB
fnp-4365	76	14	with	with	ADP
fnp-4365	76	15	only	only	ADJ
fnp-4365	76	16	partial	partial	ADJ
fnp-4365	76	17	improvement	improvement	NOUN
fnp-4365	76	18	.	.	PUNCT
fnp-4365	77	1	steroids	steroid	NOUN
fnp-4365	77	2	were	be	AUX
fnp-4365	77	3	added	add	VERB
fnp-4365	77	4	,	,	PUNCT
fnp-4365	77	5	but	but	CCONJ
fnp-4365	77	6	the	the	DET
fnp-4365	77	7	patient	patient	NOUN
fnp-4365	77	8	developed	develop	VERB
fnp-4365	77	9	confusion	confusion	NOUN
fnp-4365	77	10	,	,	PUNCT
fnp-4365	77	11	suggesting	suggest	VERB
fnp-4365	77	12	neurotoxicity	neurotoxicity	NOUN
fnp-4365	77	13	.	.	PUNCT
fnp-4365	78	1	the	the	DET
fnp-4365	78	2	electroencephalogram	electroencephalogram	NOUN
fnp-4365	78	3	(	(	PUNCT
fnp-4365	78	4	eeg	eeg	NOUN
fnp-4365	78	5	)	)	PUNCT
fnp-4365	78	6	showed	show	VERB
fnp-4365	78	7	generalized	generalized	ADJ
fnp-4365	78	8	slowing	slowing	NOUN
fnp-4365	78	9	,	,	PUNCT
fnp-4365	78	10	compatible	compatible	ADJ
fnp-4365	78	11	with	with	ADP
fnp-4365	78	12	encephalopathy	encephalopathy	NOUN
fnp-4365	78	13	,	,	PUNCT
fnp-4365	78	14	and	and	CCONJ
fnp-4365	78	15	the	the	DET
fnp-4365	78	16	brain	brain	NOUN
fnp-4365	78	17	mri	mri	NOUN
fnp-4365	78	18	showed	show	VERB
fnp-4365	78	19	two	two	NUM
fnp-4365	78	20	non	non	ADJ
fnp-4365	78	21	-	-	ADJ
fnp-4365	78	22	specific	specific	ADJ
fnp-4365	78	23	signal	signal	NOUN
fnp-4365	78	24	abnormalities	abnormality	NOUN
fnp-4365	78	25	/	/	SYM
fnp-4365	78	26	foci	focus	NOUN
fnp-4365	78	27	of	of	ADP
fnp-4365	78	28	signal	signal	ADJ
fnp-4365	78	29	alteration	alteration	NOUN
fnp-4365	78	30	without	without	ADP
fnp-4365	78	31	mass	mass	ADJ
fnp-4365	78	32	effect	effect	NOUN
fnp-4365	78	33	or	or	CCONJ
fnp-4365	78	34	contrast	contrast	VERB
fnp-4365	78	35	uptake	uptake	ADJ
fnp-4365	78	36	,	,	PUNCT
fnp-4365	78	37	lateral	lateral	ADJ
fnp-4365	78	38	to	to	ADP
fnp-4365	78	39	the	the	DET
fnp-4365	78	40	left	left	ADJ
fnp-4365	78	41	ventricular	ventricular	ADJ
fnp-4365	78	42	atrium	atrium	NOUN
fnp-4365	78	43	and	and	CCONJ
fnp-4365	78	44	in	in	ADP
fnp-4365	78	45	the	the	DET
fnp-4365	78	46	right	right	ADJ
fnp-4365	78	47	temporo	temporo	PROPN
fnp-4365	78	48	-	-	PUNCT
fnp-4365	78	49	occipital	occipital	NOUN
fnp-4365	78	50	area	area	NOUN
fnp-4365	78	51	adjacent	adjacent	ADJ
fnp-4365	78	52	to	to	ADP
fnp-4365	78	53	the	the	DET
fnp-4365	78	54	ventricular	ventricular	ADJ
fnp-4365	78	55	occipital	occipital	NOUN
fnp-4365	78	56	horn	horn	NOUN
fnp-4365	78	57	.	.	PUNCT
fnp-4365	79	1	flow	flow	NOUN
fnp-4365	79	2	cytometry	cytometry	NOUN
fnp-4365	79	3	(	(	PUNCT
fnp-4365	79	4	fc	fc	INTJ
fnp-4365	79	5	)	)	PUNCT
fnp-4365	79	6	of	of	ADP
fnp-4365	79	7	the	the	DET
fnp-4365	79	8	csf	csf	NOUN
fnp-4365	79	9	revealed	reveal	VERB
fnp-4365	79	10	the	the	DET
fnp-4365	79	11	presence	presence	NOUN
fnp-4365	79	12	of	of	ADP
fnp-4365	79	13	mature	mature	ADJ
fnp-4365	79	14	t	t	NOUN
fnp-4365	79	15	lymphocytes	lymphocyte	NOUN
fnp-4365	79	16	and	and	CCONJ
fnp-4365	79	17	isolated	isolated	ADJ
fnp-4365	79	18	blasts	blast	NOUN
fnp-4365	79	19	,	,	PUNCT
fnp-4365	79	20	and	and	CCONJ
fnp-4365	79	21	the	the	DET
fnp-4365	79	22	microbiological	microbiological	ADJ
fnp-4365	79	23	csf	csf	ADJ
fnp-4365	79	24	study	study	NOUN
fnp-4365	79	25	was	be	AUX
fnp-4365	79	26	weakly	weakly	ADV
fnp-4365	79	27	positive	positive	ADJ
fnp-4365	79	28	for	for	ADP
fnp-4365	79	29	hhv-6	hhv-6	NOUN
fnp-4365	79	30	.	.	PUNCT
fnp-4365	79	31	nineteen	nineteen	NUM
fnp-4365	79	32	days	day	NOUN
fnp-4365	79	33	after	after	ADP
fnp-4365	79	34	the	the	DET
fnp-4365	79	35	infusion	infusion	NOUN
fnp-4365	79	36	she	she	PRON
fnp-4365	79	37	presented	present	VERB
fnp-4365	79	38	rapidly	rapidly	ADV
fnp-4365	79	39	progressive	progressive	ADJ
fnp-4365	79	40	respiratory	respiratory	ADJ
fnp-4365	79	41	and	and	CCONJ
fnp-4365	79	42	hemodynamic	hemodynamic	ADJ
fnp-4365	79	43	deterioration	deterioration	NOUN
fnp-4365	79	44	requiring	require	VERB
fnp-4365	79	45	intubation	intubation	NOUN
fnp-4365	79	46	and	and	CCONJ
fnp-4365	79	47	vasoactive	vasoactive	ADJ
fnp-4365	79	48	treatment	treatment	NOUN
fnp-4365	79	49	.	.	PUNCT
fnp-4365	80	1	the	the	DET
fnp-4365	80	2	tracheal	tracheal	ADJ
fnp-4365	80	3	aspirate	aspirate	NOUN
fnp-4365	80	4	was	be	AUX
fnp-4365	80	5	positive	positive	ADJ
fnp-4365	80	6	for	for	ADP
fnp-4365	80	7	stenotrophomona	stenotrophomona	NOUN
fnp-4365	80	8	maltophila	maltophila	PROPN
fnp-4365	80	9	and	and	CCONJ
fnp-4365	80	10	the	the	DET
fnp-4365	80	11	diagnostic	diagnostic	NOUN
fnp-4365	80	12	of	of	ADP
fnp-4365	80	13	septic	septic	ADJ
fnp-4365	80	14	shock	shock	NOUN
fnp-4365	80	15	due	due	ADP
fnp-4365	80	16	to	to	ADP
fnp-4365	80	17	nosocomial	nosocomial	ADJ
fnp-4365	80	18	pneumonia	pneumonia	NOUN
fnp-4365	80	19	was	be	AUX
fnp-4365	80	20	established	establish	VERB
fnp-4365	80	21	.	.	PUNCT
fnp-4365	81	1	antibiotic	antibiotic	ADJ
fnp-4365	81	2	treatment	treatment	NOUN
fnp-4365	81	3	was	be	AUX
fnp-4365	81	4	escalated	escalate	VERB
fnp-4365	81	5	.	.	PUNCT
fnp-4365	82	1	however	however	ADV
fnp-4365	82	2	,	,	PUNCT
fnp-4365	82	3	she	she	PRON
fnp-4365	82	4	progressed	progress	VERB
fnp-4365	82	5	with	with	ADP
fnp-4365	82	6	pulmonary	pulmonary	ADJ
fnp-4365	82	7	hemorrhage	hemorrhage	NOUN
fnp-4365	82	8	and	and	CCONJ
fnp-4365	82	9	died	die	VERB
fnp-4365	82	10	23	23	NUM
fnp-4365	82	11	days	day	NOUN
fnp-4365	82	12	after	after	ADP
fnp-4365	82	13	the	the	DET
fnp-4365	82	14	infusion	infusion	NOUN
fnp-4365	82	15	.	.	PUNCT
fnp-4365	83	1	neuropathologic	neuropathologic	ADJ
fnp-4365	83	2	gross	gross	ADJ
fnp-4365	83	3	examination	examination	NOUN
fnp-4365	83	4	revealed	reveal	VERB
fnp-4365	83	5	a	a	DET
fnp-4365	83	6	1280	1280	NUM
fnp-4365	83	7	g	g	NOUN
fnp-4365	83	8	fixed	fix	VERB
fnp-4365	83	9	brain	brain	NOUN
fnp-4365	83	10	with	with	ADP
fnp-4365	83	11	diffuse	diffuse	ADJ
fnp-4365	83	12	petechiae	petechiae	NOUN
fnp-4365	83	13	in	in	ADP
fnp-4365	83	14	the	the	DET
fnp-4365	83	15	dura	dura	NOUN
fnp-4365	83	16	mater	mater	NOUN
fnp-4365	83	17	.	.	PUNCT
fnp-4365	84	1	coronal	coronal	ADJ
fnp-4365	84	2	sections	section	NOUN
fnp-4365	84	3	showed	show	VERB
fnp-4365	84	4	slight	slight	ADJ
fnp-4365	84	5	discoloration	discoloration	NOUN
fnp-4365	84	6	of	of	ADP
fnp-4365	84	7	right	right	ADJ
fnp-4365	84	8	temporal	temporal	ADJ
fnp-4365	84	9	white	white	ADJ
fnp-4365	84	10	matter	matter	NOUN
fnp-4365	84	11	.	.	PUNCT
fnp-4365	85	1	histology	histology	NOUN
fnp-4365	85	2	showed	show	VERB
fnp-4365	85	3	mild	mild	ADJ
fnp-4365	85	4	arteriosclerosis	arteriosclerosis	NOUN
fnp-4365	85	5	and	and	CCONJ
fnp-4365	85	6	arteriolar	arteriolar	ADJ
fnp-4365	85	7	hyalinosis	hyalinosis	NOUN
fnp-4365	85	8	,	,	PUNCT
fnp-4365	85	9	minimal	minimal	ADJ
fnp-4365	85	10	lymphocytic	lymphocytic	ADJ
fnp-4365	85	11	perivascular	perivascular	ADJ
fnp-4365	85	12	infiltrate	infiltrate	NOUN
fnp-4365	85	13	(	(	PUNCT
fnp-4365	85	14	t	t	NOUN
fnp-4365	85	15	-	-	PUNCT
fnp-4365	85	16	cell	cell	NOUN
fnp-4365	85	17	predominant	predominant	NOUN
fnp-4365	85	18	)	)	PUNCT
fnp-4365	85	19	and	and	CCONJ
fnp-4365	85	20	occasional	occasional	ADJ
fnp-4365	85	21	intravascular	intravascular	ADJ
fnp-4365	85	22	infiltration	infiltration	NOUN
fnp-4365	85	23	by	by	ADP
fnp-4365	85	24	atypical	atypical	ADJ
fnp-4365	85	25	cells	cell	NOUN
fnp-4365	85	26	with	with	ADP
fnp-4365	85	27	tdt	tdt	PROPN
fnp-4365	85	28	positivity	positivity	NOUN
fnp-4365	85	29	(	(	PUNCT
fnp-4365	85	30	figure	figure	NOUN
fnp-4365	85	31	2	2	NUM
fnp-4365	85	32	)	)	PUNCT
fnp-4365	85	33	,	,	PUNCT
fnp-4365	85	34	confirming	confirm	VERB
fnp-4365	85	35	the	the	DET
fnp-4365	85	36	presence	presence	NOUN
fnp-4365	85	37	of	of	ADP
fnp-4365	85	38	leukemic	leukemic	ADJ
fnp-4365	85	39	cells	cell	NOUN
fnp-4365	85	40	,	,	PUNCT
fnp-4365	85	41	without	without	ADP
fnp-4365	85	42	remarkable	remarkable	ADJ
fnp-4365	85	43	parenchymal	parenchymal	ADJ
fnp-4365	85	44	involvement	involvement	NOUN
fnp-4365	85	45	.	.	PUNCT
fnp-4365	86	1	car	car	NOUN
fnp-4365	86	2	t	t	NOUN
fnp-4365	86	3	-	-	PUNCT
fnp-4365	86	4	cell	cell	NOUN
fnp-4365	86	5	pcr	pcr	NOUN
fnp-4365	86	6	in	in	ADP
fnp-4365	86	7	the	the	DET
fnp-4365	86	8	brain	brain	NOUN
fnp-4365	86	9	was	be	AUX
fnp-4365	86	10	negative	negative	ADJ
fnp-4365	86	11	and	and	CCONJ
fnp-4365	86	12	there	there	PRON
fnp-4365	86	13	were	be	VERB
fnp-4365	86	14	no	no	DET
fnp-4365	86	15	signs	sign	NOUN
fnp-4365	86	16	suggestive	suggestive	ADJ
fnp-4365	86	17	of	of	ADP
fnp-4365	86	18	encephalitis	encephalitis	NOUN
fnp-4365	86	19	associated	associate	VERB
fnp-4365	86	20	to	to	ADP
fnp-4365	86	21	viral	viral	ADJ
fnp-4365	86	22	infection	infection	NOUN
fnp-4365	86	23	.	.	PUNCT
fnp-4365	87	1	full	full	ADJ
fnp-4365	87	2	body	body	NOUN
fnp-4365	87	3	autopsy	autopsy	NOUN
fnp-4365	87	4	demonstrated	demonstrate	VERB
fnp-4365	87	5	massive	massive	ADJ
fnp-4365	87	6	dissemination	dissemination	NOUN
fnp-4365	87	7	of	of	ADP
fnp-4365	87	8	the	the	DET
fnp-4365	87	9	lymphoproliferative	lymphoproliferative	ADJ
fnp-4365	87	10	process	process	NOUN
fnp-4365	87	11	affecting	affect	VERB
fnp-4365	87	12	the	the	DET
fnp-4365	87	13	lungs	lung	NOUN
fnp-4365	87	14	,	,	PUNCT
fnp-4365	87	15	liver	liver	NOUN
fnp-4365	87	16	,	,	PUNCT
fnp-4365	87	17	spleen	spleen	NOUN
fnp-4365	87	18	,	,	PUNCT
fnp-4365	87	19	bone	bone	NOUN
fnp-4365	87	20	marrow	marrow	NOUN
fnp-4365	87	21	,	,	PUNCT
fnp-4365	87	22	lymph	lymph	NOUN
fnp-4365	87	23	nodes	node	NOUN
fnp-4365	87	24	and	and	CCONJ
fnp-4365	87	25	mammary	mammary	ADJ
fnp-4365	87	26	gland	gland	NOUN
fnp-4365	87	27	.	.	PUNCT
fnp-4365	88	1	the	the	DET
fnp-4365	88	2	cause	cause	NOUN
fnp-4365	88	3	of	of	ADP
fnp-4365	88	4	death	death	NOUN
fnp-4365	88	5	was	be	AUX
fnp-4365	88	6	attributed	attribute	VERB
fnp-4365	88	7	to	to	ADP
fnp-4365	88	8	disease	disease	NOUN
fnp-4365	88	9	progression	progression	NOUN
fnp-4365	88	10	.	.	PUNCT
fnp-4365	89	1	figure	figure	NOUN
fnp-4365	89	2	2	2	NUM
fnp-4365	89	3	.	.	PUNCT
fnp-4365	90	1	remarkable	remarkable	ADJ
fnp-4365	90	2	histological	histological	ADJ
fnp-4365	90	3	features	feature	NOUN
fnp-4365	90	4	:	:	PUNCT
fnp-4365	90	5	case	case	NOUN
fnp-4365	90	6	1	1	NUM
fnp-4365	90	7	presented	present	VERB
fnp-4365	90	8	scant	scant	ADJ
fnp-4365	90	9	intravascular	intravascular	ADJ
fnp-4365	90	10	infiltration	infiltration	NOUN
fnp-4365	90	11	of	of	ADP
fnp-4365	90	12	the	the	DET
fnp-4365	90	13	leukemia	leukemia	NOUN
fnp-4365	90	14	(	(	PUNCT
fnp-4365	90	15	a	a	X
fnp-4365	90	16	)	)	PUNCT
fnp-4365	90	17	,	,	PUNCT
fnp-4365	90	18	which	which	PRON
fnp-4365	90	19	was	be	AUX
fnp-4365	90	20	positive	positive	ADJ
fnp-4365	90	21	for	for	ADP
fnp-4365	90	22	tdt	tdt	PROPN
fnp-4365	90	23	(	(	PUNCT
fnp-4365	90	24	a	a	PRON
fnp-4365	90	25	,	,	PUNCT
fnp-4365	90	26	inset	inset	NOUN
fnp-4365	90	27	)	)	PUNCT
fnp-4365	90	28	.	.	PUNCT
fnp-4365	91	1	case	case	NOUN
fnp-4365	91	2	5	5	NUM
fnp-4365	91	3	showed	show	VERB
fnp-4365	91	4	an	an	DET
fnp-4365	91	5	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	91	6	,	,	PUNCT
fnp-4365	91	7	with	with	ADP
fnp-4365	91	8	predominant	predominant	ADJ
fnp-4365	91	9	involvement	involvement	NOUN
fnp-4365	91	10	of	of	ADP
fnp-4365	91	11	limbic	limbic	ADJ
fnp-4365	91	12	areas	area	NOUN
fnp-4365	91	13	(	(	PUNCT
fnp-4365	91	14	b	b	NOUN
fnp-4365	91	15	,	,	PUNCT
fnp-4365	91	16	entorhinal	entorhinal	ADJ
fnp-4365	91	17	cortex	cortex	NOUN
fnp-4365	91	18	)	)	PUNCT
fnp-4365	91	19	,	,	PUNCT
fnp-4365	91	20	basal	basal	ADJ
fnp-4365	91	21	ganglia	ganglia	NOUN
fnp-4365	91	22	(	(	PUNCT
fnp-4365	91	23	c	c	X
fnp-4365	91	24	,	,	PUNCT
fnp-4365	91	25	hypothalamus	hypothalamus	PROPN
fnp-4365	91	26	)	)	PUNCT
fnp-4365	91	27	,	,	PUNCT
fnp-4365	91	28	brainstem	brainstem	NOUN
fnp-4365	91	29	(	(	PUNCT
fnp-4365	91	30	d	d	NOUN
fnp-4365	91	31	,	,	PUNCT
fnp-4365	91	32	substantia	substantia	NOUN
fnp-4365	91	33	nigra	nigra	NOUN
fnp-4365	91	34	)	)	PUNCT
fnp-4365	91	35	and	and	CCONJ
fnp-4365	91	36	spinal	spinal	ADJ
fnp-4365	91	37	cord	cord	NOUN
fnp-4365	91	38	(	(	PUNCT
fnp-4365	91	39	e	e	NOUN
fnp-4365	91	40	,	,	PUNCT
fnp-4365	91	41	lumbar	lumbar	ADJ
fnp-4365	91	42	spinal	spinal	NOUN
fnp-4365	91	43	cord	cord	NOUN
fnp-4365	91	44	)	)	PUNCT
fnp-4365	91	45	.	.	PUNCT
fnp-4365	92	1	t	t	NOUN
fnp-4365	92	2	-	-	PUNCT
fnp-4365	92	3	cell	cell	NOUN
fnp-4365	92	4	lymphocytic	lymphocytic	ADJ
fnp-4365	92	5	infiltrates	infiltrate	NOUN
fnp-4365	92	6	were	be	AUX
fnp-4365	92	7	both	both	PRON
fnp-4365	92	8	cd8	cd8	PROPN
fnp-4365	92	9	+	+	PROPN
fnp-4365	92	10	and	and	CCONJ
fnp-4365	92	11	cd4	cd4	PROPN
fnp-4365	92	12	+	+	PROPN
fnp-4365	92	13	,	,	PUNCT
fnp-4365	92	14	with	with	ADP
fnp-4365	92	15	predominance	predominance	NOUN
fnp-4365	92	16	of	of	ADP
fnp-4365	92	17	the	the	DET
fnp-4365	92	18	former	former	ADJ
fnp-4365	92	19	(	(	PUNCT
fnp-4365	92	20	f	f	PROPN
fnp-4365	92	21	and	and	CCONJ
fnp-4365	92	22	g	g	PROPN
fnp-4365	92	23	,	,	PUNCT
fnp-4365	92	24	cd8	cd8	PROPN
fnp-4365	92	25	+	+	PROPN
fnp-4365	92	26	and	and	CCONJ
fnp-4365	92	27	cd4	cd4	PROPN
fnp-4365	92	28	+	+	PROPN
fnp-4365	92	29	infiltrates	infiltrate	NOUN
fnp-4365	92	30	in	in	ADP
fnp-4365	92	31	lumbar	lumbar	ADJ
fnp-4365	92	32	spinal	spinal	NOUN
fnp-4365	92	33	cord	cord	NOUN
fnp-4365	92	34	,	,	PUNCT
fnp-4365	92	35	which	which	PRON
fnp-4365	92	36	did	do	AUX
fnp-4365	92	37	not	not	PART
fnp-4365	92	38	show	show	VERB
fnp-4365	92	39	marked	mark	VERB
fnp-4365	92	40	tropism	tropism	NOUN
fnp-4365	92	41	for	for	ADP
fnp-4365	92	42	motor	motor	NOUN
fnp-4365	92	43	neurons	neuron	NOUN
fnp-4365	92	44	(	(	PUNCT
fnp-4365	92	45	arrowheads	arrowhead	NOUN
fnp-4365	92	46	)	)	PUNCT
fnp-4365	92	47	)	)	PUNCT
fnp-4365	93	1	(	(	PUNCT
fnp-4365	93	2	a	a	DET
fnp-4365	93	3	400x	400x	ADJ
fnp-4365	93	4	,	,	PUNCT
fnp-4365	93	5	scale	scale	NOUN
fnp-4365	93	6	bar	bar	NOUN
fnp-4365	93	7	20	20	NUM
fnp-4365	93	8	µm	µm	NOUN
fnp-4365	93	9	,	,	PUNCT
fnp-4365	93	10	inset	inset	NOUN
fnp-4365	93	11	600x	600x	NOUN
fnp-4365	93	12	,	,	PUNCT
fnp-4365	93	13	scale	scale	NOUN
fnp-4365	93	14	bar	bar	NOUN
fnp-4365	93	15	20	20	NUM
fnp-4365	93	16	µm	µm	NOUN
fnp-4365	93	17	;	;	PUNCT
fnp-4365	93	18	b	b	X
fnp-4365	93	19	to	to	ADP
fnp-4365	93	20	g	g	NOUN
fnp-4365	93	21	,	,	PUNCT
fnp-4365	93	22	200x	200x	NUM
fnp-4365	93	23	,	,	PUNCT
fnp-4365	93	24	scale	scale	NOUN
fnp-4365	93	25	bar	bar	NOUN
fnp-4365	93	26	50	50	NUM
fnp-4365	93	27	µm	µm	NOUN
fnp-4365	93	28	)	)	PUNCT
fnp-4365	93	29	.	.	PUNCT
fnp-4365	94	1	case	case	NOUN
fnp-4365	94	2	2	2	NUM
fnp-4365	94	3	a	a	DET
fnp-4365	94	4	19	19	NUM
fnp-4365	94	5	-	-	PUNCT
fnp-4365	94	6	year	year	NOUN
fnp-4365	94	7	-	-	PUNCT
fnp-4365	94	8	old	old	ADJ
fnp-4365	94	9	woman	woman	NOUN
fnp-4365	94	10	presented	present	VERB
fnp-4365	94	11	with	with	ADP
fnp-4365	94	12	primary	primary	ADJ
fnp-4365	94	13	mediastinal	mediastinal	ADJ
fnp-4365	94	14	diffuse	diffuse	VERB
fnp-4365	94	15	large	large	ADJ
fnp-4365	94	16	b	b	NOUN
fnp-4365	94	17	-	-	PUNCT
fnp-4365	94	18	cell	cell	NOUN
fnp-4365	94	19	lymphoma	lymphoma	NOUN
fnp-4365	94	20	with	with	ADP
fnp-4365	94	21	infiltration	infiltration	NOUN
fnp-4365	94	22	of	of	ADP
fnp-4365	94	23	soft	soft	ADJ
fnp-4365	94	24	tissues	tissue	NOUN
fnp-4365	94	25	.	.	PUNCT
fnp-4365	95	1	she	she	PRON
fnp-4365	95	2	had	have	VERB
fnp-4365	95	3	a	a	DET
fnp-4365	95	4	protracted	protract	VERB
fnp-4365	95	5	course	course	NOUN
fnp-4365	95	6	with	with	ADP
fnp-4365	95	7	persistent	persistent	ADJ
fnp-4365	95	8	mediastinal	mediastinal	ADJ
fnp-4365	95	9	disease	disease	NOUN
fnp-4365	95	10	,	,	PUNCT
fnp-4365	95	11	gastric	gastric	ADJ
fnp-4365	95	12	relapse	relapse	NOUN
fnp-4365	95	13	,	,	PUNCT
fnp-4365	95	14	superior	superior	ADJ
fnp-4365	95	15	vena	vena	NOUN
fnp-4365	95	16	cava	cava	NOUN
fnp-4365	95	17	syndrome	syndrome	NOUN
fnp-4365	95	18	and	and	CCONJ
fnp-4365	95	19	pericardial	pericardial	ADJ
fnp-4365	95	20	and	and	CCONJ
fnp-4365	95	21	pleural	pleural	ADJ
fnp-4365	95	22	malignant	malignant	ADJ
fnp-4365	95	23	effusions	effusion	NOUN
fnp-4365	95	24	.	.	PUNCT
fnp-4365	96	1	she	she	PRON
fnp-4365	96	2	received	receive	VERB
fnp-4365	96	3	multiple	multiple	ADJ
fnp-4365	96	4	therapy	therapy	NOUN
fnp-4365	96	5	lines	line	NOUN
fnp-4365	96	6	including	include	VERB
fnp-4365	96	7	autologous	autologous	ADJ
fnp-4365	96	8	stem	stem	NOUN
fnp-4365	96	9	cell	cell	NOUN
fnp-4365	96	10	transplant	transplant	NOUN
fnp-4365	96	11	,	,	PUNCT
fnp-4365	96	12	local	local	ADJ
fnp-4365	96	13	radiotherapy	radiotherapy	NOUN
fnp-4365	96	14	,	,	PUNCT
fnp-4365	96	15	and	and	CCONJ
fnp-4365	96	16	several	several	ADJ
fnp-4365	96	17	chemotherapy	chemotherapy	NOUN
fnp-4365	96	18	lines	line	NOUN
fnp-4365	96	19	comprising	comprise	VERB
fnp-4365	96	20	burkimab	burkimab	NOUN
fnp-4365	96	21	protocol	protocol	NOUN
fnp-4365	96	22	and	and	CCONJ
fnp-4365	96	23	ibrutinib	ibrutinib	NOUN
fnp-4365	96	24	,	,	PUNCT
fnp-4365	96	25	before	before	ADP
fnp-4365	96	26	considering	consider	VERB
fnp-4365	96	27	car	car	NOUN
fnp-4365	96	28	t	t	NOUN
fnp-4365	96	29	treatment	treatment	NOUN
fnp-4365	96	30	.	.	PUNCT
fnp-4365	97	1	her	her	PRON
fnp-4365	97	2	initial	initial	ADJ
fnp-4365	97	3	mri	mri	NOUN
fnp-4365	97	4	showed	show	VERB
fnp-4365	97	5	mild	mild	ADJ
fnp-4365	97	6	global	global	ADJ
fnp-4365	97	7	cerebral	cerebral	ADJ
fnp-4365	97	8	atrophy	atrophy	NOUN
fnp-4365	97	9	without	without	ADP
fnp-4365	97	10	other	other	ADJ
fnp-4365	97	11	remarkable	remarkable	ADJ
fnp-4365	97	12	findings	finding	NOUN
fnp-4365	97	13	.	.	PUNCT
fnp-4365	98	1	on	on	ADP
fnp-4365	98	2	admission	admission	NOUN
fnp-4365	98	3	she	she	PRON
fnp-4365	98	4	was	be	AUX
fnp-4365	98	5	hypotensive	hypotensive	ADJ
fnp-4365	98	6	and	and	CCONJ
fnp-4365	98	7	tachycardic	tachycardic	ADJ
fnp-4365	98	8	and	and	CCONJ
fnp-4365	98	9	positron	positron	NOUN
fnp-4365	98	10	emission	emission	NOUN
fnp-4365	98	11	tomography	tomography	NOUN
fnp-4365	98	12	(	(	PUNCT
fnp-4365	98	13	pet	pet	NOUN
fnp-4365	98	14	)	)	PUNCT
fnp-4365	98	15	–	–	PUNCT
fnp-4365	98	16	computed	compute	VERB
fnp-4365	98	17	tomography	tomography	NOUN
fnp-4365	98	18	(	(	PUNCT
fnp-4365	98	19	ct	ct	NOUN
fnp-4365	98	20	)	)	PUNCT
fnp-4365	98	21	scan	scan	NOUN
fnp-4365	98	22	showed	show	VERB
fnp-4365	98	23	pericardial	pericardial	ADJ
fnp-4365	98	24	infiltration	infiltration	NOUN
fnp-4365	98	25	in	in	ADP
fnp-4365	98	26	addition	addition	NOUN
fnp-4365	98	27	to	to	ADP
fnp-4365	98	28	supra	supra	ADJ
fnp-4365	98	29	and	and	CCONJ
fnp-4365	98	30	infradiaphragmatic	infradiaphragmatic	ADJ
fnp-4365	98	31	lymphadenopathies	lymphadenopathy	NOUN
fnp-4365	98	32	,	,	PUNCT
fnp-4365	98	33	with	with	ADP
fnp-4365	98	34	soft	soft	ADJ
fnp-4365	98	35	tissue	tissue	NOUN
fnp-4365	98	36	,	,	PUNCT
fnp-4365	98	37	muscle	muscle	NOUN
fnp-4365	98	38	,	,	PUNCT
fnp-4365	98	39	bone	bone	NOUN
fnp-4365	98	40	,	,	PUNCT
fnp-4365	98	41	and	and	CCONJ
fnp-4365	98	42	pleural	pleural	ADJ
fnp-4365	98	43	multifocal	multifocal	ADJ
fnp-4365	98	44	enhancement	enhancement	NOUN
fnp-4365	98	45	.	.	PUNCT
fnp-4365	99	1	the	the	DET
fnp-4365	99	2	presence	presence	NOUN
fnp-4365	99	3	of	of	ADP
fnp-4365	99	4	bone	bone	NOUN
fnp-4365	99	5	marrow	marrow	PROPN
fnp-4365	99	6	aplasia	aplasia	NOUN
fnp-4365	99	7	delayed	delay	VERB
fnp-4365	99	8	the	the	DET
fnp-4365	99	9	conditioning	conditioning	NOUN
fnp-4365	99	10	with	with	ADP
fnp-4365	99	11	fludarabine	fludarabine	NOUN
fnp-4365	99	12	-	-	PUNCT
fnp-4365	99	13	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	99	14	.	.	PUNCT
fnp-4365	100	1	respiratory	respiratory	ADJ
fnp-4365	100	2	distress	distress	NOUN
fnp-4365	100	3	increased	increase	VERB
fnp-4365	100	4	after	after	ADP
fnp-4365	100	5	conditioning	condition	VERB
fnp-4365	100	6	along	along	ADP
fnp-4365	100	7	with	with	ADP
fnp-4365	100	8	the	the	DET
fnp-4365	100	9	pleural	pleural	ADJ
fnp-4365	100	10	effusion	effusion	NOUN
fnp-4365	100	11	,	,	PUNCT
fnp-4365	100	12	and	and	CCONJ
fnp-4365	100	13	she	she	PRON
fnp-4365	100	14	was	be	AUX
fnp-4365	100	15	admitted	admit	VERB
fnp-4365	100	16	to	to	ADP
fnp-4365	100	17	the	the	DET
fnp-4365	100	18	intensive	intensive	ADJ
fnp-4365	100	19	care	care	NOUN
fnp-4365	100	20	unit	unit	NOUN
fnp-4365	100	21	(	(	PUNCT
fnp-4365	100	22	icu	icu	PROPN
fnp-4365	100	23	)	)	PUNCT
fnp-4365	100	24	to	to	PART
fnp-4365	100	25	receive	receive	VERB
fnp-4365	100	26	car	car	NOUN
fnp-4365	100	27	-	-	PUNCT
fnp-4365	100	28	cd19	cd19	PROPN
fnp-4365	100	29	infusions	infusion	NOUN
fnp-4365	100	30	.	.	PUNCT
fnp-4365	101	1	the	the	DET
fnp-4365	101	2	following	follow	VERB
fnp-4365	101	3	48	48	NUM
fnp-4365	101	4	hours	hour	NOUN
fnp-4365	101	5	,	,	PUNCT
fnp-4365	101	6	her	her	PRON
fnp-4365	101	7	respiratory	respiratory	ADJ
fnp-4365	101	8	status	status	NOUN
fnp-4365	101	9	worsened	worsen	VERB
fnp-4365	101	10	,	,	PUNCT
fnp-4365	101	11	adding	add	VERB
fnp-4365	101	12	hemodynamic	hemodynamic	ADJ
fnp-4365	101	13	instability	instability	NOUN
fnp-4365	101	14	and	and	CCONJ
fnp-4365	101	15	fever	fever	NOUN
fnp-4365	101	16	.	.	PUNCT
fnp-4365	102	1	a	a	DET
fnp-4365	102	2	nosocomial	nosocomial	ADJ
fnp-4365	102	3	pneumonia	pneumonia	NOUN
fnp-4365	102	4	was	be	AUX
fnp-4365	102	5	diagnosed	diagnose	VERB
fnp-4365	102	6	by	by	ADP
fnp-4365	102	7	x	x	NOUN
fnp-4365	102	8	-	-	NOUN
fnp-4365	102	9	ray	ray	NOUN
fnp-4365	102	10	and	and	CCONJ
fnp-4365	102	11	ultrasound	ultrasound	NOUN
fnp-4365	102	12	examination	examination	NOUN
fnp-4365	102	13	,	,	PUNCT
fnp-4365	102	14	without	without	ADP
fnp-4365	102	15	microbiological	microbiological	ADJ
fnp-4365	102	16	isolation	isolation	NOUN
fnp-4365	102	17	,	,	PUNCT
fnp-4365	102	18	and	and	CCONJ
fnp-4365	102	19	she	she	PRON
fnp-4365	102	20	received	receive	VERB
fnp-4365	102	21	antibiotics	antibiotic	NOUN
fnp-4365	102	22	and	and	CCONJ
fnp-4365	102	23	fluconazole	fluconazole	NOUN
fnp-4365	102	24	.	.	PUNCT
fnp-4365	103	1	despite	despite	SCONJ
fnp-4365	103	2	treatment	treatment	NOUN
fnp-4365	103	3	,	,	PUNCT
fnp-4365	103	4	her	her	PRON
fnp-4365	103	5	status	status	NOUN
fnp-4365	103	6	worsened	worsen	VERB
fnp-4365	103	7	,	,	PUNCT
fnp-4365	103	8	requiring	require	VERB
fnp-4365	103	9	invasive	invasive	ADJ
fnp-4365	103	10	mechanical	mechanical	ADJ
fnp-4365	103	11	ventilation	ventilation	NOUN
fnp-4365	103	12	and	and	CCONJ
fnp-4365	103	13	vasoactive	vasoactive	ADJ
fnp-4365	103	14	treatment	treatment	NOUN
fnp-4365	103	15	.	.	PUNCT
fnp-4365	104	1	subsequently	subsequently	ADV
fnp-4365	104	2	,	,	PUNCT
fnp-4365	104	3	she	she	PRON
fnp-4365	104	4	presented	present	VERB
fnp-4365	104	5	superior	superior	ADJ
fnp-4365	104	6	vena	vena	NOUN
fnp-4365	104	7	cava	cava	NOUN
fnp-4365	104	8	syndrome	syndrome	NOUN
fnp-4365	104	9	and	and	CCONJ
fnp-4365	104	10	worsening	worsen	VERB
fnp-4365	104	11	of	of	ADP
fnp-4365	104	12	pericardial	pericardial	ADJ
fnp-4365	104	13	effusion	effusion	NOUN
fnp-4365	104	14	with	with	ADP
fnp-4365	104	15	progression	progression	NOUN
fnp-4365	104	16	of	of	ADP
fnp-4365	104	17	hemodynamic	hemodynamic	ADJ
fnp-4365	104	18	instability	instability	NOUN
fnp-4365	104	19	.	.	PUNCT
fnp-4365	105	1	although	although	SCONJ
fnp-4365	105	2	she	she	PRON
fnp-4365	105	3	received	receive	VERB
fnp-4365	105	4	corticosteroids	corticosteroid	NOUN
fnp-4365	105	5	and	and	CCONJ
fnp-4365	105	6	rituximab	rituximab	NOUN
fnp-4365	105	7	aiming	aim	VERB
fnp-4365	105	8	to	to	PART
fnp-4365	105	9	diminish	diminish	VERB
fnp-4365	105	10	the	the	DET
fnp-4365	105	11	tumoral	tumoral	ADJ
fnp-4365	105	12	mass	mass	NOUN
fnp-4365	105	13	,	,	PUNCT
fnp-4365	105	14	she	she	PRON
fnp-4365	105	15	progressed	progress	VERB
fnp-4365	105	16	to	to	ADP
fnp-4365	105	17	organic	organic	ADJ
fnp-4365	105	18	failure	failure	NOUN
fnp-4365	105	19	,	,	PUNCT
fnp-4365	105	20	and	and	CCONJ
fnp-4365	105	21	died	die	VERB
fnp-4365	105	22	33	33	NUM
fnp-4365	105	23	days	day	NOUN
fnp-4365	105	24	after	after	ADP
fnp-4365	105	25	car	car	NOUN
fnp-4365	105	26	t	t	NOUN
fnp-4365	105	27	infusion	infusion	NOUN
fnp-4365	105	28	.	.	PUNCT
fnp-4365	106	1	neurological	neurological	ADJ
fnp-4365	106	2	symptoms	symptom	NOUN
fnp-4365	106	3	were	be	AUX
fnp-4365	106	4	not	not	PART
fnp-4365	106	5	detected	detect	VERB
fnp-4365	106	6	in	in	ADP
fnp-4365	106	7	the	the	DET
fnp-4365	106	8	course	course	NOUN
fnp-4365	106	9	of	of	ADP
fnp-4365	106	10	the	the	DET
fnp-4365	106	11	disease	disease	NOUN
fnp-4365	106	12	,	,	PUNCT
fnp-4365	106	13	although	although	SCONJ
fnp-4365	106	14	it	it	PRON
fnp-4365	106	15	was	be	AUX
fnp-4365	106	16	difficult	difficult	ADJ
fnp-4365	106	17	to	to	PART
fnp-4365	106	18	examine	examine	VERB
fnp-4365	106	19	the	the	DET
fnp-4365	106	20	patient	patient	NOUN
fnp-4365	106	21	due	due	ADP
fnp-4365	106	22	to	to	ADP
fnp-4365	106	23	sedation	sedation	NOUN
fnp-4365	106	24	administered	administer	VERB
fnp-4365	106	25	during	during	ADP
fnp-4365	106	26	invasive	invasive	ADJ
fnp-4365	106	27	mechanical	mechanical	ADJ
fnp-4365	106	28	ventilation	ventilation	NOUN
fnp-4365	106	29	.	.	PUNCT
fnp-4365	107	1	neuropathologic	neuropathologic	ADJ
fnp-4365	107	2	gross	gross	ADJ
fnp-4365	107	3	examination	examination	NOUN
fnp-4365	107	4	was	be	AUX
fnp-4365	107	5	unavailable	unavailable	ADJ
fnp-4365	107	6	.	.	PUNCT
fnp-4365	108	1	histology	histology	NOUN
fnp-4365	108	2	revealed	reveal	VERB
fnp-4365	108	3	basal	basal	ADJ
fnp-4365	108	4	ganglia	ganglia	NOUN
fnp-4365	108	5	mild	mild	ADJ
fnp-4365	108	6	gliosis	gliosis	NOUN
fnp-4365	108	7	,	,	PUNCT
fnp-4365	108	8	and	and	CCONJ
fnp-4365	108	9	occasional	occasional	ADJ
fnp-4365	108	10	perivascular	perivascular	ADJ
fnp-4365	108	11	hemosiderin	hemosiderin	ADJ
fnp-4365	108	12	deposits	deposit	NOUN
fnp-4365	108	13	in	in	ADP
fnp-4365	108	14	parenchymal	parenchymal	ADJ
fnp-4365	108	15	blood	blood	NOUN
fnp-4365	108	16	vessels	vessel	NOUN
fnp-4365	108	17	of	of	ADP
fnp-4365	108	18	the	the	DET
fnp-4365	108	19	white	white	ADJ
fnp-4365	108	20	matter	matter	NOUN
fnp-4365	108	21	and	and	CCONJ
fnp-4365	108	22	basal	basal	ADJ
fnp-4365	108	23	ganglia	ganglia	NOUN
fnp-4365	108	24	.	.	PUNCT
fnp-4365	109	1	immunohistochemical	immunohistochemical	ADJ
fnp-4365	109	2	studies	study	NOUN
fnp-4365	109	3	showed	show	VERB
fnp-4365	109	4	scarce	scarce	ADJ
fnp-4365	109	5	perivascular	perivascular	ADJ
fnp-4365	109	6	cd3	cd3	PROPN
fnp-4365	109	7	+	+	PROPN
fnp-4365	109	8	t	t	PROPN
fnp-4365	109	9	-	-	PUNCT
fnp-4365	109	10	cells	cell	NOUN
fnp-4365	109	11	with	with	ADP
fnp-4365	109	12	minimal	minimal	ADJ
fnp-4365	109	13	intraparenchymal	intraparenchymal	ADJ
fnp-4365	109	14	extension	extension	NOUN
fnp-4365	109	15	in	in	ADP
fnp-4365	109	16	the	the	DET
fnp-4365	109	17	midbrain	midbrain	NOUN
fnp-4365	109	18	tegmentum	tegmentum	NOUN
fnp-4365	109	19	,	,	PUNCT
fnp-4365	109	20	as	as	ADV
fnp-4365	109	21	well	well	ADV
fnp-4365	109	22	as	as	ADP
fnp-4365	109	23	in	in	ADP
fnp-4365	109	24	perithalamic	perithalamic	ADJ
fnp-4365	109	25	white	white	ADJ
fnp-4365	109	26	matter	matter	NOUN
fnp-4365	109	27	and	and	CCONJ
fnp-4365	109	28	cervical	cervical	ADJ
fnp-4365	109	29	spinal	spinal	NOUN
fnp-4365	109	30	cord	cord	NOUN
fnp-4365	109	31	.	.	PUNCT
fnp-4365	110	1	t	t	NOUN
fnp-4365	110	2	-	-	PUNCT
fnp-4365	110	3	cells	cell	NOUN
fnp-4365	110	4	were	be	AUX
fnp-4365	110	5	not	not	PART
fnp-4365	110	6	detected	detect	VERB
fnp-4365	110	7	in	in	ADP
fnp-4365	110	8	the	the	DET
fnp-4365	110	9	hippocampus	hippocampus	NOUN
fnp-4365	110	10	,	,	PUNCT
fnp-4365	110	11	and	and	CCONJ
fnp-4365	110	12	there	there	PRON
fnp-4365	110	13	were	be	VERB
fnp-4365	110	14	almost	almost	ADV
fnp-4365	110	15	no	no	PRON
fnp-4365	110	16	cd20	cd20	PROPN
fnp-4365	110	17	+	+	CCONJ
fnp-4365	110	18	b	b	NOUN
fnp-4365	110	19	-	-	PUNCT
fnp-4365	110	20	cells	cell	NOUN
fnp-4365	110	21	.	.	PUNCT
fnp-4365	111	1	pcr	pcr	PROPN
fnp-4365	111	2	for	for	ADP
fnp-4365	111	3	the	the	DET
fnp-4365	111	4	detection	detection	NOUN
fnp-4365	111	5	of	of	ADP
fnp-4365	111	6	car	car	NOUN
fnp-4365	111	7	t	t	NOUN
fnp-4365	111	8	-	-	PUNCT
fnp-4365	111	9	cells	cell	NOUN
fnp-4365	111	10	in	in	ADP
fnp-4365	111	11	paraffin	paraffin	NOUN
fnp-4365	111	12	blocks	block	NOUN
fnp-4365	111	13	of	of	ADP
fnp-4365	111	14	midbrain	midbrain	NOUN
fnp-4365	111	15	and	and	CCONJ
fnp-4365	111	16	spinal	spinal	ADJ
fnp-4365	111	17	cord	cord	NOUN
fnp-4365	111	18	was	be	AUX
fnp-4365	111	19	positive	positive	ADJ
fnp-4365	111	20	,	,	PUNCT
fnp-4365	111	21	while	while	SCONJ
fnp-4365	111	22	it	it	PRON
fnp-4365	111	23	was	be	AUX
fnp-4365	111	24	negative	negative	ADJ
fnp-4365	111	25	in	in	ADP
fnp-4365	111	26	the	the	DET
fnp-4365	111	27	hippocampus	hippocampus	NOUN
fnp-4365	111	28	.	.	PUNCT
fnp-4365	112	1	full	full	ADJ
fnp-4365	112	2	body	body	NOUN
fnp-4365	112	3	autopsy	autopsy	NOUN
fnp-4365	112	4	revealed	reveal	VERB
fnp-4365	112	5	a	a	DET
fnp-4365	112	6	large	large	ADJ
fnp-4365	112	7	mediastinal	mediastinal	ADJ
fnp-4365	112	8	mass	mass	NOUN
fnp-4365	112	9	with	with	ADP
fnp-4365	112	10	pericardial	pericardial	ADJ
fnp-4365	112	11	extension	extension	NOUN
fnp-4365	112	12	causing	cause	VERB
fnp-4365	112	13	severe	severe	ADJ
fnp-4365	112	14	constrictive	constrictive	ADJ
fnp-4365	112	15	pericarditis	pericarditis	NOUN
fnp-4365	112	16	,	,	PUNCT
fnp-4365	112	17	as	as	ADV
fnp-4365	112	18	well	well	ADV
fnp-4365	112	19	as	as	ADP
fnp-4365	112	20	extension	extension	NOUN
fnp-4365	112	21	to	to	ADP
fnp-4365	112	22	cervical	cervical	ADJ
fnp-4365	112	23	region	region	NOUN
fnp-4365	112	24	,	,	PUNCT
fnp-4365	112	25	diaphragm	diaphragm	PROPN
fnp-4365	112	26	,	,	PUNCT
fnp-4365	112	27	rib	rib	NOUN
fnp-4365	112	28	wall	wall	NOUN
fnp-4365	112	29	and	and	CCONJ
fnp-4365	112	30	skin	skin	NOUN
fnp-4365	112	31	,	,	PUNCT
fnp-4365	112	32	and	and	CCONJ
fnp-4365	112	33	multiorgan	multiorgan	VERB
fnp-4365	112	34	tumor	tumor	NOUN
fnp-4365	112	35	implants	implant	NOUN
fnp-4365	112	36	.	.	PUNCT
fnp-4365	113	1	no	no	DET
fnp-4365	113	2	clear	clear	ADJ
fnp-4365	113	3	histological	histological	ADJ
fnp-4365	113	4	signs	sign	NOUN
fnp-4365	113	5	of	of	ADP
fnp-4365	113	6	acute	acute	ADJ
fnp-4365	113	7	neutrophilic	neutrophilic	ADJ
fnp-4365	113	8	pneumonia	pneumonia	NOUN
fnp-4365	113	9	were	be	AUX
fnp-4365	113	10	found	find	VERB
fnp-4365	113	11	,	,	PUNCT
fnp-4365	113	12	although	although	SCONJ
fnp-4365	113	13	the	the	DET
fnp-4365	113	14	immunosuppressive	immunosuppressive	ADJ
fnp-4365	113	15	and	and	CCONJ
fnp-4365	113	16	neutropenic	neutropenic	ADJ
fnp-4365	113	17	status	status	NOUN
fnp-4365	113	18	may	may	AUX
fnp-4365	113	19	have	have	AUX
fnp-4365	113	20	had	have	AUX
fnp-4365	113	21	hindered	hinder	VERB
fnp-4365	113	22	the	the	DET
fnp-4365	113	23	presence	presence	NOUN
fnp-4365	113	24	of	of	ADP
fnp-4365	113	25	histological	histological	ADJ
fnp-4365	113	26	signs	sign	NOUN
fnp-4365	113	27	.	.	PUNCT
fnp-4365	114	1	the	the	DET
fnp-4365	114	2	cause	cause	NOUN
fnp-4365	114	3	of	of	ADP
fnp-4365	114	4	death	death	NOUN
fnp-4365	114	5	was	be	AUX
fnp-4365	114	6	attributed	attribute	VERB
fnp-4365	114	7	to	to	ADP
fnp-4365	114	8	disease	disease	NOUN
fnp-4365	114	9	progression	progression	NOUN
fnp-4365	114	10	.	.	PUNCT
fnp-4365	115	1	case	case	NOUN
fnp-4365	115	2	3	3	NUM
fnp-4365	115	3	a	a	DET
fnp-4365	115	4	19	19	NUM
fnp-4365	115	5	-	-	PUNCT
fnp-4365	115	6	year	year	NOUN
fnp-4365	115	7	-	-	PUNCT
fnp-4365	115	8	old	old	ADJ
fnp-4365	115	9	man	man	NOUN
fnp-4365	115	10	with	with	ADP
fnp-4365	115	11	acute	acute	PROPN
fnp-4365	115	12	b	b	NOUN
fnp-4365	115	13	-	-	PUNCT
fnp-4365	115	14	cell	cell	NOUN
fnp-4365	115	15	lymphoblastic	lymphoblastic	ADJ
fnp-4365	115	16	leukemia	leukemia	NOUN
fnp-4365	115	17	was	be	AUX
fnp-4365	115	18	referred	refer	VERB
fnp-4365	115	19	to	to	ADP
fnp-4365	115	20	our	our	PRON
fnp-4365	115	21	center	center	NOUN
fnp-4365	115	22	one	one	NUM
fnp-4365	115	23	year	year	NOUN
fnp-4365	115	24	after	after	SCONJ
fnp-4365	115	25	disease	disease	NOUN
fnp-4365	115	26	onset	onset	VERB
fnp-4365	115	27	.	.	PUNCT
fnp-4365	116	1	he	he	PRON
fnp-4365	116	2	had	have	AUX
fnp-4365	116	3	relapsed	relapse	VERB
fnp-4365	116	4	disease	disease	NOUN
fnp-4365	116	5	despite	despite	SCONJ
fnp-4365	116	6	induction	induction	NOUN
fnp-4365	116	7	protocol	protocol	NOUN
fnp-4365	116	8	and	and	CCONJ
fnp-4365	116	9	six	six	NUM
fnp-4365	116	10	consolidation	consolidation	NOUN
fnp-4365	116	11	treatment	treatment	NOUN
fnp-4365	116	12	cycles	cycle	NOUN
fnp-4365	116	13	,	,	PUNCT
fnp-4365	116	14	as	as	ADV
fnp-4365	116	15	well	well	ADV
fnp-4365	116	16	as	as	ADP
fnp-4365	116	17	one	one	NUM
fnp-4365	116	18	cycle	cycle	NOUN
fnp-4365	116	19	of	of	ADP
fnp-4365	116	20	inotuzumab	inotuzumab	NOUN
fnp-4365	116	21	-	-	PUNCT
fnp-4365	116	22	ozogamicine	ozogamicine	NOUN
fnp-4365	116	23	.	.	PUNCT
fnp-4365	117	1	he	he	PRON
fnp-4365	117	2	received	receive	VERB
fnp-4365	117	3	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	117	4	and	and	CCONJ
fnp-4365	117	5	corticosteroid	corticosteroid	ADJ
fnp-4365	117	6	bolus	bolus	NOUN
fnp-4365	117	7	as	as	ADP
fnp-4365	117	8	bridge	bridge	NOUN
fnp-4365	117	9	therapy	therapy	NOUN
fnp-4365	117	10	before	before	ADP
fnp-4365	117	11	the	the	DET
fnp-4365	117	12	infusion	infusion	NOUN
fnp-4365	117	13	of	of	ADP
fnp-4365	117	14	car	car	NOUN
fnp-4365	117	15	-	-	PUNCT
fnp-4365	117	16	cd19	cd19	PROPN
fnp-4365	117	17	.	.	PUNCT
fnp-4365	118	1	his	his	PRON
fnp-4365	118	2	initial	initial	ADJ
fnp-4365	118	3	brain	brain	NOUN
fnp-4365	118	4	mri	mri	NOUN
fnp-4365	118	5	showed	show	VERB
fnp-4365	118	6	multiple	multiple	ADJ
fnp-4365	118	7	bilateral	bilateral	ADJ
fnp-4365	118	8	cortical	cortical	ADJ
fnp-4365	118	9	and	and	CCONJ
fnp-4365	118	10	subcortical	subcortical	ADJ
fnp-4365	118	11	frontoparietal	frontoparietal	ADJ
fnp-4365	118	12	signal	signal	NOUN
fnp-4365	118	13	abnormalities	abnormality	NOUN
fnp-4365	118	14	suggesting	suggest	VERB
fnp-4365	118	15	chronic	chronic	ADJ
fnp-4365	118	16	hemorrhages	hemorrhage	NOUN
fnp-4365	118	17	from	from	ADP
fnp-4365	118	18	multiple	multiple	ADJ
fnp-4365	118	19	cerebral	cerebral	ADJ
fnp-4365	118	20	cavernomatosis	cavernomatosis	NOUN
fnp-4365	118	21	,	,	PUNCT
fnp-4365	118	22	but	but	CCONJ
fnp-4365	118	23	no	no	DET
fnp-4365	118	24	contraindication	contraindication	NOUN
fnp-4365	118	25	for	for	ADP
fnp-4365	118	26	the	the	DET
fnp-4365	118	27	car	car	NOUN
fnp-4365	118	28	t	t	NOUN
fnp-4365	118	29	therapy	therapy	NOUN
fnp-4365	118	30	was	be	AUX
fnp-4365	118	31	found	find	VERB
fnp-4365	118	32	.	.	PUNCT
fnp-4365	119	1	after	after	ADP
fnp-4365	119	2	conditioning	condition	VERB
fnp-4365	119	3	with	with	ADP
fnp-4365	119	4	fludarabine	fludarabine	NOUN
fnp-4365	119	5	and	and	CCONJ
fnp-4365	119	6	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	119	7	,	,	PUNCT
fnp-4365	119	8	antibiotics	antibiotic	NOUN
fnp-4365	119	9	were	be	AUX
fnp-4365	119	10	started	start	VERB
fnp-4365	119	11	due	due	ADP
fnp-4365	119	12	to	to	ADP
fnp-4365	119	13	fever	fever	NOUN
fnp-4365	119	14	and	and	CCONJ
fnp-4365	119	15	isolation	isolation	NOUN
fnp-4365	119	16	of	of	ADP
fnp-4365	119	17	enterococcus	enterococcus	NOUN
fnp-4365	119	18	faecalis	faecali	NOUN
fnp-4365	119	19	in	in	ADP
fnp-4365	119	20	urine	urine	NOUN
fnp-4365	119	21	culture	culture	NOUN
fnp-4365	119	22	.	.	PUNCT
fnp-4365	120	1	twelve	twelve	NUM
fnp-4365	120	2	hours	hour	NOUN
fnp-4365	120	3	after	after	ADP
fnp-4365	120	4	the	the	DET
fnp-4365	120	5	first	first	ADJ
fnp-4365	120	6	car	car	NOUN
fnp-4365	120	7	t	t	NOUN
fnp-4365	120	8	-	-	PUNCT
fnp-4365	120	9	cell	cell	NOUN
fnp-4365	120	10	infusion	infusion	NOUN
fnp-4365	120	11	,	,	PUNCT
fnp-4365	120	12	he	he	PRON
fnp-4365	120	13	presented	present	VERB
fnp-4365	120	14	fever	fever	NOUN
fnp-4365	120	15	and	and	CCONJ
fnp-4365	120	16	hemodynamic	hemodynamic	ADJ
fnp-4365	120	17	instability	instability	NOUN
fnp-4365	120	18	refractory	refractory	NOUN
fnp-4365	120	19	to	to	ADP
fnp-4365	120	20	fluids	fluid	NOUN
fnp-4365	120	21	.	.	PUNCT
fnp-4365	121	1	he	he	PRON
fnp-4365	121	2	was	be	AUX
fnp-4365	121	3	transferred	transfer	VERB
fnp-4365	121	4	to	to	ADP
fnp-4365	121	5	the	the	DET
fnp-4365	121	6	intensive	intensive	ADJ
fnp-4365	121	7	care	care	NOUN
fnp-4365	121	8	unit	unit	NOUN
fnp-4365	121	9	(	(	PUNCT
fnp-4365	121	10	icu	icu	PROPN
fnp-4365	121	11	)	)	PUNCT
fnp-4365	121	12	with	with	ADP
fnp-4365	121	13	the	the	DET
fnp-4365	121	14	diagnosis	diagnosis	NOUN
fnp-4365	121	15	of	of	ADP
fnp-4365	121	16	crs	crs	PROPN
fnp-4365	121	17	grade	grade	NOUN
fnp-4365	121	18	3	3	NUM
fnp-4365	122	1	.	.	PUNCT
fnp-4365	122	2	tocilizumab	tocilizumab	NOUN
fnp-4365	122	3	,	,	PUNCT
fnp-4365	122	4	high	high	ADJ
fnp-4365	122	5	doses	dose	NOUN
fnp-4365	122	6	of	of	ADP
fnp-4365	122	7	methylprednisolone	methylprednisolone	NOUN
fnp-4365	122	8	and	and	CCONJ
fnp-4365	122	9	siltuximab	siltuximab	VERB
fnp-4365	122	10	,	,	PUNCT
fnp-4365	122	11	as	as	ADV
fnp-4365	122	12	well	well	ADV
fnp-4365	122	13	as	as	ADP
fnp-4365	122	14	support	support	NOUN
fnp-4365	122	15	treatment	treatment	NOUN
fnp-4365	122	16	with	with	ADP
fnp-4365	122	17	several	several	ADJ
fnp-4365	122	18	vasopressors	vasopressor	NOUN
fnp-4365	122	19	,	,	PUNCT
fnp-4365	122	20	mechanical	mechanical	ADJ
fnp-4365	122	21	ventilation	ventilation	NOUN
fnp-4365	122	22	,	,	PUNCT
fnp-4365	122	23	and	and	CCONJ
fnp-4365	122	24	empirical	empirical	ADJ
fnp-4365	122	25	treatment	treatment	NOUN
fnp-4365	122	26	with	with	ADP
fnp-4365	122	27	antifungal	antifungal	ADJ
fnp-4365	122	28	and	and	CCONJ
fnp-4365	122	29	antibacterial	antibacterial	ADJ
fnp-4365	122	30	agents	agent	NOUN
fnp-4365	122	31	were	be	AUX
fnp-4365	122	32	administered	administer	VERB
fnp-4365	122	33	.	.	PUNCT
fnp-4365	123	1	however	however	ADV
fnp-4365	123	2	,	,	PUNCT
fnp-4365	123	3	he	he	PRON
fnp-4365	123	4	developed	develop	VERB
fnp-4365	123	5	refractory	refractory	NOUN
fnp-4365	123	6	multiorgan	multiorgan	NOUN
fnp-4365	123	7	failure	failure	NOUN
fnp-4365	123	8	,	,	PUNCT
fnp-4365	123	9	with	with	ADP
fnp-4365	123	10	negative	negative	ADJ
fnp-4365	123	11	microbiological	microbiological	ADJ
fnp-4365	123	12	analyses	analysis	NOUN
fnp-4365	123	13	,	,	PUNCT
fnp-4365	123	14	and	and	CCONJ
fnp-4365	123	15	he	he	PRON
fnp-4365	123	16	died	die	VERB
fnp-4365	123	17	five	five	NUM
fnp-4365	123	18	days	day	NOUN
fnp-4365	123	19	after	after	ADP
fnp-4365	123	20	car	car	NOUN
fnp-4365	123	21	t	t	NOUN
fnp-4365	123	22	-	-	PUNCT
fnp-4365	123	23	cell	cell	NOUN
fnp-4365	123	24	infusion	infusion	NOUN
fnp-4365	123	25	.	.	PUNCT
fnp-4365	124	1	no	no	DET
fnp-4365	124	2	neurological	neurological	ADJ
fnp-4365	124	3	symptoms	symptom	NOUN
fnp-4365	124	4	were	be	AUX
fnp-4365	124	5	noted	note	VERB
fnp-4365	124	6	,	,	PUNCT
fnp-4365	124	7	and	and	CCONJ
fnp-4365	124	8	he	he	PRON
fnp-4365	124	9	was	be	AUX
fnp-4365	124	10	clinically	clinically	ADV
fnp-4365	124	11	diagnosed	diagnose	VERB
fnp-4365	124	12	as	as	ADP
fnp-4365	124	13	fatal	fatal	ADJ
fnp-4365	124	14	crs	crs	PROPN
fnp-4365	124	15	(	(	PUNCT
fnp-4365	124	16	grade	grade	NOUN
fnp-4365	124	17	5	5	NUM
fnp-4365	124	18	)	)	PUNCT
fnp-4365	124	19	.	.	PUNCT
fnp-4365	125	1	neuropathologic	neuropathologic	ADJ
fnp-4365	125	2	gross	gross	ADJ
fnp-4365	125	3	examination	examination	NOUN
fnp-4365	125	4	revealed	reveal	VERB
fnp-4365	125	5	a	a	DET
fnp-4365	125	6	1255	1255	NUM
fnp-4365	125	7	g	g	NOUN
fnp-4365	125	8	fixed	fix	VERB
fnp-4365	125	9	brain	brain	NOUN
fnp-4365	125	10	.	.	PUNCT
fnp-4365	126	1	coronal	coronal	ADJ
fnp-4365	126	2	sections	section	NOUN
fnp-4365	126	3	showed	show	VERB
fnp-4365	126	4	mild	mild	ADJ
fnp-4365	126	5	congestive	congestive	ADJ
fnp-4365	126	6	appearance	appearance	NOUN
fnp-4365	126	7	of	of	ADP
fnp-4365	126	8	left	left	ADJ
fnp-4365	126	9	amygdala	amygdala	NOUN
fnp-4365	126	10	,	,	PUNCT
fnp-4365	126	11	putamen	putaman	NOUN
fnp-4365	126	12	,	,	PUNCT
fnp-4365	126	13	front	front	ADJ
fnp-4365	126	14	-	-	PUNCT
fnp-4365	126	15	temporo	temporo	NOUN
fnp-4365	126	16	-	-	PUNCT
fnp-4365	126	17	parieto	parieto	NOUN
fnp-4365	126	18	-	-	PUNCT
fnp-4365	126	19	occipital	occipital	NOUN
fnp-4365	126	20	white	white	ADJ
fnp-4365	126	21	matter	matter	NOUN
fnp-4365	126	22	,	,	PUNCT
fnp-4365	126	23	and	and	CCONJ
fnp-4365	126	24	pontine	pontine	ADJ
fnp-4365	126	25	nuclei	nucleus	NOUN
fnp-4365	126	26	,	,	PUNCT
fnp-4365	126	27	as	as	ADV
fnp-4365	126	28	well	well	ADV
fnp-4365	126	29	as	as	ADP
fnp-4365	126	30	mild	mild	ADJ
fnp-4365	126	31	greyish	greyish	ADJ
fnp-4365	126	32	discoloration	discoloration	NOUN
fnp-4365	126	33	of	of	ADP
fnp-4365	126	34	white	white	ADJ
fnp-4365	126	35	matter	matter	NOUN
fnp-4365	126	36	,	,	PUNCT
fnp-4365	126	37	midbrain	midbrain	NOUN
fnp-4365	126	38	tegmentum	tegmentum	NOUN
fnp-4365	126	39	and	and	CCONJ
fnp-4365	126	40	pons	pon	NOUN
fnp-4365	126	41	.	.	PUNCT
fnp-4365	127	1	the	the	DET
fnp-4365	127	2	brainstem	brainstem	NOUN
fnp-4365	127	3	showed	show	VERB
fnp-4365	127	4	moderate	moderate	ADJ
fnp-4365	127	5	substantia	substantia	NOUN
fnp-4365	127	6	nigra	nigra	NOUN
fnp-4365	127	7	depigmentation	depigmentation	NOUN
fnp-4365	127	8	.	.	PUNCT
fnp-4365	128	1	histology	histology	NOUN
fnp-4365	128	2	confirmed	confirm	VERB
fnp-4365	128	3	mild	mild	ADJ
fnp-4365	128	4	white	white	ADJ
fnp-4365	128	5	matter	matter	NOUN
fnp-4365	128	6	oedema	oedema	NOUN
fnp-4365	128	7	with	with	ADP
fnp-4365	128	8	mild	mild	ADJ
fnp-4365	128	9	gliosis	gliosis	NOUN
fnp-4365	128	10	,	,	PUNCT
fnp-4365	128	11	mainly	mainly	ADV
fnp-4365	128	12	in	in	ADP
fnp-4365	128	13	basal	basal	ADJ
fnp-4365	128	14	ganglia	ganglia	NOUN
fnp-4365	128	15	(	(	PUNCT
fnp-4365	128	16	ventral	ventral	ADJ
fnp-4365	128	17	thalamus	thalamus	NOUN
fnp-4365	128	18	)	)	PUNCT
fnp-4365	128	19	and	and	CCONJ
fnp-4365	128	20	midbrain	midbrain	NOUN
fnp-4365	128	21	tegmentum	tegmentum	NOUN
fnp-4365	128	22	/	/	SYM
fnp-4365	128	23	periaqueductal	periaqueductal	ADJ
fnp-4365	128	24	grey	grey	NOUN
fnp-4365	128	25	matter	matter	NOUN
fnp-4365	128	26	.	.	PUNCT
fnp-4365	129	1	blue	blue	ADJ
fnp-4365	129	2	dark	dark	ADJ
fnp-4365	129	3	neurons	neuron	NOUN
fnp-4365	129	4	were	be	AUX
fnp-4365	129	5	observed	observe	VERB
fnp-4365	129	6	in	in	ADP
fnp-4365	129	7	cortical	cortical	ADJ
fnp-4365	129	8	areas	area	NOUN
fnp-4365	129	9	,	,	PUNCT
fnp-4365	129	10	predominantly	predominantly	ADV
fnp-4365	129	11	in	in	ADP
fnp-4365	129	12	layers	layers	PROPN
fnp-4365	129	13	ii	ii	PROPN
fnp-4365	129	14	and	and	CCONJ
fnp-4365	129	15	iii	iii	PROPN
fnp-4365	129	16	,	,	PUNCT
fnp-4365	129	17	suggestive	suggestive	ADJ
fnp-4365	129	18	of	of	ADP
fnp-4365	129	19	incipient	incipient	ADJ
fnp-4365	129	20	mild	mild	ADJ
fnp-4365	129	21	hypoxic	hypoxic	ADJ
fnp-4365	129	22	-	-	PUNCT
fnp-4365	129	23	ischemic	ischemic	ADJ
fnp-4365	129	24	changes	change	NOUN
fnp-4365	129	25	.	.	PUNCT
fnp-4365	130	1	histology	histology	NOUN
fnp-4365	130	2	also	also	ADV
fnp-4365	130	3	revealed	reveal	VERB
fnp-4365	130	4	mild	mild	ADJ
fnp-4365	130	5	congestion	congestion	NOUN
fnp-4365	130	6	and	and	CCONJ
fnp-4365	130	7	minimal	minimal	ADJ
fnp-4365	130	8	arteriosclerosis	arteriosclerosis	NOUN
fnp-4365	130	9	of	of	ADP
fnp-4365	130	10	parenchymal	parenchymal	ADJ
fnp-4365	130	11	blood	blood	NOUN
fnp-4365	130	12	vessels	vessel	NOUN
fnp-4365	130	13	with	with	ADP
fnp-4365	130	14	occasional	occasional	ADJ
fnp-4365	130	15	perivascular	perivascular	ADJ
fnp-4365	130	16	histiocytes	histiocyte	NOUN
fnp-4365	130	17	with	with	ADP
fnp-4365	130	18	hematic	hematic	ADJ
fnp-4365	130	19	component	component	NOUN
fnp-4365	130	20	,	,	PUNCT
fnp-4365	130	21	without	without	ADP
fnp-4365	130	22	perivascular	perivascular	ADJ
fnp-4365	130	23	tissue	tissue	NOUN
fnp-4365	130	24	damage	damage	NOUN
fnp-4365	130	25	.	.	PUNCT
fnp-4365	131	1	no	no	DET
fnp-4365	131	2	evidence	evidence	NOUN
fnp-4365	131	3	of	of	ADP
fnp-4365	131	4	venous	venous	ADJ
fnp-4365	131	5	dilations	dilation	NOUN
fnp-4365	131	6	or	or	CCONJ
fnp-4365	131	7	vascular	vascular	ADJ
fnp-4365	131	8	malformations	malformation	NOUN
fnp-4365	131	9	were	be	AUX
fnp-4365	131	10	observed	observe	VERB
fnp-4365	131	11	;	;	PUNCT
fnp-4365	131	12	the	the	DET
fnp-4365	131	13	changes	change	NOUN
fnp-4365	131	14	reported	report	VERB
fnp-4365	131	15	by	by	ADP
fnp-4365	131	16	mri	mri	NOUN
fnp-4365	131	17	study	study	NOUN
fnp-4365	131	18	were	be	AUX
fnp-4365	131	19	attributed	attribute	VERB
fnp-4365	131	20	to	to	ADP
fnp-4365	131	21	hemodynamic	hemodynamic	ADJ
fnp-4365	131	22	fluctuations	fluctuation	NOUN
fnp-4365	131	23	in	in	ADP
fnp-4365	131	24	life	life	NOUN
fnp-4365	131	25	rather	rather	ADV
fnp-4365	131	26	than	than	ADP
fnp-4365	131	27	to	to	ADP
fnp-4365	131	28	the	the	DET
fnp-4365	131	29	presence	presence	NOUN
fnp-4365	131	30	of	of	ADP
fnp-4365	131	31	established	establish	VERB
fnp-4365	131	32	vascular	vascular	ADJ
fnp-4365	131	33	malformations	malformation	NOUN
fnp-4365	131	34	.	.	PUNCT
fnp-4365	132	1	pcr	pcr	NOUN
fnp-4365	132	2	for	for	ADP
fnp-4365	132	3	the	the	DET
fnp-4365	132	4	detection	detection	NOUN
fnp-4365	132	5	of	of	ADP
fnp-4365	132	6	car	car	NOUN
fnp-4365	132	7	t	t	NOUN
fnp-4365	132	8	-	-	PUNCT
fnp-4365	132	9	cells	cell	NOUN
fnp-4365	132	10	in	in	ADP
fnp-4365	132	11	paraffin	paraffin	NOUN
fnp-4365	132	12	blocks	block	NOUN
fnp-4365	132	13	was	be	AUX
fnp-4365	132	14	negative	negative	ADJ
fnp-4365	132	15	.	.	PUNCT
fnp-4365	133	1	full	full	ADJ
fnp-4365	133	2	body	body	NOUN
fnp-4365	133	3	autopsy	autopsy	NOUN
fnp-4365	133	4	revealed	reveal	VERB
fnp-4365	133	5	no	no	DET
fnp-4365	133	6	significant	significant	ADJ
fnp-4365	133	7	findings	finding	NOUN
fnp-4365	133	8	.	.	PUNCT
fnp-4365	134	1	the	the	DET
fnp-4365	134	2	cause	cause	NOUN
fnp-4365	134	3	of	of	ADP
fnp-4365	134	4	death	death	NOUN
fnp-4365	134	5	was	be	AUX
fnp-4365	134	6	attributed	attribute	VERB
fnp-4365	134	7	to	to	ADP
fnp-4365	134	8	crs	crs	PROPN
fnp-4365	134	9	after	after	ADP
fnp-4365	134	10	car	car	NOUN
fnp-4365	134	11	t	t	NOUN
fnp-4365	134	12	-	-	PUNCT
fnp-4365	134	13	cell	cell	NOUN
fnp-4365	134	14	infusion	infusion	NOUN
fnp-4365	134	15	.	.	PUNCT
fnp-4365	135	1	case	case	NOUN
fnp-4365	135	2	4	4	NUM
fnp-4365	135	3	a	a	DET
fnp-4365	135	4	63	63	NUM
fnp-4365	135	5	-	-	PUNCT
fnp-4365	135	6	year	year	NOUN
fnp-4365	135	7	-	-	PUNCT
fnp-4365	135	8	old	old	ADJ
fnp-4365	135	9	male	male	ADJ
fnp-4365	135	10	patient	patient	NOUN
fnp-4365	135	11	with	with	ADP
fnp-4365	135	12	a	a	DET
fnp-4365	135	13	grade	grade	NOUN
fnp-4365	135	14	3a	3a	NUM
fnp-4365	135	15	,	,	PUNCT
fnp-4365	135	16	stage	stage	NOUN
fnp-4365	135	17	iv	iv	NUM
fnp-4365	135	18	follicular	follicular	ADJ
fnp-4365	135	19	lymphoma	lymphoma	NOUN
fnp-4365	135	20	with	with	ADP
fnp-4365	135	21	abdominal	abdominal	ADJ
fnp-4365	135	22	extranodal	extranodal	NOUN
fnp-4365	135	23	and	and	CCONJ
fnp-4365	135	24	mesenteric	mesenteric	ADJ
fnp-4365	135	25	involvement	involvement	NOUN
fnp-4365	135	26	that	that	PRON
fnp-4365	135	27	had	have	AUX
fnp-4365	135	28	been	be	AUX
fnp-4365	135	29	treated	treat	VERB
fnp-4365	135	30	with	with	ADP
fnp-4365	135	31	a	a	DET
fnp-4365	135	32	first	first	ADJ
fnp-4365	135	33	line	line	NOUN
fnp-4365	135	34	of	of	ADP
fnp-4365	135	35	r	r	NOUN
fnp-4365	135	36	-	-	PUNCT
fnp-4365	135	37	chop	chop	NOUN
fnp-4365	135	38	and	and	CCONJ
fnp-4365	135	39	had	have	AUX
fnp-4365	135	40	reached	reach	VERB
fnp-4365	135	41	partial	partial	ADJ
fnp-4365	135	42	response	response	NOUN
fnp-4365	135	43	.	.	PUNCT
fnp-4365	136	1	following	follow	VERB
fnp-4365	136	2	maintenance	maintenance	NOUN
fnp-4365	136	3	with	with	ADP
fnp-4365	136	4	rituximab	rituximab	NOUN
fnp-4365	136	5	for	for	ADP
fnp-4365	136	6	2	2	NUM
fnp-4365	136	7	years	year	NOUN
fnp-4365	136	8	,	,	PUNCT
fnp-4365	136	9	he	he	PRON
fnp-4365	136	10	remained	remain	VERB
fnp-4365	136	11	stable	stable	ADJ
fnp-4365	136	12	one	one	NUM
fnp-4365	136	13	more	more	ADJ
fnp-4365	136	14	year	year	NOUN
fnp-4365	136	15	,	,	PUNCT
fnp-4365	136	16	until	until	ADP
fnp-4365	136	17	progression	progression	NOUN
fnp-4365	136	18	of	of	ADP
fnp-4365	136	19	the	the	DET
fnp-4365	136	20	abdominal	abdominal	ADJ
fnp-4365	136	21	mass	mass	NOUN
fnp-4365	136	22	,	,	PUNCT
fnp-4365	136	23	new	new	ADJ
fnp-4365	136	24	gastric	gastric	ADJ
fnp-4365	136	25	infiltration	infiltration	NOUN
fnp-4365	136	26	,	,	PUNCT
fnp-4365	136	27	and	and	CCONJ
fnp-4365	136	28	pet	pet	ADJ
fnp-4365	136	29	hypermetabolism	hypermetabolism	NOUN
fnp-4365	136	30	in	in	ADP
fnp-4365	136	31	the	the	DET
fnp-4365	136	32	esophagus	esophagus	NOUN
fnp-4365	136	33	.	.	PUNCT
fnp-4365	137	1	after	after	ADP
fnp-4365	137	2	a	a	DET
fnp-4365	137	3	third	third	ADJ
fnp-4365	137	4	line	line	NOUN
fnp-4365	137	5	with	with	ADP
fnp-4365	137	6	obinotuzumab	obinotuzumab	NOUN
fnp-4365	137	7	and	and	CCONJ
fnp-4365	137	8	bendamustine	bendamustine	NOUN
fnp-4365	137	9	,	,	PUNCT
fnp-4365	137	10	a	a	DET
fnp-4365	137	11	failed	fail	VERB
fnp-4365	137	12	attempt	attempt	NOUN
fnp-4365	137	13	of	of	ADP
fnp-4365	137	14	autologous	autologous	ADJ
fnp-4365	137	15	stem	stem	NOUN
fnp-4365	137	16	cell	cell	NOUN
fnp-4365	137	17	aphaeresis	aphaeresis	NOUN
fnp-4365	137	18	,	,	PUNCT
fnp-4365	137	19	and	and	CCONJ
fnp-4365	137	20	maintenance	maintenance	NOUN
fnp-4365	137	21	with	with	ADP
fnp-4365	137	22	obinutuzumab	obinutuzumab	NOUN
fnp-4365	137	23	,	,	PUNCT
fnp-4365	137	24	a	a	DET
fnp-4365	137	25	fourth	fourth	ADJ
fnp-4365	137	26	line	line	NOUN
fnp-4365	137	27	with	with	ADP
fnp-4365	137	28	idelalisib	idelalisib	PROPN
fnp-4365	137	29	was	be	AUX
fnp-4365	137	30	started	start	VERB
fnp-4365	137	31	.	.	PUNCT
fnp-4365	138	1	however	however	ADV
fnp-4365	138	2	,	,	PUNCT
fnp-4365	138	3	the	the	DET
fnp-4365	138	4	abdominal	abdominal	ADJ
fnp-4365	138	5	disease	disease	NOUN
fnp-4365	138	6	progressed	progress	VERB
fnp-4365	138	7	with	with	ADP
fnp-4365	138	8	involvement	involvement	NOUN
fnp-4365	138	9	of	of	ADP
fnp-4365	138	10	peripancreatic	peripancreatic	ADJ
fnp-4365	138	11	,	,	PUNCT
fnp-4365	138	12	renal	renal	ADJ
fnp-4365	138	13	and	and	CCONJ
fnp-4365	138	14	iliac	iliac	NOUN
fnp-4365	138	15	lymph	lymph	NOUN
fnp-4365	138	16	nodes	node	NOUN
fnp-4365	138	17	,	,	PUNCT
fnp-4365	138	18	the	the	DET
fnp-4365	138	19	patient	patient	NOUN
fnp-4365	138	20	was	be	AUX
fnp-4365	138	21	not	not	PART
fnp-4365	138	22	eligible	eligible	ADJ
fnp-4365	138	23	to	to	ADP
fnp-4365	138	24	allogeneic	allogeneic	VERB
fnp-4365	138	25	stem	stem	NOUN
fnp-4365	138	26	cell	cell	NOUN
fnp-4365	138	27	transplant	transplant	NOUN
fnp-4365	138	28	,	,	PUNCT
fnp-4365	138	29	and	and	CCONJ
fnp-4365	138	30	he	he	PRON
fnp-4365	138	31	received	receive	VERB
fnp-4365	138	32	car	car	NOUN
fnp-4365	138	33	-	-	PUNCT
fnp-4365	138	34	cd19	cd19	PROPN
fnp-4365	138	35	therapy	therapy	NOUN
fnp-4365	138	36	with	with	ADP
fnp-4365	138	37	prior	prior	ADJ
fnp-4365	138	38	fludarabine	fludarabine	NOUN
fnp-4365	138	39	and	and	CCONJ
fnp-4365	138	40	cyclophosphamide	cyclophosphamide	PROPN
fnp-4365	138	41	conditioning	conditioning	NOUN
fnp-4365	138	42	.	.	PUNCT
fnp-4365	139	1	after	after	ADP
fnp-4365	139	2	the	the	DET
fnp-4365	139	3	third	third	ADJ
fnp-4365	139	4	day	day	NOUN
fnp-4365	139	5	of	of	ADP
fnp-4365	139	6	consecutive	consecutive	ADJ
fnp-4365	139	7	infusion	infusion	NOUN
fnp-4365	139	8	,	,	PUNCT
fnp-4365	139	9	the	the	DET
fnp-4365	139	10	patient	patient	NOUN
fnp-4365	139	11	developed	develop	VERB
fnp-4365	139	12	fever	fever	NOUN
fnp-4365	139	13	with	with	ADP
fnp-4365	139	14	mild	mild	ADJ
fnp-4365	139	15	hypotension	hypotension	NOUN
fnp-4365	139	16	that	that	PRON
fnp-4365	139	17	was	be	AUX
fnp-4365	139	18	diagnosed	diagnose	VERB
fnp-4365	139	19	as	as	ADP
fnp-4365	139	20	grade	grade	NOUN
fnp-4365	139	21	2	2	NUM
fnp-4365	139	22	crs	crs	NOUN
fnp-4365	139	23	and	and	CCONJ
fnp-4365	139	24	had	have	VERB
fnp-4365	139	25	a	a	DET
fnp-4365	139	26	good	good	ADJ
fnp-4365	139	27	response	response	NOUN
fnp-4365	139	28	to	to	AUX
fnp-4365	139	29	tocilizumab	tocilizumab	VERB
fnp-4365	139	30	.	.	PUNCT
fnp-4365	140	1	he	he	PRON
fnp-4365	140	2	had	have	VERB
fnp-4365	140	3	an	an	DET
fnp-4365	140	4	episode	episode	NOUN
fnp-4365	140	5	of	of	ADP
fnp-4365	140	6	toxic	toxic	ADJ
fnp-4365	140	7	epidermolytic	epidermolytic	ADJ
fnp-4365	140	8	necrolysis	necrolysis	NOUN
fnp-4365	140	9	(	(	PUNCT
fnp-4365	140	10	diagnosed	diagnose	VERB
fnp-4365	140	11	by	by	ADP
fnp-4365	140	12	skin	skin	NOUN
fnp-4365	140	13	biopsy	biopsy	NOUN
fnp-4365	140	14	)	)	PUNCT
fnp-4365	140	15	with	with	ADP
fnp-4365	140	16	severe	severe	ADJ
fnp-4365	140	17	extensive	extensive	ADJ
fnp-4365	140	18	rash	rash	NOUN
fnp-4365	140	19	and	and	CCONJ
fnp-4365	140	20	oral	oral	ADJ
fnp-4365	140	21	lesions	lesion	NOUN
fnp-4365	140	22	.	.	PUNCT
fnp-4365	141	1	he	he	PRON
fnp-4365	141	2	also	also	ADV
fnp-4365	141	3	presented	present	VERB
fnp-4365	141	4	with	with	ADP
fnp-4365	141	5	severe	severe	ADJ
fnp-4365	141	6	aplasia	aplasia	NOUN
fnp-4365	141	7	,	,	PUNCT
fnp-4365	141	8	as	as	ADV
fnp-4365	141	9	well	well	ADV
fnp-4365	141	10	as	as	ADP
fnp-4365	141	11	a	a	DET
fnp-4365	141	12	septic	septic	ADJ
fnp-4365	141	13	shock	shock	NOUN
fnp-4365	141	14	due	due	ADP
fnp-4365	141	15	to	to	ADP
fnp-4365	141	16	urinary	urinary	ADJ
fnp-4365	141	17	tract	tract	NOUN
fnp-4365	141	18	infection	infection	NOUN
fnp-4365	141	19	that	that	PRON
fnp-4365	141	20	was	be	AUX
fnp-4365	141	21	treated	treat	VERB
fnp-4365	141	22	in	in	ADP
fnp-4365	141	23	the	the	DET
fnp-4365	141	24	icu	icu	PROPN
fnp-4365	141	25	.	.	PUNCT
fnp-4365	142	1	after	after	ADP
fnp-4365	142	2	initial	initial	ADJ
fnp-4365	142	3	improvement	improvement	NOUN
fnp-4365	142	4	,	,	PUNCT
fnp-4365	142	5	he	he	PRON
fnp-4365	142	6	presented	present	VERB
fnp-4365	142	7	a	a	DET
fnp-4365	142	8	pulmonary	pulmonary	ADJ
fnp-4365	142	9	hemorrhage	hemorrhage	NOUN
fnp-4365	142	10	with	with	ADP
fnp-4365	142	11	colonization	colonization	NOUN
fnp-4365	142	12	by	by	ADP
fnp-4365	142	13	candida	candida	PROPN
fnp-4365	142	14	glabrata	glabrata	NOUN
fnp-4365	142	15	,	,	PUNCT
fnp-4365	142	16	and	and	CCONJ
fnp-4365	142	17	developed	develop	VERB
fnp-4365	142	18	kidney	kidney	NOUN
fnp-4365	142	19	failure	failure	NOUN
fnp-4365	142	20	,	,	PUNCT
fnp-4365	142	21	hyperkaliemia	hyperkaliemia	NOUN
fnp-4365	142	22	,	,	PUNCT
fnp-4365	142	23	tracheobronchitis	tracheobronchitis	NOUN
fnp-4365	142	24	,	,	PUNCT
fnp-4365	142	25	more	more	ADJ
fnp-4365	142	26	episodes	episode	NOUN
fnp-4365	142	27	of	of	ADP
fnp-4365	142	28	septic	septic	ADJ
fnp-4365	142	29	shock	shock	NOUN
fnp-4365	142	30	due	due	ADP
fnp-4365	142	31	to	to	ADP
fnp-4365	142	32	bacteremia	bacteremia	NOUN
fnp-4365	142	33	of	of	ADP
fnp-4365	142	34	intestinal	intestinal	ADJ
fnp-4365	142	35	and	and	CCONJ
fnp-4365	142	36	skin	skin	NOUN
fnp-4365	142	37	origin	origin	NOUN
fnp-4365	142	38	(	(	PUNCT
fnp-4365	142	39	bacteroides	bacteroide	VERB
fnp-4365	142	40	fragilis	fragili	NOUN
fnp-4365	142	41	,	,	PUNCT
fnp-4365	142	42	pseudomona	pseudomona	ADJ
fnp-4365	142	43	aeruginosa	aeruginosa	NOUN
fnp-4365	142	44	,	,	PUNCT
fnp-4365	142	45	enterococcus	enterococcus	NOUN
fnp-4365	142	46	faecium	faecium	NOUN
fnp-4365	142	47	)	)	PUNCT
fnp-4365	142	48	,	,	PUNCT
fnp-4365	142	49	and	and	CCONJ
fnp-4365	142	50	persistent	persistent	ADJ
fnp-4365	142	51	candidemia	candidemia	NOUN
fnp-4365	142	52	as	as	ADV
fnp-4365	142	53	well	well	ADV
fnp-4365	142	54	as	as	ADP
fnp-4365	142	55	cmv	cmv	NOUN
fnp-4365	142	56	reactivation	reactivation	NOUN
fnp-4365	142	57	.	.	PUNCT
fnp-4365	143	1	due	due	ADP
fnp-4365	143	2	to	to	ADP
fnp-4365	143	3	persistent	persistent	ADJ
fnp-4365	143	4	skin	skin	NOUN
fnp-4365	143	5	lesions	lesion	NOUN
fnp-4365	143	6	,	,	PUNCT
fnp-4365	143	7	an	an	DET
fnp-4365	143	8	alternative	alternative	ADJ
fnp-4365	143	9	diagnosis	diagnosis	NOUN
fnp-4365	143	10	of	of	ADP
fnp-4365	143	11	car	car	NOUN
fnp-4365	143	12	t	t	NOUN
fnp-4365	143	13	-	-	PUNCT
fnp-4365	143	14	cell	cell	NOUN
fnp-4365	143	15	associated	associate	VERB
fnp-4365	143	16	dermatosis	dermatosis	NOUN
fnp-4365	143	17	was	be	AUX
fnp-4365	143	18	suspected	suspect	VERB
fnp-4365	143	19	.	.	PUNCT
fnp-4365	144	1	immunosuppression	immunosuppression	NOUN
fnp-4365	144	2	was	be	AUX
fnp-4365	144	3	restarted	restart	VERB
fnp-4365	144	4	,	,	PUNCT
fnp-4365	144	5	improving	improve	VERB
fnp-4365	144	6	the	the	DET
fnp-4365	144	7	skin	skin	NOUN
fnp-4365	144	8	lesions	lesion	NOUN
fnp-4365	144	9	,	,	PUNCT
fnp-4365	144	10	but	but	CCONJ
fnp-4365	144	11	it	it	PRON
fnp-4365	144	12	had	have	VERB
fnp-4365	144	13	to	to	PART
fnp-4365	144	14	be	be	AUX
fnp-4365	144	15	stopped	stop	VERB
fnp-4365	144	16	due	due	ADJ
fnp-4365	144	17	to	to	ADP
fnp-4365	144	18	bone	bone	NOUN
fnp-4365	144	19	marrow	marrow	NOUN
fnp-4365	144	20	aplasia	aplasia	NOUN
fnp-4365	144	21	and	and	CCONJ
fnp-4365	144	22	worsening	worsen	VERB
fnp-4365	144	23	neutropenia	neutropenia	NOUN
fnp-4365	144	24	.	.	PUNCT
fnp-4365	145	1	of	of	ADP
fnp-4365	145	2	note	note	NOUN
fnp-4365	145	3	,	,	PUNCT
fnp-4365	145	4	the	the	DET
fnp-4365	145	5	refractory	refractory	NOUN
fnp-4365	145	6	follicular	follicular	ADJ
fnp-4365	145	7	lymphoma	lymphoma	NOUN
fnp-4365	145	8	showed	show	VERB
fnp-4365	145	9	morpho	morpho	NOUN
fnp-4365	145	10	-	-	PUNCT
fnp-4365	145	11	metabolic	metabolic	ADJ
fnp-4365	145	12	decrease	decrease	NOUN
fnp-4365	145	13	in	in	ADP
fnp-4365	145	14	post	post	NOUN
fnp-4365	145	15	car	car	NOUN
fnp-4365	145	16	t	t	NOUN
fnp-4365	145	17	infusion	infusion	NOUN
fnp-4365	145	18	ct	ct	PROPN
fnp-4365	145	19	and	and	CCONJ
fnp-4365	145	20	pet	pet	ADJ
fnp-4365	145	21	scans	scan	NOUN
fnp-4365	145	22	,	,	PUNCT
fnp-4365	145	23	attributed	attribute	VERB
fnp-4365	145	24	to	to	ADP
fnp-4365	145	25	the	the	DET
fnp-4365	145	26	presence	presence	NOUN
fnp-4365	145	27	of	of	ADP
fnp-4365	145	28	circulating	circulate	VERB
fnp-4365	145	29	car	car	NOUN
fnp-4365	145	30	t	t	NOUN
fnp-4365	145	31	-	-	PUNCT
fnp-4365	145	32	cells	cell	NOUN
fnp-4365	145	33	.	.	PUNCT
fnp-4365	146	1	eventually	eventually	ADV
fnp-4365	146	2	,	,	PUNCT
fnp-4365	146	3	the	the	DET
fnp-4365	146	4	last	last	ADJ
fnp-4365	146	5	episode	episode	NOUN
fnp-4365	146	6	of	of	ADP
fnp-4365	146	7	septic	septic	ADJ
fnp-4365	146	8	shock	shock	NOUN
fnp-4365	146	9	and	and	CCONJ
fnp-4365	146	10	ventilator	ventilator	NOUN
fnp-4365	146	11	associated	associate	VERB
fnp-4365	146	12	pneumonia	pneumonia	NOUN
fnp-4365	146	13	were	be	AUX
fnp-4365	146	14	refractory	refractory	NOUN
fnp-4365	146	15	,	,	PUNCT
fnp-4365	146	16	which	which	PRON
fnp-4365	146	17	led	lead	VERB
fnp-4365	146	18	to	to	ADP
fnp-4365	146	19	death	death	NOUN
fnp-4365	146	20	after	after	ADP
fnp-4365	146	21	4	4	NUM
fnp-4365	146	22	months	month	NOUN
fnp-4365	146	23	in	in	ADP
fnp-4365	146	24	the	the	DET
fnp-4365	146	25	icu	icu	PROPN
fnp-4365	146	26	at	at	ADP
fnp-4365	146	27	5	5	NUM
fnp-4365	146	28	months	month	NOUN
fnp-4365	146	29	of	of	ADP
fnp-4365	146	30	car	car	NOUN
fnp-4365	146	31	t	t	NOUN
fnp-4365	146	32	-	-	PUNCT
fnp-4365	146	33	cell	cell	NOUN
fnp-4365	146	34	therapy	therapy	NOUN
fnp-4365	146	35	.	.	PUNCT
fnp-4365	147	1	he	he	PRON
fnp-4365	147	2	died	die	VERB
fnp-4365	147	3	without	without	ADP
fnp-4365	147	4	evidence	evidence	NOUN
fnp-4365	147	5	of	of	ADP
fnp-4365	147	6	neurological	neurological	ADJ
fnp-4365	147	7	symptoms	symptom	NOUN
fnp-4365	147	8	in	in	ADP
fnp-4365	147	9	the	the	DET
fnp-4365	147	10	course	course	NOUN
fnp-4365	147	11	of	of	ADP
fnp-4365	147	12	the	the	DET
fnp-4365	147	13	disease	disease	NOUN
fnp-4365	147	14	,	,	PUNCT
fnp-4365	147	15	and	and	CCONJ
fnp-4365	147	16	a	a	DET
fnp-4365	147	17	brain	brain	NOUN
fnp-4365	147	18	computerized	computerize	VERB
fnp-4365	147	19	tomography	tomography	NOUN
fnp-4365	147	20	(	(	PUNCT
fnp-4365	147	21	ct	ct	NOUN
fnp-4365	147	22	)	)	PUNCT
fnp-4365	147	23	done	do	VERB
fnp-4365	147	24	45	45	NUM
fnp-4365	147	25	days	day	NOUN
fnp-4365	147	26	after	after	SCONJ
fnp-4365	147	27	the	the	DET
fnp-4365	147	28	car	car	NOUN
fnp-4365	147	29	t	t	NOUN
fnp-4365	147	30	infusions	infusion	NOUN
fnp-4365	147	31	showed	show	VERB
fnp-4365	147	32	no	no	DET
fnp-4365	147	33	significant	significant	ADJ
fnp-4365	147	34	findings	finding	NOUN
fnp-4365	147	35	.	.	PUNCT
fnp-4365	148	1	neuropathologic	neuropathologic	ADJ
fnp-4365	148	2	gross	gross	ADJ
fnp-4365	148	3	examination	examination	NOUN
fnp-4365	148	4	showed	show	VERB
fnp-4365	148	5	a	a	DET
fnp-4365	148	6	1240	1240	NUM
fnp-4365	148	7	g	g	NOUN
fnp-4365	148	8	fixed	fix	VERB
fnp-4365	148	9	brain	brain	NOUN
fnp-4365	148	10	.	.	PUNCT
fnp-4365	149	1	coronal	coronal	ADJ
fnp-4365	149	2	sections	section	NOUN
fnp-4365	149	3	showed	show	VERB
fnp-4365	149	4	mild	mild	ADJ
fnp-4365	149	5	congestive	congestive	NOUN
fnp-4365	149	6	changes	change	NOUN
fnp-4365	149	7	in	in	ADP
fnp-4365	149	8	caudate	caudate	NOUN
fnp-4365	149	9	,	,	PUNCT
fnp-4365	149	10	putamen	putaman	NOUN
fnp-4365	149	11	,	,	PUNCT
fnp-4365	149	12	thalamus	thalamus	NOUN
fnp-4365	149	13	,	,	PUNCT
fnp-4365	149	14	and	and	CCONJ
fnp-4365	149	15	parieto	parieto	ADJ
fnp-4365	149	16	-	-	PUNCT
fnp-4365	149	17	occipital	occipital	NOUN
fnp-4365	149	18	white	white	ADJ
fnp-4365	149	19	matter	matter	NOUN
fnp-4365	149	20	.	.	PUNCT
fnp-4365	150	1	histology	histology	NOUN
fnp-4365	150	2	revealed	reveal	VERB
fnp-4365	150	3	cortical	cortical	ADJ
fnp-4365	150	4	gliosis	gliosis	NOUN
fnp-4365	150	5	in	in	ADP
fnp-4365	150	6	frontal	frontal	ADJ
fnp-4365	150	7	and	and	CCONJ
fnp-4365	150	8	parahippocampal	parahippocampal	ADJ
fnp-4365	150	9	cortices	cortex	NOUN
fnp-4365	150	10	,	,	PUNCT
fnp-4365	150	11	in	in	ADP
fnp-4365	150	12	possible	possible	ADJ
fnp-4365	150	13	relation	relation	NOUN
fnp-4365	150	14	to	to	PART
fnp-4365	150	15	acute	acute	VERB
fnp-4365	150	16	hypoxic	hypoxic	ADJ
fnp-4365	150	17	-	-	PUNCT
fnp-4365	150	18	ischemic	ischemic	ADJ
fnp-4365	150	19	injury	injury	NOUN
fnp-4365	150	20	,	,	PUNCT
fnp-4365	150	21	as	as	ADV
fnp-4365	150	22	well	well	ADV
fnp-4365	150	23	as	as	ADP
fnp-4365	150	24	mild	mild	ADJ
fnp-4365	150	25	scattered	scatter	VERB
fnp-4365	150	26	foci	focus	NOUN
fnp-4365	150	27	of	of	ADP
fnp-4365	150	28	gliosis	gliosis	NOUN
fnp-4365	150	29	with	with	ADP
fnp-4365	150	30	minimal	minimal	ADJ
fnp-4365	150	31	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	150	32	in	in	ADP
fnp-4365	150	33	frontal	frontal	ADJ
fnp-4365	150	34	and	and	CCONJ
fnp-4365	150	35	parahippocampal	parahippocampal	ADJ
fnp-4365	150	36	subcortical	subcortical	ADJ
fnp-4365	150	37	white	white	ADJ
fnp-4365	150	38	matter	matter	NOUN
fnp-4365	150	39	,	,	PUNCT
fnp-4365	150	40	highlighted	highlight	VERB
fnp-4365	150	41	with	with	ADP
fnp-4365	150	42	gfap	gfap	ADJ
fnp-4365	150	43	immunohistochemistry	immunohistochemistry	NOUN
fnp-4365	150	44	(	(	PUNCT
fnp-4365	150	45	see	see	VERB
fnp-4365	150	46	figure	figure	NOUN
fnp-4365	150	47	1	1	NUM
fnp-4365	150	48	)	)	PUNCT
fnp-4365	150	49	.	.	PUNCT
fnp-4365	151	1	mild	mild	ADJ
fnp-4365	151	2	parenchymal	parenchymal	ADJ
fnp-4365	151	3	blood	blood	NOUN
fnp-4365	151	4	vessel	vessel	NOUN
fnp-4365	151	5	arteriosclerosis	arteriosclerosis	NOUN
fnp-4365	151	6	and	and	CCONJ
fnp-4365	151	7	arteriolar	arteriolar	ADJ
fnp-4365	151	8	hyalinosis	hyalinosis	NOUN
fnp-4365	151	9	,	,	PUNCT
fnp-4365	151	10	with	with	ADP
fnp-4365	151	11	occasional	occasional	ADJ
fnp-4365	151	12	hemosiderin	hemosiderin	ADJ
fnp-4365	151	13	deposits	deposit	NOUN
fnp-4365	151	14	,	,	PUNCT
fnp-4365	151	15	and	and	CCONJ
fnp-4365	151	16	isolated	isolate	VERB
fnp-4365	151	17	perivascular	perivascular	ADJ
fnp-4365	151	18	rarefaction	rarefaction	NOUN
fnp-4365	151	19	in	in	ADP
fnp-4365	151	20	deep	deep	ADJ
fnp-4365	151	21	vessels	vessel	NOUN
fnp-4365	151	22	was	be	AUX
fnp-4365	151	23	observed	observe	VERB
fnp-4365	151	24	.	.	PUNCT
fnp-4365	152	1	histology	histology	NOUN
fnp-4365	152	2	also	also	ADV
fnp-4365	152	3	showed	show	VERB
fnp-4365	152	4	isolated	isolated	ADJ
fnp-4365	152	5	diffuse	diffuse	ADJ
fnp-4365	152	6	cortical	cortical	ADJ
fnp-4365	152	7	amyloid	amyloid	NOUN
fnp-4365	152	8	beta	beta	NOUN
fnp-4365	152	9	deposits	deposit	NOUN
fnp-4365	152	10	,	,	PUNCT
fnp-4365	152	11	and	and	CCONJ
fnp-4365	152	12	minimal	minimal	ADJ
fnp-4365	152	13	amygdala	amygdala	NOUN
fnp-4365	152	14	neurofibrillary	neurofibrillary	ADJ
fnp-4365	152	15	pathology	pathology	NOUN
fnp-4365	152	16	.	.	PUNCT
fnp-4365	153	1	pcr	pcr	PROPN
fnp-4365	153	2	for	for	ADP
fnp-4365	153	3	the	the	DET
fnp-4365	153	4	detection	detection	NOUN
fnp-4365	153	5	of	of	ADP
fnp-4365	153	6	car	car	NOUN
fnp-4365	153	7	t	t	NOUN
fnp-4365	153	8	-	-	PUNCT
fnp-4365	153	9	cells	cell	NOUN
fnp-4365	153	10	in	in	ADP
fnp-4365	153	11	paraffin	paraffin	NOUN
fnp-4365	153	12	blocks	block	NOUN
fnp-4365	153	13	was	be	AUX
fnp-4365	153	14	negative	negative	ADJ
fnp-4365	153	15	.	.	PUNCT
fnp-4365	154	1	full	full	ADJ
fnp-4365	154	2	body	body	NOUN
fnp-4365	154	3	autopsy	autopsy	NOUN
fnp-4365	154	4	excluded	exclude	VERB
fnp-4365	154	5	residual	residual	ADJ
fnp-4365	154	6	neoplasia	neoplasia	NOUN
fnp-4365	154	7	and	and	CCONJ
fnp-4365	154	8	evidenced	evidence	VERB
fnp-4365	154	9	a	a	DET
fnp-4365	154	10	pneumonic	pneumonic	ADJ
fnp-4365	154	11	process	process	NOUN
fnp-4365	154	12	in	in	ADP
fnp-4365	154	13	context	context	NOUN
fnp-4365	154	14	of	of	ADP
fnp-4365	154	15	the	the	DET
fnp-4365	154	16	septic	septic	ADJ
fnp-4365	154	17	condition	condition	NOUN
fnp-4365	154	18	.	.	PUNCT
fnp-4365	155	1	the	the	DET
fnp-4365	155	2	final	final	ADJ
fnp-4365	155	3	cause	cause	NOUN
fnp-4365	155	4	of	of	ADP
fnp-4365	155	5	death	death	NOUN
fnp-4365	155	6	was	be	AUX
fnp-4365	155	7	a	a	DET
fnp-4365	155	8	respiratory	respiratory	ADJ
fnp-4365	155	9	failure	failure	NOUN
fnp-4365	155	10	.	.	PUNCT
fnp-4365	156	1	case	case	NOUN
fnp-4365	156	2	5	5	NUM
fnp-4365	156	3	a	a	DET
fnp-4365	156	4	28	28	NUM
fnp-4365	156	5	-	-	PUNCT
fnp-4365	156	6	year	year	NOUN
fnp-4365	156	7	-	-	PUNCT
fnp-4365	156	8	old	old	ADJ
fnp-4365	156	9	man	man	NOUN
fnp-4365	156	10	with	with	ADP
fnp-4365	156	11	b	b	NOUN
fnp-4365	156	12	-	-	PUNCT
fnp-4365	156	13	cell	cell	NOUN
fnp-4365	156	14	acute	acute	ADJ
fnp-4365	156	15	lymphoblastic	lymphoblastic	ADJ
fnp-4365	156	16	leukemia	leukemia	NOUN
fnp-4365	156	17	with	with	ADP
fnp-4365	156	18	disease	disease	NOUN
fnp-4365	156	19	progression	progression	NOUN
fnp-4365	156	20	with	with	ADP
fnp-4365	156	21	orbital	orbital	ADJ
fnp-4365	156	22	infiltration	infiltration	NOUN
fnp-4365	156	23	.	.	PUNCT
fnp-4365	157	1	after	after	ADP
fnp-4365	157	2	diagnosis	diagnosis	NOUN
fnp-4365	157	3	,	,	PUNCT
fnp-4365	157	4	induction	induction	NOUN
fnp-4365	157	5	,	,	PUNCT
fnp-4365	157	6	and	and	CCONJ
fnp-4365	157	7	consolidation	consolidation	NOUN
fnp-4365	157	8	treatment	treatment	NOUN
fnp-4365	157	9	,	,	PUNCT
fnp-4365	157	10	he	he	PRON
fnp-4365	157	11	received	receive	VERB
fnp-4365	157	12	haploidentical	haploidentical	ADJ
fnp-4365	157	13	stem	stem	NOUN
fnp-4365	157	14	cell	cell	NOUN
fnp-4365	157	15	transplant	transplant	NOUN
fnp-4365	157	16	(	(	PUNCT
fnp-4365	157	17	sct	sct	PROPN
fnp-4365	157	18	)	)	PUNCT
fnp-4365	157	19	,	,	PUNCT
fnp-4365	157	20	which	which	PRON
fnp-4365	157	21	was	be	AUX
fnp-4365	157	22	previously	previously	ADV
fnp-4365	157	23	conditioned	condition	VERB
fnp-4365	157	24	with	with	ADP
fnp-4365	157	25	thiotepa	thiotepa	NOUN
fnp-4365	157	26	,	,	PUNCT
fnp-4365	157	27	fludarabine	fludarabine	NOUN
fnp-4365	157	28	,	,	PUNCT
fnp-4365	157	29	busulfan	busulfan	NOUN
fnp-4365	157	30	and	and	CCONJ
fnp-4365	157	31	prophylaxis	prophylaxis	NOUN
fnp-4365	157	32	of	of	ADP
fnp-4365	157	33	graft	graft	NOUN
fnp-4365	157	34	versus	versus	ADP
fnp-4365	157	35	host	host	NOUN
fnp-4365	157	36	disease	disease	NOUN
fnp-4365	157	37	(	(	PUNCT
fnp-4365	157	38	gvhd	gvhd	PROPN
fnp-4365	157	39	)	)	PUNCT
fnp-4365	157	40	with	with	ADP
fnp-4365	157	41	tacrolimus	tacrolimus	NOUN
fnp-4365	157	42	and	and	CCONJ
fnp-4365	157	43	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	157	44	.	.	PUNCT
fnp-4365	158	1	he	he	PRON
fnp-4365	158	2	developed	develop	VERB
fnp-4365	158	3	hemorrhagic	hemorrhagic	NOUN
fnp-4365	158	4	cystitis	cystitis	NOUN
fnp-4365	158	5	,	,	PUNCT
fnp-4365	158	6	cmv	cmv	NOUN
fnp-4365	158	7	reactivation	reactivation	NOUN
fnp-4365	158	8	,	,	PUNCT
fnp-4365	158	9	escherichia	escherichia	NOUN
fnp-4365	158	10	coli	coli	NOUN
fnp-4365	158	11	orchitis	orchitis	NOUN
fnp-4365	158	12	and	and	CCONJ
fnp-4365	158	13	tacrolimus	tacrolimus	PROPN
fnp-4365	158	14	nephrotoxicity	nephrotoxicity	NOUN
fnp-4365	158	15	as	as	ADP
fnp-4365	158	16	complications	complication	NOUN
fnp-4365	158	17	,	,	PUNCT
fnp-4365	158	18	but	but	CCONJ
fnp-4365	158	19	never	never	ADV
fnp-4365	158	20	gvhd	gvhd	PROPN
fnp-4365	158	21	.	.	PUNCT
fnp-4365	159	1	he	he	PRON
fnp-4365	159	2	relapsed	relapse	VERB
fnp-4365	159	3	one	one	NUM
fnp-4365	159	4	year	year	NOUN
fnp-4365	159	5	after	after	ADP
fnp-4365	159	6	sct	sct	PROPN
fnp-4365	159	7	with	with	ADP
fnp-4365	159	8	testicular	testicular	ADJ
fnp-4365	159	9	infiltration	infiltration	NOUN
fnp-4365	159	10	,	,	PUNCT
fnp-4365	159	11	which	which	PRON
fnp-4365	159	12	required	require	VERB
fnp-4365	159	13	blinatumomab	blinatumomab	NOUN
fnp-4365	159	14	rescue	rescue	NOUN
fnp-4365	159	15	treatment	treatment	NOUN
fnp-4365	159	16	and	and	CCONJ
fnp-4365	159	17	lymphocyte	lymphocyte	ADJ
fnp-4365	159	18	donor	donor	NOUN
fnp-4365	159	19	infusion	infusion	NOUN
fnp-4365	159	20	plus	plus	CCONJ
fnp-4365	159	21	intrathecal	intrathecal	ADJ
fnp-4365	159	22	prophylaxis	prophylaxis	NOUN
fnp-4365	159	23	,	,	PUNCT
fnp-4365	159	24	but	but	CCONJ
fnp-4365	159	25	ultimately	ultimately	ADV
fnp-4365	159	26	led	lead	VERB
fnp-4365	159	27	to	to	ADP
fnp-4365	159	28	radiotherapy	radiotherapy	NOUN
fnp-4365	159	29	and	and	CCONJ
fnp-4365	159	30	posterior	posterior	ADJ
fnp-4365	159	31	bilateral	bilateral	ADJ
fnp-4365	159	32	orchiectomy	orchiectomy	NOUN
fnp-4365	159	33	.	.	PUNCT
fnp-4365	160	1	two	two	NUM
fnp-4365	160	2	years	year	NOUN
fnp-4365	160	3	after	after	ADP
fnp-4365	160	4	diagnosis	diagnosis	NOUN
fnp-4365	160	5	,	,	PUNCT
fnp-4365	160	6	he	he	PRON
fnp-4365	160	7	had	have	VERB
fnp-4365	160	8	progressive	progressive	ADJ
fnp-4365	160	9	disease	disease	NOUN
fnp-4365	160	10	and	and	CCONJ
fnp-4365	160	11	was	be	AUX
fnp-4365	160	12	planned	plan	VERB
fnp-4365	160	13	for	for	ADP
fnp-4365	160	14	car	car	NOUN
fnp-4365	160	15	-	-	PUNCT
fnp-4365	160	16	cd19	cd19	PROPN
fnp-4365	160	17	therapy	therapy	NOUN
fnp-4365	160	18	.	.	PUNCT
fnp-4365	161	1	his	his	PRON
fnp-4365	161	2	initial	initial	ADJ
fnp-4365	161	3	brain	brain	NOUN
fnp-4365	161	4	mri	mri	NOUN
fnp-4365	161	5	showed	show	VERB
fnp-4365	161	6	few	few	ADJ
fnp-4365	161	7	nonspecific	nonspecific	ADJ
fnp-4365	161	8	subcortical	subcortical	ADJ
fnp-4365	161	9	white	white	ADJ
fnp-4365	161	10	matter	matter	NOUN
fnp-4365	161	11	hyperintense	hyperintense	NOUN
fnp-4365	161	12	signal	signal	NOUN
fnp-4365	161	13	abnormalities	abnormality	NOUN
fnp-4365	161	14	,	,	PUNCT
fnp-4365	161	15	and	and	CCONJ
fnp-4365	161	16	tumor	tumor	NOUN
fnp-4365	161	17	infiltration	infiltration	NOUN
fnp-4365	161	18	of	of	ADP
fnp-4365	161	19	the	the	DET
fnp-4365	161	20	right	right	ADJ
fnp-4365	161	21	orbit	orbit	NOUN
fnp-4365	161	22	.	.	PUNCT
fnp-4365	162	1	after	after	ADP
fnp-4365	162	2	lymphodepletion	lymphodepletion	NOUN
fnp-4365	162	3	with	with	ADP
fnp-4365	162	4	fludarabine	fludarabine	NOUN
fnp-4365	162	5	and	and	CCONJ
fnp-4365	162	6	cyclophosphamide	cyclophosphamide	PROPN
fnp-4365	162	7	,	,	PUNCT
fnp-4365	162	8	he	he	PRON
fnp-4365	162	9	received	receive	VERB
fnp-4365	162	10	a	a	DET
fnp-4365	162	11	first	first	ADJ
fnp-4365	162	12	car	car	NOUN
fnp-4365	162	13	t	t	NOUN
fnp-4365	162	14	-	-	PUNCT
fnp-4365	162	15	cell	cell	NOUN
fnp-4365	162	16	infusion	infusion	NOUN
fnp-4365	162	17	with	with	ADP
fnp-4365	162	18	good	good	ADJ
fnp-4365	162	19	tolerance	tolerance	NOUN
fnp-4365	162	20	,	,	PUNCT
fnp-4365	162	21	no	no	DET
fnp-4365	162	22	signs	sign	NOUN
fnp-4365	162	23	of	of	ADP
fnp-4365	162	24	crs	crs	PROPN
fnp-4365	162	25	and	and	CCONJ
fnp-4365	162	26	good	good	ADJ
fnp-4365	162	27	response	response	NOUN
fnp-4365	162	28	observing	observe	VERB
fnp-4365	162	29	non	non	ADJ
fnp-4365	162	30	-	-	ADJ
fnp-4365	162	31	neoplastic	neoplastic	ADJ
fnp-4365	162	32	b	b	NOUN
fnp-4365	162	33	-	-	PUNCT
fnp-4365	162	34	cells	cell	NOUN
fnp-4365	162	35	.	.	PUNCT
fnp-4365	163	1	due	due	ADP
fnp-4365	163	2	to	to	ADP
fnp-4365	163	3	loss	loss	NOUN
fnp-4365	163	4	of	of	ADP
fnp-4365	163	5	car	car	NOUN
fnp-4365	163	6	t	t	NOUN
fnp-4365	163	7	-	-	PUNCT
fnp-4365	163	8	cells	cell	NOUN
fnp-4365	163	9	in	in	ADP
fnp-4365	163	10	peripheral	peripheral	ADJ
fnp-4365	163	11	blood	blood	NOUN
fnp-4365	163	12	,	,	PUNCT
fnp-4365	163	13	he	he	PRON
fnp-4365	163	14	received	receive	VERB
fnp-4365	163	15	two	two	NUM
fnp-4365	163	16	reinfusions	reinfusion	NOUN
fnp-4365	163	17	in	in	ADP
fnp-4365	163	18	a	a	DET
fnp-4365	163	19	10	10	NUM
fnp-4365	163	20	-	-	PUNCT
fnp-4365	163	21	month	month	NOUN
fnp-4365	163	22	period	period	NOUN
fnp-4365	163	23	.	.	PUNCT
fnp-4365	164	1	the	the	DET
fnp-4365	164	2	second	second	ADJ
fnp-4365	164	3	was	be	AUX
fnp-4365	164	4	followed	follow	VERB
fnp-4365	164	5	by	by	ADP
fnp-4365	164	6	an	an	DET
fnp-4365	164	7	early	early	ADJ
fnp-4365	164	8	loss	loss	NOUN
fnp-4365	164	9	of	of	ADP
fnp-4365	164	10	car	car	NOUN
fnp-4365	164	11	t	t	NOUN
fnp-4365	164	12	-	-	PUNCT
fnp-4365	164	13	cells	cell	NOUN
fnp-4365	164	14	due	due	ADJ
fnp-4365	164	15	to	to	ADP
fnp-4365	164	16	antibodies	antibodie	VERB
fnp-4365	164	17	,	,	PUNCT
fnp-4365	164	18	and	and	CCONJ
fnp-4365	164	19	the	the	DET
fnp-4365	164	20	third	third	ADJ
fnp-4365	164	21	infusion	infusion	NOUN
fnp-4365	164	22	was	be	AUX
fnp-4365	164	23	made	make	VERB
fnp-4365	164	24	after	after	SCONJ
fnp-4365	164	25	plasma	plasma	NOUN
fnp-4365	164	26	exchange	exchange	NOUN
fnp-4365	164	27	to	to	PART
fnp-4365	164	28	remove	remove	VERB
fnp-4365	164	29	the	the	DET
fnp-4365	164	30	antibodies	antibody	NOUN
fnp-4365	164	31	.	.	PUNCT
fnp-4365	165	1	after	after	ADP
fnp-4365	165	2	the	the	DET
fnp-4365	165	3	third	third	ADJ
fnp-4365	165	4	infusion	infusion	NOUN
fnp-4365	165	5	,	,	PUNCT
fnp-4365	165	6	he	he	PRON
fnp-4365	165	7	presented	present	VERB
fnp-4365	165	8	with	with	ADP
fnp-4365	165	9	fever	fever	NOUN
fnp-4365	165	10	without	without	ADP
fnp-4365	165	11	a	a	DET
fnp-4365	165	12	clear	clear	ADJ
fnp-4365	165	13	origin	origin	NOUN
fnp-4365	165	14	that	that	PRON
fnp-4365	165	15	was	be	AUX
fnp-4365	165	16	treated	treat	VERB
fnp-4365	165	17	with	with	ADP
fnp-4365	165	18	antibiotics	antibiotic	NOUN
fnp-4365	165	19	,	,	PUNCT
fnp-4365	165	20	with	with	ADP
fnp-4365	165	21	low	low	ADJ
fnp-4365	165	22	clinical	clinical	ADJ
fnp-4365	165	23	suspicion	suspicion	NOUN
fnp-4365	165	24	of	of	ADP
fnp-4365	165	25	crs	crs	PROPN
fnp-4365	165	26	due	due	ADP
fnp-4365	165	27	to	to	ADP
fnp-4365	165	28	the	the	DET
fnp-4365	165	29	absence	absence	NOUN
fnp-4365	165	30	of	of	ADP
fnp-4365	165	31	analytical	analytical	ADJ
fnp-4365	165	32	alterations	alteration	NOUN
fnp-4365	165	33	.	.	PUNCT
fnp-4365	166	1	almost	almost	ADV
fnp-4365	166	2	one	one	NUM
fnp-4365	166	3	month	month	NOUN
fnp-4365	166	4	after	after	ADP
fnp-4365	166	5	this	this	DET
fnp-4365	166	6	last	last	ADJ
fnp-4365	166	7	infusion	infusion	NOUN
fnp-4365	166	8	,	,	PUNCT
fnp-4365	166	9	he	he	PRON
fnp-4365	166	10	presented	present	VERB
fnp-4365	166	11	with	with	ADP
fnp-4365	166	12	confusion	confusion	NOUN
fnp-4365	166	13	,	,	PUNCT
fnp-4365	166	14	bradypsychia	bradypsychia	NOUN
fnp-4365	166	15	and	and	CCONJ
fnp-4365	166	16	generalized	generalized	ADJ
fnp-4365	166	17	tremor	tremor	NOUN
fnp-4365	166	18	.	.	PUNCT
fnp-4365	167	1	repeated	repeat	VERB
fnp-4365	167	2	,	,	PUNCT
fnp-4365	167	3	a	a	DET
fnp-4365	167	4	brain	brain	NOUN
fnp-4365	167	5	mri	mri	NOUN
fnp-4365	167	6	showed	show	VERB
fnp-4365	167	7	no	no	DET
fnp-4365	167	8	significant	significant	ADJ
fnp-4365	167	9	changes	change	NOUN
fnp-4365	167	10	,	,	PUNCT
fnp-4365	167	11	and	and	CCONJ
fnp-4365	167	12	persistent	persistent	ADJ
fnp-4365	167	13	tumor	tumor	NOUN
fnp-4365	167	14	infiltration	infiltration	NOUN
fnp-4365	167	15	of	of	ADP
fnp-4365	167	16	the	the	DET
fnp-4365	167	17	right	right	ADJ
fnp-4365	167	18	orbit	orbit	NOUN
fnp-4365	167	19	.	.	PUNCT
fnp-4365	168	1	eeg	eeg	PROPN
fnp-4365	168	2	study	study	NOUN
fnp-4365	168	3	showed	show	VERB
fnp-4365	168	4	diffuse	diffuse	NOUN
fnp-4365	168	5	slowing	slowing	NOUN
fnp-4365	168	6	,	,	PUNCT
fnp-4365	168	7	and	and	CCONJ
fnp-4365	168	8	there	there	PRON
fnp-4365	168	9	were	be	VERB
fnp-4365	168	10	not	not	PART
fnp-4365	168	11	significant	significant	ADJ
fnp-4365	168	12	findings	finding	NOUN
fnp-4365	168	13	in	in	ADP
fnp-4365	168	14	the	the	DET
fnp-4365	168	15	csf	csf	ADJ
fnp-4365	168	16	study	study	NOUN
fnp-4365	168	17	.	.	PUNCT
fnp-4365	169	1	the	the	DET
fnp-4365	169	2	neurological	neurological	ADJ
fnp-4365	169	3	symptoms	symptom	NOUN
fnp-4365	169	4	were	be	AUX
fnp-4365	169	5	refractory	refractory	NOUN
fnp-4365	169	6	,	,	PUNCT
fnp-4365	169	7	and	and	CCONJ
fnp-4365	169	8	he	he	PRON
fnp-4365	169	9	died	die	VERB
fnp-4365	169	10	43	43	NUM
fnp-4365	169	11	days	day	NOUN
fnp-4365	169	12	after	after	ADP
fnp-4365	169	13	the	the	DET
fnp-4365	169	14	third	third	ADJ
fnp-4365	169	15	car	car	NOUN
fnp-4365	169	16	t	t	NOUN
fnp-4365	169	17	-	-	PUNCT
fnp-4365	169	18	cell	cell	NOUN
fnp-4365	169	19	infusion	infusion	NOUN
fnp-4365	169	20	.	.	PUNCT
fnp-4365	170	1	neuropathologic	neuropathologic	ADJ
fnp-4365	170	2	gross	gross	ADJ
fnp-4365	170	3	examination	examination	NOUN
fnp-4365	170	4	showed	show	VERB
fnp-4365	170	5	a	a	DET
fnp-4365	170	6	1385	1385	NUM
fnp-4365	170	7	g	g	NOUN
fnp-4365	170	8	fixed	fix	VERB
fnp-4365	170	9	brain	brain	NOUN
fnp-4365	170	10	.	.	PUNCT
fnp-4365	171	1	coronal	coronal	ADJ
fnp-4365	171	2	sections	section	NOUN
fnp-4365	171	3	showed	show	VERB
fnp-4365	171	4	softening	soften	VERB
fnp-4365	171	5	in	in	ADP
fnp-4365	171	6	both	both	DET
fnp-4365	171	7	putamen	putaman	NOUN
fnp-4365	171	8	.	.	PUNCT
fnp-4365	172	1	histology	histology	NOUN
fnp-4365	172	2	revealed	reveal	VERB
fnp-4365	172	3	diffuse	diffuse	ADJ
fnp-4365	172	4	gliosis	gliosis	NOUN
fnp-4365	172	5	predominant	predominant	ADJ
fnp-4365	172	6	in	in	ADP
fnp-4365	172	7	basal	basal	ADJ
fnp-4365	172	8	ganglia	ganglia	NOUN
fnp-4365	172	9	,	,	PUNCT
fnp-4365	172	10	hippocampus	hippocampus	NOUN
fnp-4365	172	11	,	,	PUNCT
fnp-4365	172	12	substantia	substantia	NOUN
fnp-4365	172	13	nigra	nigra	NOUN
fnp-4365	172	14	and	and	CCONJ
fnp-4365	172	15	brainstem	brainstem	NOUN
fnp-4365	172	16	.	.	PUNCT
fnp-4365	173	1	the	the	DET
fnp-4365	173	2	most	most	ADV
fnp-4365	173	3	relevant	relevant	ADJ
fnp-4365	173	4	finding	finding	NOUN
fnp-4365	173	5	was	be	AUX
fnp-4365	173	6	interstitial	interstitial	ADJ
fnp-4365	173	7	and	and	CCONJ
fnp-4365	173	8	perivascular	perivascular	ADJ
fnp-4365	173	9	lymphocytic	lymphocytic	ADJ
fnp-4365	173	10	infiltrates	infiltrate	NOUN
fnp-4365	173	11	,	,	PUNCT
fnp-4365	173	12	together	together	ADV
fnp-4365	173	13	with	with	ADP
fnp-4365	173	14	histiocytic	histiocytic	ADJ
fnp-4365	173	15	infiltrates	infiltrate	NOUN
fnp-4365	173	16	,	,	PUNCT
fnp-4365	173	17	which	which	PRON
fnp-4365	173	18	were	be	AUX
fnp-4365	173	19	severe	severe	ADJ
fnp-4365	173	20	in	in	ADP
fnp-4365	173	21	anterior	anterior	ADJ
fnp-4365	173	22	horns	horn	NOUN
fnp-4365	173	23	and	and	CCONJ
fnp-4365	173	24	grey	grey	ADJ
fnp-4365	173	25	matter	matter	NOUN
fnp-4365	173	26	of	of	ADP
fnp-4365	173	27	spinal	spinal	ADJ
fnp-4365	173	28	cord	cord	NOUN
fnp-4365	173	29	,	,	PUNCT
fnp-4365	173	30	and	and	CCONJ
fnp-4365	173	31	to	to	ADP
fnp-4365	173	32	a	a	DET
fnp-4365	173	33	lesser	less	ADJ
fnp-4365	173	34	extent	extent	NOUN
fnp-4365	173	35	in	in	ADP
fnp-4365	173	36	the	the	DET
fnp-4365	173	37	midbrain	midbrain	NOUN
fnp-4365	173	38	and	and	CCONJ
fnp-4365	173	39	hippocampus	hippocampus	NOUN
fnp-4365	173	40	(	(	PUNCT
fnp-4365	173	41	figure	figure	NOUN
fnp-4365	173	42	2	2	NUM
fnp-4365	173	43	)	)	PUNCT
fnp-4365	173	44	.	.	PUNCT
fnp-4365	174	1	immunohistochemical	immunohistochemical	ADJ
fnp-4365	174	2	studies	study	NOUN
fnp-4365	174	3	revealed	reveal	VERB
fnp-4365	174	4	that	that	SCONJ
fnp-4365	174	5	lymphocytic	lymphocytic	ADJ
fnp-4365	174	6	infiltrates	infiltrate	NOUN
fnp-4365	174	7	were	be	AUX
fnp-4365	174	8	cd3	cd3	VERB
fnp-4365	174	9	+	+	PROPN
fnp-4365	174	10	t	t	PROPN
fnp-4365	174	11	-	-	PUNCT
fnp-4365	174	12	cells	cell	NOUN
fnp-4365	174	13	,	,	PUNCT
fnp-4365	174	14	predominantly	predominantly	ADV
fnp-4365	174	15	cd8	cd8	PROPN
fnp-4365	174	16	+	+	PROPN
fnp-4365	174	17	,	,	PUNCT
fnp-4365	174	18	with	with	SCONJ
fnp-4365	174	19	practically	practically	ADV
fnp-4365	174	20	no	no	DET
fnp-4365	174	21	b	b	NOUN
fnp-4365	174	22	-	-	PUNCT
fnp-4365	174	23	cells	cell	NOUN
fnp-4365	174	24	being	be	AUX
fnp-4365	174	25	observed	observe	VERB
fnp-4365	174	26	,	,	PUNCT
fnp-4365	174	27	and	and	CCONJ
fnp-4365	174	28	were	be	AUX
fnp-4365	174	29	accompanied	accompany	VERB
fnp-4365	174	30	by	by	ADP
fnp-4365	174	31	severe	severe	ADJ
fnp-4365	174	32	cd68	cd68	PROPN
fnp-4365	174	33	+	+	NOUN
fnp-4365	174	34	microglial	microglial	ADJ
fnp-4365	174	35	activation	activation	NOUN
fnp-4365	174	36	with	with	ADP
fnp-4365	174	37	foamy	foamy	ADJ
fnp-4365	174	38	histiocytes	histiocyte	NOUN
fnp-4365	174	39	.	.	PUNCT
fnp-4365	175	1	neurofilament	neurofilament	ADJ
fnp-4365	175	2	staining	stain	VERB
fnp-4365	175	3	showed	show	VERB
fnp-4365	175	4	occasional	occasional	ADJ
fnp-4365	175	5	phosphorylated	phosphorylate	VERB
fnp-4365	175	6	somas	soma	NOUN
fnp-4365	175	7	as	as	ADV
fnp-4365	175	8	well	well	ADV
fnp-4365	175	9	as	as	ADP
fnp-4365	175	10	isolated	isolated	ADJ
fnp-4365	175	11	axonal	axonal	ADJ
fnp-4365	175	12	spheroids	spheroid	NOUN
fnp-4365	175	13	in	in	ADP
fnp-4365	175	14	cortical	cortical	ADJ
fnp-4365	175	15	and	and	CCONJ
fnp-4365	175	16	hippocampal	hippocampal	ADJ
fnp-4365	175	17	white	white	ADJ
fnp-4365	175	18	matter	matter	NOUN
fnp-4365	175	19	,	,	PUNCT
fnp-4365	175	20	without	without	ADP
fnp-4365	175	21	axonal	axonal	ADJ
fnp-4365	175	22	loss	loss	NOUN
fnp-4365	175	23	in	in	ADP
fnp-4365	175	24	spinal	spinal	ADJ
fnp-4365	175	25	cord	cord	NOUN
fnp-4365	175	26	tracts	tract	NOUN
fnp-4365	175	27	.	.	PUNCT
fnp-4365	176	1	gfap	gfap	ADJ
fnp-4365	176	2	staining	stain	VERB
fnp-4365	176	3	showed	show	VERB
fnp-4365	176	4	mild	mild	ADJ
fnp-4365	176	5	and	and	CCONJ
fnp-4365	176	6	focal	focal	ADJ
fnp-4365	176	7	clasmatodendritic	clasmatodendritic	ADJ
fnp-4365	176	8	changes	change	NOUN
fnp-4365	176	9	in	in	ADP
fnp-4365	176	10	the	the	DET
fnp-4365	176	11	white	white	ADJ
fnp-4365	176	12	matter	matter	NOUN
fnp-4365	176	13	.	.	PUNCT
fnp-4365	177	1	all	all	DET
fnp-4365	177	2	the	the	DET
fnp-4365	177	3	findings	finding	NOUN
fnp-4365	177	4	above	above	ADV
fnp-4365	177	5	were	be	AUX
fnp-4365	177	6	concordant	concordant	ADJ
fnp-4365	177	7	with	with	ADP
fnp-4365	177	8	the	the	DET
fnp-4365	177	9	diagnosis	diagnosis	NOUN
fnp-4365	177	10	of	of	ADP
fnp-4365	177	11	a	a	DET
fnp-4365	177	12	diffuse	diffuse	ADJ
fnp-4365	177	13	lymphocytic	lymphocytic	ADJ
fnp-4365	177	14	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	177	15	predominant	predominant	NOUN
fnp-4365	177	16	in	in	ADP
fnp-4365	177	17	brainstem	brainstem	NOUN
fnp-4365	177	18	,	,	PUNCT
fnp-4365	177	19	spinal	spinal	ADJ
fnp-4365	177	20	cord	cord	NOUN
fnp-4365	177	21	and	and	CCONJ
fnp-4365	177	22	limbic	limbic	ADJ
fnp-4365	177	23	system	system	NOUN
fnp-4365	177	24	,	,	PUNCT
fnp-4365	177	25	with	with	ADP
fnp-4365	177	26	milder	mild	ADJ
fnp-4365	177	27	disease	disease	NOUN
fnp-4365	177	28	in	in	ADP
fnp-4365	177	29	cortex	cortex	NOUN
fnp-4365	177	30	and	and	CCONJ
fnp-4365	177	31	basal	basal	ADJ
fnp-4365	177	32	ganglia	ganglion	NOUN
fnp-4365	177	33	,	,	PUNCT
fnp-4365	177	34	and	and	CCONJ
fnp-4365	177	35	relative	relative	ADJ
fnp-4365	177	36	sparing	sparing	NOUN
fnp-4365	177	37	of	of	ADP
fnp-4365	177	38	cerebellum	cerebellum	NOUN
fnp-4365	177	39	.	.	PUNCT
fnp-4365	178	1	no	no	DET
fnp-4365	178	2	viral	viral	ADJ
fnp-4365	178	3	inclusions	inclusion	NOUN
fnp-4365	178	4	were	be	AUX
fnp-4365	178	5	observed	observe	VERB
fnp-4365	178	6	,	,	PUNCT
fnp-4365	178	7	and	and	CCONJ
fnp-4365	178	8	virus	virus	NOUN
fnp-4365	178	9	detection	detection	NOUN
fnp-4365	178	10	stains	stain	NOUN
fnp-4365	178	11	for	for	ADP
fnp-4365	178	12	hsv-1	hsv-1	PRON
fnp-4365	178	13	,	,	PUNCT
fnp-4365	178	14	hsv-2	hsv-2	NOUN
fnp-4365	178	15	,	,	PUNCT
fnp-4365	178	16	hhv-6	hhv-6	NOUN
fnp-4365	178	17	,	,	PUNCT
fnp-4365	178	18	hhv-8	hhv-8	NOUN
fnp-4365	178	19	,	,	PUNCT
fnp-4365	178	20	cmv	cmv	NOUN
fnp-4365	178	21	,	,	PUNCT
fnp-4365	178	22	ebv	ebv	NOUN
fnp-4365	178	23	and	and	CCONJ
fnp-4365	178	24	polyomavirus	polyomavirus	NOUN
fnp-4365	178	25	,	,	PUNCT
fnp-4365	178	26	and	and	CCONJ
fnp-4365	178	27	pcr	pcr	NOUN
fnp-4365	178	28	for	for	ADP
fnp-4365	178	29	hhv-6	hhv-6	NOUN
fnp-4365	178	30	,	,	PUNCT
fnp-4365	178	31	west	west	PROPN
fnp-4365	178	32	nile	nile	PROPN
fnp-4365	178	33	virus	virus	PROPN
fnp-4365	178	34	,	,	PUNCT
fnp-4365	178	35	adenovirus	adenovirus	NOUN
fnp-4365	178	36	,	,	PUNCT
fnp-4365	178	37	enterovirus	enterovirus	NOUN
fnp-4365	178	38	,	,	PUNCT
fnp-4365	178	39	measles	measle	NOUN
fnp-4365	178	40	,	,	PUNCT
fnp-4365	178	41	mumps	mump	NOUN
fnp-4365	178	42	and	and	CCONJ
fnp-4365	178	43	lymphocytic	lymphocytic	ADJ
fnp-4365	178	44	choriomeningitis	choriomeningitis	NOUN
fnp-4365	178	45	were	be	AUX
fnp-4365	178	46	negative	negative	ADJ
fnp-4365	178	47	.	.	PUNCT
fnp-4365	179	1	pcr	pcr	ADJ
fnp-4365	179	2	in	in	ADP
fnp-4365	179	3	paraffin	paraffin	NOUN
fnp-4365	179	4	blocks	block	NOUN
fnp-4365	179	5	for	for	ADP
fnp-4365	179	6	the	the	DET
fnp-4365	179	7	detection	detection	NOUN
fnp-4365	179	8	of	of	ADP
fnp-4365	179	9	car	car	NOUN
fnp-4365	179	10	t	t	PROPN
fnp-4365	179	11	-	-	PUNCT
fnp-4365	179	12	cells	cell	NOUN
fnp-4365	179	13	was	be	AUX
fnp-4365	179	14	negative	negative	ADJ
fnp-4365	179	15	.	.	PUNCT
fnp-4365	180	1	full	full	ADJ
fnp-4365	180	2	body	body	NOUN
fnp-4365	180	3	autopsy	autopsy	NOUN
fnp-4365	180	4	revealed	reveal	VERB
fnp-4365	180	5	extensive	extensive	ADJ
fnp-4365	180	6	pulmonary	pulmonary	ADJ
fnp-4365	180	7	hemorrhage	hemorrhage	NOUN
fnp-4365	180	8	with	with	ADP
fnp-4365	180	9	no	no	DET
fnp-4365	180	10	apparent	apparent	ADJ
fnp-4365	180	11	signs	sign	NOUN
fnp-4365	180	12	of	of	ADP
fnp-4365	180	13	infection	infection	NOUN
fnp-4365	180	14	and	and	CCONJ
fnp-4365	180	15	foci	focus	NOUN
fnp-4365	180	16	of	of	ADP
fnp-4365	180	17	extramedullary	extramedullary	ADJ
fnp-4365	180	18	hematopoiesis	hematopoiesis	NOUN
fnp-4365	180	19	in	in	ADP
fnp-4365	180	20	the	the	DET
fnp-4365	180	21	liver	liver	NOUN
fnp-4365	180	22	.	.	PUNCT
fnp-4365	181	1	after	after	ADV
fnp-4365	181	2	all	all	ADV
fnp-4365	181	3	,	,	PUNCT
fnp-4365	181	4	the	the	DET
fnp-4365	181	5	cause	cause	NOUN
fnp-4365	181	6	of	of	ADP
fnp-4365	181	7	death	death	NOUN
fnp-4365	181	8	was	be	AUX
fnp-4365	181	9	attributed	attribute	VERB
fnp-4365	181	10	to	to	ADP
fnp-4365	181	11	an	an	DET
fnp-4365	181	12	unspecified	unspecified	ADJ
fnp-4365	181	13	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	181	14	,	,	PUNCT
fnp-4365	181	15	suggesting	suggest	VERB
fnp-4365	181	16	primarily	primarily	ADV
fnp-4365	181	17	an	an	DET
fnp-4365	181	18	infectious	infectious	ADJ
fnp-4365	181	19	etiology	etiology	NOUN
fnp-4365	181	20	but	but	CCONJ
fnp-4365	181	21	not	not	PART
fnp-4365	181	22	ruling	rule	VERB
fnp-4365	181	23	out	out	ADP
fnp-4365	181	24	immune	immune	ADJ
fnp-4365	181	25	causes	cause	NOUN
fnp-4365	181	26	.	.	PUNCT
fnp-4365	182	1	case	case	NOUN
fnp-4365	182	2	6	6	NUM
fnp-4365	182	3	a	a	DET
fnp-4365	182	4	71	71	NUM
fnp-4365	182	5	-	-	PUNCT
fnp-4365	182	6	year	year	NOUN
fnp-4365	182	7	-	-	PUNCT
fnp-4365	182	8	old	old	ADJ
fnp-4365	182	9	woman	woman	NOUN
fnp-4365	182	10	with	with	ADP
fnp-4365	182	11	multiple	multiple	ADJ
fnp-4365	182	12	myeloma	myeloma	PROPN
fnp-4365	182	13	iga	iga	PROPN
fnp-4365	182	14	kappa	kappa	PROPN
fnp-4365	182	15	r	r	X
fnp-4365	182	16	-	-	PUNCT
fnp-4365	182	17	iss	iss	PROPN
fnp-4365	182	18	ii	ii	PROPN
fnp-4365	182	19	,	,	PUNCT
fnp-4365	182	20	diagnosed	diagnose	VERB
fnp-4365	182	21	from	from	ADP
fnp-4365	182	22	a	a	DET
fnp-4365	182	23	scalp	scalp	NOUN
fnp-4365	182	24	extramedullary	extramedullary	ADJ
fnp-4365	182	25	plasmacytoma	plasmacytoma	NOUN
fnp-4365	182	26	.	.	PUNCT
fnp-4365	183	1	cytogenetic	cytogenetic	PROPN
fnp-4365	183	2	showed	show	VERB
fnp-4365	183	3	high	high	ADJ
fnp-4365	183	4	risk	risk	NOUN
fnp-4365	183	5	(	(	PUNCT
fnp-4365	183	6	17p	17p	NOUN
fnp-4365	183	7	deletion	deletion	NOUN
fnp-4365	183	8	)	)	PUNCT
fnp-4365	183	9	and	and	CCONJ
fnp-4365	183	10	it	it	PRON
fnp-4365	183	11	relapsed	relapse	VERB
fnp-4365	183	12	after	after	ADP
fnp-4365	183	13	four	four	NUM
fnp-4365	183	14	therapy	therapy	NOUN
fnp-4365	183	15	lines	line	NOUN
fnp-4365	183	16	.	.	PUNCT
fnp-4365	184	1	she	she	PRON
fnp-4365	184	2	received	receive	VERB
fnp-4365	184	3	fludarabine	fludarabine	NOUN
fnp-4365	184	4	and	and	CCONJ
fnp-4365	184	5	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	184	6	conditioning	conditioning	NOUN
fnp-4365	184	7	after	after	ADP
fnp-4365	184	8	bridging	bridge	VERB
fnp-4365	184	9	therapy	therapy	NOUN
fnp-4365	184	10	.	.	PUNCT
fnp-4365	185	1	after	after	ADP
fnp-4365	185	2	one	one	NUM
fnp-4365	185	3	week	week	NOUN
fnp-4365	185	4	of	of	ADP
fnp-4365	185	5	the	the	DET
fnp-4365	185	6	first	first	ADJ
fnp-4365	185	7	car	car	NOUN
fnp-4365	185	8	-	-	PUNCT
fnp-4365	185	9	bcma	bcma	NOUN
fnp-4365	185	10	infusion	infusion	NOUN
fnp-4365	185	11	,	,	PUNCT
fnp-4365	185	12	she	she	PRON
fnp-4365	185	13	was	be	AUX
fnp-4365	185	14	admitted	admit	VERB
fnp-4365	185	15	to	to	ADP
fnp-4365	185	16	the	the	DET
fnp-4365	185	17	icu	icu	PROPN
fnp-4365	185	18	due	due	ADP
fnp-4365	185	19	to	to	ADP
fnp-4365	185	20	a	a	DET
fnp-4365	185	21	grade	grade	NOUN
fnp-4365	185	22	2	2	NUM
fnp-4365	185	23	crs	crs	NOUN
fnp-4365	185	24	with	with	ADP
fnp-4365	185	25	fever	fever	NOUN
fnp-4365	185	26	and	and	CCONJ
fnp-4365	185	27	hypotension	hypotension	NOUN
fnp-4365	185	28	that	that	PRON
fnp-4365	185	29	were	be	AUX
fnp-4365	185	30	successfully	successfully	ADV
fnp-4365	185	31	treated	treat	VERB
fnp-4365	185	32	with	with	ADP
fnp-4365	185	33	one	one	NUM
fnp-4365	185	34	dose	dose	NOUN
fnp-4365	185	35	of	of	ADP
fnp-4365	185	36	tocilizumab	tocilizumab	NOUN
fnp-4365	185	37	and	and	CCONJ
fnp-4365	185	38	corticosteroids	corticosteroid	NOUN
fnp-4365	185	39	.	.	PUNCT
fnp-4365	186	1	ten	ten	NUM
fnp-4365	186	2	days	day	NOUN
fnp-4365	186	3	later	later	ADV
fnp-4365	186	4	,	,	PUNCT
fnp-4365	186	5	she	she	PRON
fnp-4365	186	6	presented	present	VERB
fnp-4365	186	7	episodes	episode	NOUN
fnp-4365	186	8	of	of	ADP
fnp-4365	186	9	hypotension	hypotension	NOUN
fnp-4365	186	10	without	without	ADP
fnp-4365	186	11	fever	fever	NOUN
fnp-4365	186	12	or	or	CCONJ
fnp-4365	186	13	alterations	alteration	NOUN
fnp-4365	186	14	in	in	ADP
fnp-4365	186	15	chest	chest	NOUN
fnp-4365	186	16	and	and	CCONJ
fnp-4365	186	17	brain	brain	NOUN
fnp-4365	186	18	ct	ct	NOUN
fnp-4365	186	19	or	or	CCONJ
fnp-4365	186	20	echocardiography	echocardiography	NOUN
fnp-4365	186	21	.	.	PUNCT
fnp-4365	187	1	in	in	ADP
fnp-4365	187	2	the	the	DET
fnp-4365	187	3	differential	differential	ADJ
fnp-4365	187	4	diagnosis	diagnosis	NOUN
fnp-4365	187	5	,	,	PUNCT
fnp-4365	187	6	neurotoxicity	neurotoxicity	NOUN
fnp-4365	187	7	related	relate	VERB
fnp-4365	187	8	to	to	ADP
fnp-4365	187	9	treatment	treatment	NOUN
fnp-4365	187	10	was	be	AUX
fnp-4365	187	11	considered	consider	VERB
fnp-4365	187	12	,	,	PUNCT
fnp-4365	187	13	corticosteroid	corticosteroid	ADJ
fnp-4365	187	14	dose	dose	NOUN
fnp-4365	187	15	was	be	AUX
fnp-4365	187	16	increased	increase	VERB
fnp-4365	187	17	,	,	PUNCT
fnp-4365	187	18	and	and	CCONJ
fnp-4365	187	19	antibiotics	antibiotic	NOUN
fnp-4365	187	20	were	be	AUX
fnp-4365	187	21	added	add	VERB
fnp-4365	187	22	.	.	PUNCT
fnp-4365	188	1	she	she	PRON
fnp-4365	188	2	worsened	worsen	VERB
fnp-4365	188	3	with	with	ADP
fnp-4365	188	4	agitation	agitation	NOUN
fnp-4365	188	5	,	,	PUNCT
fnp-4365	188	6	tachypnoea	tachypnoea	NOUN
fnp-4365	188	7	,	,	PUNCT
fnp-4365	188	8	and	and	CCONJ
fnp-4365	188	9	respiratory	respiratory	ADJ
fnp-4365	188	10	failure	failure	NOUN
fnp-4365	188	11	;	;	PUNCT
fnp-4365	188	12	and	and	CCONJ
fnp-4365	188	13	progressed	progress	VERB
fnp-4365	188	14	to	to	ADP
fnp-4365	188	15	refractory	refractory	NOUN
fnp-4365	188	16	multiorgan	multiorgan	NOUN
fnp-4365	188	17	failure	failure	NOUN
fnp-4365	188	18	with	with	ADP
fnp-4365	188	19	ischemic	ischemic	ADJ
fnp-4365	188	20	hepatitis	hepatitis	NOUN
fnp-4365	188	21	,	,	PUNCT
fnp-4365	188	22	renal	renal	ADJ
fnp-4365	188	23	failure	failure	NOUN
fnp-4365	188	24	,	,	PUNCT
fnp-4365	188	25	and	and	CCONJ
fnp-4365	188	26	hemorrhagic	hemorrhagic	VERB
fnp-4365	188	27	complications	complication	NOUN
fnp-4365	188	28	in	in	ADP
fnp-4365	188	29	the	the	DET
fnp-4365	188	30	context	context	NOUN
fnp-4365	188	31	of	of	ADP
fnp-4365	188	32	thrombocytopenia	thrombocytopenia	PROPN
fnp-4365	188	33	.	.	PUNCT
fnp-4365	189	1	a	a	DET
fnp-4365	189	2	macrophagic	macrophagic	ADJ
fnp-4365	189	3	activation	activation	NOUN
fnp-4365	189	4	syndrome	syndrome	NOUN
fnp-4365	189	5	was	be	AUX
fnp-4365	189	6	suspected	suspect	VERB
fnp-4365	189	7	due	due	ADP
fnp-4365	189	8	to	to	ADP
fnp-4365	189	9	ldh	ldh	VERB
fnp-4365	189	10	and	and	CCONJ
fnp-4365	189	11	ferritin	ferritin	ADJ
fnp-4365	189	12	increase	increase	NOUN
fnp-4365	189	13	,	,	PUNCT
fnp-4365	189	14	and	and	CCONJ
fnp-4365	189	15	treatment	treatment	NOUN
fnp-4365	189	16	was	be	AUX
fnp-4365	189	17	attempted	attempt	VERB
fnp-4365	189	18	with	with	ADP
fnp-4365	189	19	corticosteroids	corticosteroid	NOUN
fnp-4365	189	20	,	,	PUNCT
fnp-4365	189	21	anakinra	anakinra	NOUN
fnp-4365	189	22	,	,	PUNCT
fnp-4365	189	23	siltuximab	siltuximab	NOUN
fnp-4365	189	24	and	and	CCONJ
fnp-4365	189	25	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	189	26	.	.	PUNCT
fnp-4365	190	1	amid	amid	ADP
fnp-4365	190	2	this	this	DET
fnp-4365	190	3	situation	situation	NOUN
fnp-4365	190	4	,	,	PUNCT
fnp-4365	190	5	she	she	PRON
fnp-4365	190	6	presented	present	VERB
fnp-4365	190	7	a	a	DET
fnp-4365	190	8	blood	blood	NOUN
fnp-4365	190	9	culture	culture	NOUN
fnp-4365	190	10	positive	positive	ADJ
fnp-4365	190	11	for	for	ADP
fnp-4365	190	12	escherichia	escherichia	NOUN
fnp-4365	190	13	coli	coli	NOUN
fnp-4365	190	14	without	without	ADP
fnp-4365	190	15	detectable	detectable	ADJ
fnp-4365	190	16	septic	septic	ADJ
fnp-4365	190	17	focus	focus	NOUN
fnp-4365	190	18	.	.	PUNCT
fnp-4365	191	1	despite	despite	SCONJ
fnp-4365	191	2	all	all	DET
fnp-4365	191	3	measures	measure	NOUN
fnp-4365	191	4	,	,	PUNCT
fnp-4365	191	5	she	she	PRON
fnp-4365	191	6	remained	remain	VERB
fnp-4365	191	7	in	in	ADP
fnp-4365	191	8	multiorgan	multiorgan	NOUN
fnp-4365	191	9	failure	failure	NOUN
fnp-4365	191	10	with	with	ADP
fnp-4365	191	11	acidosis	acidosis	NOUN
fnp-4365	191	12	and	and	CCONJ
fnp-4365	191	13	hyperlactacidemia	hyperlactacidemia	NOUN
fnp-4365	191	14	,	,	PUNCT
fnp-4365	191	15	and	and	CCONJ
fnp-4365	191	16	she	she	PRON
fnp-4365	191	17	died	die	VERB
fnp-4365	191	18	19	19	NUM
fnp-4365	191	19	days	day	NOUN
fnp-4365	191	20	after	after	SCONJ
fnp-4365	191	21	car	car	NOUN
fnp-4365	191	22	t	t	NOUN
fnp-4365	191	23	-	-	PUNCT
fnp-4365	191	24	cell	cell	NOUN
fnp-4365	191	25	therapy	therapy	NOUN
fnp-4365	191	26	start	start	VERB
fnp-4365	191	27	.	.	PUNCT
fnp-4365	192	1	additional	additional	ADJ
fnp-4365	192	2	neurotoxicity	neurotoxicity	NOUN
fnp-4365	192	3	signs	sign	NOUN
fnp-4365	192	4	were	be	AUX
fnp-4365	192	5	not	not	PART
fnp-4365	192	6	evident	evident	ADJ
fnp-4365	192	7	.	.	PUNCT
fnp-4365	193	1	neuropathologic	neuropathologic	ADJ
fnp-4365	193	2	gross	gross	ADJ
fnp-4365	193	3	examination	examination	NOUN
fnp-4365	193	4	showed	show	VERB
fnp-4365	193	5	a	a	DET
fnp-4365	193	6	1045	1045	NUM
fnp-4365	193	7	g	g	NOUN
fnp-4365	193	8	fixed	fix	VERB
fnp-4365	193	9	brain	brain	NOUN
fnp-4365	193	10	with	with	ADP
fnp-4365	193	11	mild	mild	ADJ
fnp-4365	193	12	hippocampal	hippocampal	NOUN
fnp-4365	193	13	and	and	CCONJ
fnp-4365	193	14	amygdalar	amygdalar	ADJ
fnp-4365	193	15	atrophy	atrophy	NOUN
fnp-4365	193	16	.	.	PUNCT
fnp-4365	194	1	neuropathologic	neuropathologic	ADJ
fnp-4365	194	2	evaluation	evaluation	NOUN
fnp-4365	194	3	revealed	reveal	VERB
fnp-4365	194	4	mild	mild	ADJ
fnp-4365	194	5	arteriosclerosis	arteriosclerosis	NOUN
fnp-4365	194	6	(	(	PUNCT
fnp-4365	194	7	with	with	ADP
fnp-4365	194	8	focal	focal	ADJ
fnp-4365	194	9	mural	mural	ADJ
fnp-4365	194	10	calcification	calcification	NOUN
fnp-4365	194	11	in	in	ADP
fnp-4365	194	12	globus	globus	ADJ
fnp-4365	194	13	pallidus	pallidus	NOUN
fnp-4365	194	14	arteries	artery	NOUN
fnp-4365	194	15	)	)	PUNCT
fnp-4365	194	16	and	and	CCONJ
fnp-4365	194	17	diffuse	diffuse	VERB
fnp-4365	194	18	minimal	minimal	ADJ
fnp-4365	194	19	gliosis	gliosis	NOUN
fnp-4365	194	20	.	.	PUNCT
fnp-4365	195	1	histology	histology	NOUN
fnp-4365	195	2	revealed	reveal	VERB
fnp-4365	195	3	scattered	scatter	VERB
fnp-4365	195	4	perivascular	perivascular	ADJ
fnp-4365	195	5	t	t	PROPN
fnp-4365	195	6	-	-	PUNCT
fnp-4365	195	7	cells	cell	NOUN
fnp-4365	195	8	(	(	PUNCT
fnp-4365	195	9	cd3	cd3	VERB
fnp-4365	195	10	+	+	NOUN
fnp-4365	195	11	)	)	PUNCT
fnp-4365	195	12	in	in	ADP
fnp-4365	195	13	basal	basal	ADJ
fnp-4365	195	14	nuclei	nucleus	NOUN
fnp-4365	195	15	,	,	PUNCT
fnp-4365	195	16	frontal	frontal	ADJ
fnp-4365	195	17	cortex	cortex	NOUN
fnp-4365	195	18	,	,	PUNCT
fnp-4365	195	19	and	and	CCONJ
fnp-4365	195	20	hippocampus	hippocampus	NOUN
fnp-4365	195	21	.	.	PUNCT
fnp-4365	196	1	minimal	minimal	ADJ
fnp-4365	196	2	microglial	microglial	ADJ
fnp-4365	196	3	activation	activation	NOUN
fnp-4365	196	4	highlighted	highlight	VERB
fnp-4365	196	5	with	with	ADP
fnp-4365	196	6	cd68	cd68	PROPN
fnp-4365	196	7	accompanied	accompany	VERB
fnp-4365	196	8	these	these	DET
fnp-4365	196	9	findings	finding	NOUN
fnp-4365	196	10	.	.	PUNCT
fnp-4365	197	1	she	she	PRON
fnp-4365	197	2	also	also	ADV
fnp-4365	197	3	had	have	VERB
fnp-4365	197	4	a	a	DET
fnp-4365	197	5	definite	definite	ADJ
fnp-4365	197	6	primary	primary	ADJ
fnp-4365	197	7	age	age	NOUN
fnp-4365	197	8	related	relate	VERB
fnp-4365	197	9	tauopathy	tauopathy	NOUN
fnp-4365	197	10	or	or	CCONJ
fnp-4365	197	11	part	part	NOUN
fnp-4365	197	12	(	(	PUNCT
fnp-4365	197	13	braak	braak	NOUN
fnp-4365	197	14	stage	stage	NOUN
fnp-4365	197	15	i	i	PROPN
fnp-4365	197	16	/	/	SYM
fnp-4365	197	17	vi	vi	PROPN
fnp-4365	197	18	,	,	PUNCT
fnp-4365	197	19	thal	thal	NOUN
fnp-4365	197	20	0	0	NUM
fnp-4365	197	21	)	)	PUNCT
fnp-4365	197	22	and	and	CCONJ
fnp-4365	197	23	mild	mild	ADJ
fnp-4365	197	24	periamygdaline	periamygdaline	NOUN
fnp-4365	197	25	age	age	NOUN
fnp-4365	197	26	related	relate	VERB
fnp-4365	197	27	tau	tau	PROPN
fnp-4365	197	28	astrogliopathy	astrogliopathy	ADJ
fnp-4365	197	29	or	or	CCONJ
fnp-4365	197	30	artag	artag	ADJ
fnp-4365	197	31	.	.	PUNCT
fnp-4365	198	1	pcr	pcr	PROPN
fnp-4365	198	2	for	for	ADP
fnp-4365	198	3	the	the	DET
fnp-4365	198	4	detection	detection	NOUN
fnp-4365	198	5	of	of	ADP
fnp-4365	198	6	car	car	NOUN
fnp-4365	198	7	t	t	NOUN
fnp-4365	198	8	-	-	PUNCT
fnp-4365	198	9	cells	cell	NOUN
fnp-4365	198	10	in	in	ADP
fnp-4365	198	11	paraffin	paraffin	NOUN
fnp-4365	198	12	blocks	block	NOUN
fnp-4365	198	13	was	be	AUX
fnp-4365	198	14	negative	negative	ADJ
fnp-4365	198	15	.	.	PUNCT
fnp-4365	199	1	the	the	DET
fnp-4365	199	2	most	most	ADV
fnp-4365	199	3	remarkable	remarkable	ADJ
fnp-4365	199	4	systemic	systemic	ADJ
fnp-4365	199	5	finding	finding	NOUN
fnp-4365	199	6	was	be	AUX
fnp-4365	199	7	a	a	DET
fnp-4365	199	8	submassive	submassive	ADJ
fnp-4365	199	9	acute	acute	ADJ
fnp-4365	199	10	hepatic	hepatic	NOUN
fnp-4365	199	11	necrosis	necrosis	NOUN
fnp-4365	199	12	.	.	PUNCT
fnp-4365	200	1	the	the	DET
fnp-4365	200	2	prominent	prominent	ADJ
fnp-4365	200	3	center	center	NOUN
fnp-4365	200	4	lobular	lobular	ADJ
fnp-4365	200	5	location	location	NOUN
fnp-4365	200	6	,	,	PUNCT
fnp-4365	200	7	the	the	DET
fnp-4365	200	8	lack	lack	NOUN
fnp-4365	200	9	of	of	ADP
fnp-4365	200	10	cytopathic	cytopathic	ADJ
fnp-4365	200	11	changes	change	NOUN
fnp-4365	200	12	and	and	CCONJ
fnp-4365	200	13	negative	negative	ADJ
fnp-4365	200	14	immunohistochemical	immunohistochemical	ADJ
fnp-4365	200	15	stains	stain	NOUN
fnp-4365	200	16	for	for	ADP
fnp-4365	200	17	hsv-1	hsv-1	PRON
fnp-4365	200	18	,	,	PUNCT
fnp-4365	200	19	hsv-2	hsv-2	NOUN
fnp-4365	200	20	,	,	PUNCT
fnp-4365	200	21	hvv-8	hvv-8	NOUN
fnp-4365	200	22	,	,	PUNCT
fnp-4365	200	23	cmv	cmv	NOUN
fnp-4365	200	24	,	,	PUNCT
fnp-4365	200	25	ebv	ebv	NOUN
fnp-4365	200	26	lmp1	lmp1	NOUN
fnp-4365	200	27	and	and	CCONJ
fnp-4365	200	28	eber	eber	PROPN
fnp-4365	200	29	oriented	orient	VERB
fnp-4365	200	30	to	to	ADP
fnp-4365	200	31	a	a	DET
fnp-4365	200	32	hemodynamic	hemodynamic	ADJ
fnp-4365	200	33	–	–	PUNCT
fnp-4365	200	34	hypovolemic	hypovolemic	ADJ
fnp-4365	200	35	etiology	etiology	NOUN
fnp-4365	200	36	.	.	PUNCT
fnp-4365	201	1	there	there	PRON
fnp-4365	201	2	were	be	VERB
fnp-4365	201	3	additional	additional	ADJ
fnp-4365	201	4	acute	acute	ADJ
fnp-4365	201	5	hemorrhagic	hemorrhagic	NOUN
fnp-4365	201	6	foci	focus	NOUN
fnp-4365	201	7	,	,	PUNCT
fnp-4365	201	8	like	like	ADP
fnp-4365	201	9	in	in	ADP
fnp-4365	201	10	myocardium	myocardium	NOUN
fnp-4365	201	11	and	and	CCONJ
fnp-4365	201	12	intestines	intestine	NOUN
fnp-4365	201	13	,	,	PUNCT
fnp-4365	201	14	but	but	CCONJ
fnp-4365	201	15	the	the	DET
fnp-4365	201	16	lack	lack	NOUN
fnp-4365	201	17	of	of	ADP
fnp-4365	201	18	tissue	tissue	NOUN
fnp-4365	201	19	ischemia	ischemia	NOUN
fnp-4365	201	20	or	or	CCONJ
fnp-4365	201	21	inflammatory	inflammatory	ADJ
fnp-4365	201	22	reaction	reaction	NOUN
fnp-4365	201	23	surrounding	surround	VERB
fnp-4365	201	24	them	they	PRON
fnp-4365	201	25	suggested	suggest	VERB
fnp-4365	201	26	they	they	PRON
fnp-4365	201	27	were	be	AUX
fnp-4365	201	28	acute	acute	ADJ
fnp-4365	201	29	premortem	premortem	NOUN
fnp-4365	201	30	ischemic	ischemic	ADJ
fnp-4365	201	31	changes	change	NOUN
fnp-4365	201	32	.	.	PUNCT
fnp-4365	202	1	remarkably	remarkably	ADV
fnp-4365	202	2	,	,	PUNCT
fnp-4365	202	3	there	there	PRON
fnp-4365	202	4	was	be	VERB
fnp-4365	202	5	hypercellular	hypercellular	ADJ
fnp-4365	202	6	bone	bone	NOUN
fnp-4365	202	7	marrow	marrow	NOUN
fnp-4365	202	8	with	with	ADP
fnp-4365	202	9	t	t	NOUN
fnp-4365	202	10	-	-	PUNCT
fnp-4365	202	11	cell	cell	NOUN
fnp-4365	202	12	expansion	expansion	NOUN
fnp-4365	202	13	and	and	CCONJ
fnp-4365	202	14	hemophagocytosis	hemophagocytosis	NOUN
fnp-4365	202	15	.	.	PUNCT
fnp-4365	203	1	immunohistochemistry	immunohistochemistry	NOUN
fnp-4365	203	2	for	for	ADP
fnp-4365	203	3	cd68	cd68	PROPN
fnp-4365	203	4	in	in	ADP
fnp-4365	203	5	different	different	ADJ
fnp-4365	203	6	organs	organ	NOUN
fnp-4365	203	7	showed	show	VERB
fnp-4365	203	8	moderate	moderate	ADJ
fnp-4365	203	9	histiocytic	histiocytic	ADJ
fnp-4365	203	10	activation	activation	NOUN
fnp-4365	203	11	in	in	ADP
fnp-4365	203	12	the	the	DET
fnp-4365	203	13	spleen	spleen	NOUN
fnp-4365	203	14	and	and	CCONJ
fnp-4365	203	15	mild	mild	ADJ
fnp-4365	203	16	activation	activation	NOUN
fnp-4365	203	17	in	in	ADP
fnp-4365	203	18	the	the	DET
fnp-4365	203	19	heart	heart	NOUN
fnp-4365	203	20	,	,	PUNCT
fnp-4365	203	21	liver	liver	NOUN
fnp-4365	203	22	,	,	PUNCT
fnp-4365	203	23	intestine	intestine	NOUN
fnp-4365	203	24	and	and	CCONJ
fnp-4365	203	25	brain	brain	NOUN
fnp-4365	203	26	.	.	PUNCT
fnp-4365	204	1	in	in	ADP
fnp-4365	204	2	the	the	DET
fnp-4365	204	3	latter	latter	ADJ
fnp-4365	204	4	,	,	PUNCT
fnp-4365	204	5	it	it	PRON
fnp-4365	204	6	did	do	AUX
fnp-4365	204	7	not	not	PART
fnp-4365	204	8	seem	seem	VERB
fnp-4365	204	9	to	to	PART
fnp-4365	204	10	induce	induce	VERB
fnp-4365	204	11	secondary	secondary	ADJ
fnp-4365	204	12	tissue	tissue	NOUN
fnp-4365	204	13	alterations	alteration	NOUN
fnp-4365	204	14	,	,	PUNCT
fnp-4365	204	15	hence	hence	ADV
fnp-4365	204	16	its	its	PRON
fnp-4365	204	17	impact	impact	NOUN
fnp-4365	204	18	may	may	AUX
fnp-4365	204	19	had	have	AUX
fnp-4365	204	20	been	be	AUX
fnp-4365	204	21	limited	limit	VERB
fnp-4365	204	22	.	.	PUNCT
fnp-4365	205	1	a	a	DET
fnp-4365	205	2	lithic	lithic	ADJ
fnp-4365	205	3	focus	focus	NOUN
fnp-4365	205	4	in	in	ADP
fnp-4365	205	5	the	the	DET
fnp-4365	205	6	cranium	cranium	NOUN
fnp-4365	205	7	was	be	AUX
fnp-4365	205	8	constituted	constitute	VERB
fnp-4365	205	9	mainly	mainly	ADV
fnp-4365	205	10	by	by	ADP
fnp-4365	205	11	fibrotic	fibrotic	ADJ
fnp-4365	205	12	reactive	reactive	ADJ
fnp-4365	205	13	tissue	tissue	NOUN
fnp-4365	205	14	without	without	ADP
fnp-4365	205	15	evidence	evidence	NOUN
fnp-4365	205	16	of	of	ADP
fnp-4365	205	17	plasma	plasma	NOUN
fnp-4365	205	18	cell	cell	NOUN
fnp-4365	205	19	disease	disease	NOUN
fnp-4365	205	20	.	.	PUNCT
fnp-4365	206	1	after	after	ADV
fnp-4365	206	2	all	all	ADV
fnp-4365	206	3	,	,	PUNCT
fnp-4365	206	4	the	the	DET
fnp-4365	206	5	cause	cause	NOUN
fnp-4365	206	6	of	of	ADP
fnp-4365	206	7	death	death	NOUN
fnp-4365	206	8	was	be	AUX
fnp-4365	206	9	attributed	attribute	VERB
fnp-4365	206	10	to	to	AUX
fnp-4365	206	11	submassive	submassive	VERB
fnp-4365	206	12	liver	liver	NOUN
fnp-4365	206	13	necrosis	necrosis	NOUN
fnp-4365	206	14	of	of	ADP
fnp-4365	206	15	probable	probable	ADJ
fnp-4365	206	16	ischemic	ischemic	ADJ
fnp-4365	206	17	cause	cause	NOUN
fnp-4365	206	18	.	.	PUNCT
fnp-4365	207	1	discussion	discussion	NOUN
fnp-4365	207	2	here	here	ADV
fnp-4365	207	3	we	we	PRON
fnp-4365	207	4	present	present	VERB
fnp-4365	207	5	the	the	DET
fnp-4365	207	6	neuropathological	neuropathological	ADJ
fnp-4365	207	7	findings	finding	NOUN
fnp-4365	207	8	of	of	ADP
fnp-4365	207	9	6	6	NUM
fnp-4365	207	10	deceased	deceased	ADJ
fnp-4365	207	11	patients	patient	NOUN
fnp-4365	207	12	,	,	PUNCT
fnp-4365	207	13	3	3	NUM
fnp-4365	207	14	women	woman	NOUN
fnp-4365	207	15	and	and	CCONJ
fnp-4365	207	16	3	3	NUM
fnp-4365	207	17	men	man	NOUN
fnp-4365	207	18	,	,	PUNCT
fnp-4365	207	19	who	who	PRON
fnp-4365	207	20	received	receive	VERB
fnp-4365	207	21	a	a	DET
fnp-4365	207	22	cd19(5	cd19(5	NOUN
fnp-4365	207	23	)	)	PUNCT
fnp-4365	207	24	and	and	CCONJ
fnp-4365	207	25	bcma(1	bcma(1	NOUN
fnp-4365	207	26	)	)	PUNCT
fnp-4365	207	27	targeted	target	VERB
fnp-4365	207	28	car	car	NOUN
fnp-4365	207	29	t	t	NOUN
fnp-4365	207	30	-	-	PUNCT
fnp-4365	207	31	cell	cell	NOUN
fnp-4365	207	32	therapy	therapy	NOUN
fnp-4365	207	33	.	.	PUNCT
fnp-4365	208	1	three	three	NUM
fnp-4365	208	2	of	of	ADP
fnp-4365	208	3	them	they	PRON
fnp-4365	208	4	had	have	VERB
fnp-4365	208	5	a	a	DET
fnp-4365	208	6	b	b	NOUN
fnp-4365	208	7	-	-	PUNCT
fnp-4365	208	8	cell	cell	NOUN
fnp-4365	208	9	acute	acute	ADJ
fnp-4365	208	10	lymphoblastic	lymphoblastic	ADJ
fnp-4365	208	11	leukemia	leukemia	NOUN
fnp-4365	208	12	,	,	PUNCT
fnp-4365	208	13	one	one	NUM
fnp-4365	208	14	a	a	DET
fnp-4365	208	15	follicular	follicular	ADJ
fnp-4365	208	16	lymphoma	lymphoma	NOUN
fnp-4365	208	17	3a	3a	NUM
fnp-4365	208	18	grade	grade	NOUN
fnp-4365	208	19	,	,	PUNCT
fnp-4365	208	20	one	one	NUM
fnp-4365	208	21	a	a	DET
fnp-4365	208	22	primary	primary	ADJ
fnp-4365	208	23	mediastinal	mediastinal	ADJ
fnp-4365	208	24	diffuse	diffuse	NOUN
fnp-4365	208	25	large	large	ADJ
fnp-4365	208	26	b	b	NOUN
fnp-4365	208	27	-	-	PUNCT
fnp-4365	208	28	cell	cell	NOUN
fnp-4365	208	29	lymphoma	lymphoma	NOUN
fnp-4365	208	30	,	,	PUNCT
fnp-4365	208	31	and	and	CCONJ
fnp-4365	208	32	the	the	DET
fnp-4365	208	33	other	other	ADJ
fnp-4365	208	34	a	a	DET
fnp-4365	208	35	multiple	multiple	ADJ
fnp-4365	208	36	myeloma	myeloma	NOUN
fnp-4365	208	37	with	with	ADP
fnp-4365	208	38	plasmocytoma	plasmocytoma	NOUN
fnp-4365	208	39	.	.	PUNCT
fnp-4365	209	1	only	only	ADV
fnp-4365	209	2	2	2	NUM
fnp-4365	209	3	of	of	ADP
fnp-4365	209	4	them	they	PRON
fnp-4365	209	5	presented	present	VERB
fnp-4365	209	6	explicit	explicit	ADJ
fnp-4365	209	7	neurological	neurological	ADJ
fnp-4365	209	8	symptoms	symptom	NOUN
fnp-4365	209	9	in	in	ADP
fnp-4365	209	10	the	the	DET
fnp-4365	209	11	course	course	NOUN
fnp-4365	209	12	of	of	ADP
fnp-4365	209	13	the	the	DET
fnp-4365	209	14	disease	disease	NOUN
fnp-4365	209	15	.	.	PUNCT
fnp-4365	210	1	brain	brain	NOUN
fnp-4365	210	2	gross	gross	ADJ
fnp-4365	210	3	examination	examination	NOUN
fnp-4365	210	4	did	do	AUX
fnp-4365	210	5	not	not	PART
fnp-4365	210	6	show	show	VERB
fnp-4365	210	7	significant	significant	ADJ
fnp-4365	210	8	alterations	alteration	NOUN
fnp-4365	210	9	in	in	ADP
fnp-4365	210	10	any	any	PRON
fnp-4365	210	11	of	of	ADP
fnp-4365	210	12	the	the	DET
fnp-4365	210	13	patients	patient	NOUN
fnp-4365	210	14	.	.	PUNCT
fnp-4365	211	1	histological	histological	ADJ
fnp-4365	211	2	findings	finding	NOUN
fnp-4365	211	3	in	in	ADP
fnp-4365	211	4	one	one	NUM
fnp-4365	211	5	of	of	ADP
fnp-4365	211	6	the	the	DET
fnp-4365	211	7	patients	patient	NOUN
fnp-4365	211	8	with	with	ADP
fnp-4365	211	9	neurological	neurological	ADJ
fnp-4365	211	10	symptoms	symptom	NOUN
fnp-4365	211	11	were	be	AUX
fnp-4365	211	12	mild	mild	ADJ
fnp-4365	211	13	arteriosclerosis	arteriosclerosis	NOUN
fnp-4365	211	14	and	and	CCONJ
fnp-4365	211	15	arteriolar	arteriolar	ADJ
fnp-4365	211	16	hyalinosis	hyalinosis	NOUN
fnp-4365	211	17	,	,	PUNCT
fnp-4365	211	18	minimal	minimal	ADJ
fnp-4365	211	19	lymphocytic	lymphocytic	ADJ
fnp-4365	211	20	perivascular	perivascular	ADJ
fnp-4365	211	21	infiltrate	infiltrate	NOUN
fnp-4365	211	22	(	(	PUNCT
fnp-4365	211	23	mainly	mainly	ADV
fnp-4365	211	24	cd5	cd5	PROPN
fnp-4365	211	25	+	+	PROPN
fnp-4365	211	26	)	)	PUNCT
fnp-4365	211	27	and	and	CCONJ
fnp-4365	211	28	leukemic	leukemic	ADJ
fnp-4365	211	29	cells	cell	NOUN
fnp-4365	211	30	,	,	PUNCT
fnp-4365	211	31	in	in	ADP
fnp-4365	211	32	line	line	NOUN
fnp-4365	211	33	with	with	ADP
fnp-4365	211	34	the	the	DET
fnp-4365	211	35	systemic	systemic	ADJ
fnp-4365	211	36	progression	progression	NOUN
fnp-4365	211	37	of	of	ADP
fnp-4365	211	38	the	the	DET
fnp-4365	211	39	hematologic	hematologic	NOUN
fnp-4365	211	40	malignancy	malignancy	NOUN
fnp-4365	211	41	as	as	ADP
fnp-4365	211	42	the	the	DET
fnp-4365	211	43	cause	cause	NOUN
fnp-4365	211	44	of	of	ADP
fnp-4365	211	45	death	death	NOUN
fnp-4365	211	46	.	.	PUNCT
fnp-4365	212	1	the	the	DET
fnp-4365	212	2	histological	histological	ADJ
fnp-4365	212	3	examination	examination	NOUN
fnp-4365	212	4	of	of	ADP
fnp-4365	212	5	the	the	DET
fnp-4365	212	6	other	other	ADJ
fnp-4365	212	7	patient	patient	NOUN
fnp-4365	212	8	with	with	ADP
fnp-4365	212	9	neurological	neurological	ADJ
fnp-4365	212	10	symptoms	symptom	NOUN
fnp-4365	212	11	showed	show	VERB
fnp-4365	212	12	a	a	DET
fnp-4365	212	13	severe	severe	ADJ
fnp-4365	212	14	perivascular	perivascular	ADJ
fnp-4365	212	15	and	and	CCONJ
fnp-4365	212	16	interstitial	interstitial	ADJ
fnp-4365	212	17	lymphocytic	lymphocytic	ADJ
fnp-4365	212	18	infiltration	infiltration	NOUN
fnp-4365	212	19	,	,	PUNCT
fnp-4365	212	20	predominantly	predominantly	ADV
fnp-4365	212	21	cd8	cd8	PROPN
fnp-4365	212	22	+	+	PROPN
fnp-4365	212	23	,	,	PUNCT
fnp-4365	212	24	admixed	admix	VERB
fnp-4365	212	25	with	with	ADP
fnp-4365	212	26	a	a	DET
fnp-4365	212	27	diffuse	diffuse	ADJ
fnp-4365	212	28	interstitial	interstitial	ADJ
fnp-4365	212	29	histiocytic	histiocytic	ADJ
fnp-4365	212	30	infiltration	infiltration	NOUN
fnp-4365	212	31	,	,	PUNCT
fnp-4365	212	32	affecting	affect	VERB
fnp-4365	212	33	mainly	mainly	ADV
fnp-4365	212	34	the	the	DET
fnp-4365	212	35	spinal	spinal	ADJ
fnp-4365	212	36	cord	cord	NOUN
fnp-4365	212	37	,	,	PUNCT
fnp-4365	212	38	midbrain	midbrain	NOUN
fnp-4365	212	39	,	,	PUNCT
fnp-4365	212	40	and	and	CCONJ
fnp-4365	212	41	hippocampus	hippocampus	NOUN
fnp-4365	212	42	,	,	PUNCT
fnp-4365	212	43	along	along	ADP
fnp-4365	212	44	with	with	ADP
fnp-4365	212	45	a	a	DET
fnp-4365	212	46	diffuse	diffuse	ADJ
fnp-4365	212	47	gliosis	gliosis	NOUN
fnp-4365	212	48	of	of	ADP
fnp-4365	212	49	basal	basal	ADJ
fnp-4365	212	50	ganglia	ganglia	NOUN
fnp-4365	212	51	,	,	PUNCT
fnp-4365	212	52	hippocampus	hippocampus	NOUN
fnp-4365	212	53	,	,	PUNCT
fnp-4365	212	54	and	and	CCONJ
fnp-4365	212	55	brainstem	brainstem	NOUN
fnp-4365	212	56	.	.	PUNCT
fnp-4365	213	1	microbiologic	microbiologic	ADJ
fnp-4365	213	2	studies	study	NOUN
fnp-4365	213	3	were	be	AUX
fnp-4365	213	4	negative	negative	ADJ
fnp-4365	213	5	for	for	ADP
fnp-4365	213	6	neurotropic	neurotropic	ADJ
fnp-4365	213	7	viruses	virus	NOUN
fnp-4365	213	8	,	,	PUNCT
fnp-4365	213	9	and	and	CCONJ
fnp-4365	213	10	pcr	pcr	PROPN
fnp-4365	213	11	failed	fail	VERB
fnp-4365	213	12	to	to	PART
fnp-4365	213	13	detect	detect	VERB
fnp-4365	213	14	car	car	NOUN
fnp-4365	213	15	t	t	NOUN
fnp-4365	213	16	-	-	PUNCT
fnp-4365	213	17	cells	cell	NOUN
fnp-4365	213	18	.	.	PUNCT
fnp-4365	214	1	finally	finally	ADV
fnp-4365	214	2	,	,	PUNCT
fnp-4365	214	3	the	the	DET
fnp-4365	214	4	cause	cause	NOUN
fnp-4365	214	5	of	of	ADP
fnp-4365	214	6	death	death	NOUN
fnp-4365	214	7	was	be	AUX
fnp-4365	214	8	attributed	attribute	VERB
fnp-4365	214	9	to	to	ADP
fnp-4365	214	10	a	a	DET
fnp-4365	214	11	lymphocytic	lymphocytic	ADJ
fnp-4365	214	12	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	214	13	of	of	ADP
fnp-4365	214	14	unknown	unknown	ADJ
fnp-4365	214	15	etiology	etiology	NOUN
fnp-4365	214	16	,	,	PUNCT
fnp-4365	214	17	infectious	infectious	ADJ
fnp-4365	214	18	versus	versus	ADP
fnp-4365	214	19	toxic	toxic	ADJ
fnp-4365	214	20	,	,	PUNCT
fnp-4365	214	21	without	without	ADP
fnp-4365	214	22	being	be	AUX
fnp-4365	214	23	able	able	ADJ
fnp-4365	214	24	to	to	PART
fnp-4365	214	25	demonstrate	demonstrate	VERB
fnp-4365	214	26	viral	viral	ADJ
fnp-4365	214	27	infection	infection	NOUN
fnp-4365	214	28	nor	nor	CCONJ
fnp-4365	214	29	car	car	NOUN
fnp-4365	214	30	t	t	NOUN
fnp-4365	214	31	-	-	PUNCT
fnp-4365	214	32	cells	cell	NOUN
fnp-4365	214	33	in	in	ADP
fnp-4365	214	34	brain	brain	NOUN
fnp-4365	214	35	tissue	tissue	NOUN
fnp-4365	214	36	.	.	PUNCT
fnp-4365	215	1	one	one	NUM
fnp-4365	215	2	of	of	ADP
fnp-4365	215	3	the	the	DET
fnp-4365	215	4	cases	case	NOUN
fnp-4365	215	5	without	without	ADP
fnp-4365	215	6	neurological	neurological	ADJ
fnp-4365	215	7	signs	sign	NOUN
fnp-4365	215	8	showed	show	VERB
fnp-4365	215	9	mild	mild	ADJ
fnp-4365	215	10	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	215	11	in	in	ADP
fnp-4365	215	12	context	context	NOUN
fnp-4365	215	13	of	of	ADP
fnp-4365	215	14	terminal	terminal	ADJ
fnp-4365	215	15	hypoxic	hypoxic	ADJ
fnp-4365	215	16	-	-	PUNCT
fnp-4365	215	17	ischemic	ischemic	ADJ
fnp-4365	215	18	damage	damage	NOUN
fnp-4365	215	19	.	.	PUNCT
fnp-4365	216	1	the	the	DET
fnp-4365	216	2	rest	rest	NOUN
fnp-4365	216	3	showed	show	VERB
fnp-4365	216	4	a	a	DET
fnp-4365	216	5	mild	mild	ADJ
fnp-4365	216	6	patchy	patchy	ADJ
fnp-4365	216	7	gliosis	gliosis	NOUN
fnp-4365	216	8	and	and	CCONJ
fnp-4365	216	9	microglial	microglial	ADJ
fnp-4365	216	10	activation	activation	NOUN
fnp-4365	216	11	,	,	PUNCT
fnp-4365	216	12	with	with	ADP
fnp-4365	216	13	no	no	DET
fnp-4365	216	14	other	other	ADJ
fnp-4365	216	15	remarkable	remarkable	ADJ
fnp-4365	216	16	histologic	histologic	ADJ
fnp-4365	216	17	changes	change	NOUN
fnp-4365	216	18	.	.	PUNCT
fnp-4365	217	1	car	car	NOUN
fnp-4365	217	2	t	t	PROPN
fnp-4365	217	3	-	-	PUNCT
fnp-4365	217	4	cells	cell	NOUN
fnp-4365	217	5	were	be	AUX
fnp-4365	217	6	detected	detect	VERB
fnp-4365	217	7	by	by	ADP
fnp-4365	217	8	pcr	pcr	NOUN
fnp-4365	217	9	only	only	ADV
fnp-4365	217	10	in	in	ADP
fnp-4365	217	11	one	one	NUM
fnp-4365	217	12	of	of	ADP
fnp-4365	217	13	them	they	PRON
fnp-4365	217	14	,	,	PUNCT
fnp-4365	217	15	without	without	ADP
fnp-4365	217	16	histological	histological	ADJ
fnp-4365	217	17	particularities	particularity	NOUN
fnp-4365	217	18	.	.	PUNCT
fnp-4365	218	1	reports	report	NOUN
fnp-4365	218	2	of	of	ADP
fnp-4365	218	3	neuropathological	neuropathological	ADJ
fnp-4365	218	4	findings	finding	NOUN
fnp-4365	218	5	after	after	SCONJ
fnp-4365	218	6	car	car	NOUN
fnp-4365	218	7	t	t	NOUN
fnp-4365	218	8	-	-	PUNCT
fnp-4365	218	9	cell	cell	NOUN
fnp-4365	218	10	therapy	therapy	NOUN
fnp-4365	218	11	are	be	AUX
fnp-4365	218	12	scarce	scarce	ADJ
fnp-4365	218	13	.	.	PUNCT
fnp-4365	219	1	neuropathological	neuropathological	ADJ
fnp-4365	219	2	findings	finding	NOUN
fnp-4365	219	3	in	in	ADP
fnp-4365	219	4	autopsies	autopsy	NOUN
fnp-4365	219	5	of	of	ADP
fnp-4365	219	6	different	different	ADJ
fnp-4365	219	7	types	type	NOUN
fnp-4365	219	8	of	of	ADP
fnp-4365	219	9	patients	patient	NOUN
fnp-4365	219	10	vary	vary	VERB
fnp-4365	219	11	,	,	PUNCT
fnp-4365	219	12	but	but	CCONJ
fnp-4365	219	13	there	there	PRON
fnp-4365	219	14	are	be	VERB
fnp-4365	219	15	common	common	ADJ
fnp-4365	219	16	changes	change	NOUN
fnp-4365	219	17	suggesting	suggest	VERB
fnp-4365	219	18	astrocyte	astrocyte	NOUN
fnp-4365	219	19	dysfunction	dysfunction	NOUN
fnp-4365	219	20	,	,	PUNCT
fnp-4365	219	21	blood	blood	NOUN
fnp-4365	219	22	-	-	PUNCT
fnp-4365	219	23	brain	brain	NOUN
fnp-4365	219	24	barrier	barrier	NOUN
fnp-4365	219	25	disruption	disruption	NOUN
fnp-4365	219	26	with	with	ADP
fnp-4365	219	27	endothelial	endothelial	ADJ
fnp-4365	219	28	damage	damage	NOUN
fnp-4365	219	29	and	and	CCONJ
fnp-4365	219	30	activation	activation	NOUN
fnp-4365	219	31	,	,	PUNCT
fnp-4365	219	32	and	and	CCONJ
fnp-4365	219	33	a	a	DET
fnp-4365	219	34	subsequent	subsequent	ADJ
fnp-4365	219	35	increase	increase	NOUN
fnp-4365	219	36	in	in	ADP
fnp-4365	219	37	vascular	vascular	ADJ
fnp-4365	219	38	permeability	permeability	NOUN
fnp-4365	219	39	.	.	PUNCT
fnp-4365	220	1	we	we	PRON
fnp-4365	220	2	found	find	VERB
fnp-4365	220	3	four	four	NUM
fnp-4365	220	4	cases	case	NOUN
fnp-4365	220	5	described	describe	VERB
fnp-4365	220	6	in	in	ADP
fnp-4365	220	7	the	the	DET
fnp-4365	220	8	literature	literature	NOUN
fnp-4365	220	9	,	,	PUNCT
fnp-4365	220	10	all	all	PRON
fnp-4365	220	11	of	of	ADP
fnp-4365	220	12	them	they	PRON
fnp-4365	220	13	with	with	ADP
fnp-4365	220	14	neurological	neurological	ADJ
fnp-4365	220	15	involvement	involvement	NOUN
fnp-4365	220	16	that	that	PRON
fnp-4365	220	17	led	lead	VERB
fnp-4365	220	18	to	to	ADP
fnp-4365	220	19	death	death	NOUN
fnp-4365	220	20	.	.	PUNCT
fnp-4365	221	1	the	the	DET
fnp-4365	221	2	autopsy	autopsy	NOUN
fnp-4365	221	3	of	of	ADP
fnp-4365	221	4	a	a	DET
fnp-4365	221	5	patient	patient	NOUN
fnp-4365	221	6	who	who	PRON
fnp-4365	221	7	died	die	VERB
fnp-4365	221	8	from	from	ADP
fnp-4365	221	9	fulminant	fulminant	ADJ
fnp-4365	221	10	cerebral	cerebral	ADJ
fnp-4365	221	11	oedema	oedema	NOUN
fnp-4365	221	12	showed	show	VERB
fnp-4365	221	13	signs	sign	NOUN
fnp-4365	221	14	of	of	ADP
fnp-4365	221	15	blood	blood	NOUN
fnp-4365	221	16	-	-	PUNCT
fnp-4365	221	17	brain	brain	NOUN
fnp-4365	221	18	-	-	PUNCT
fnp-4365	221	19	barrier	barrier	NOUN
fnp-4365	221	20	disruption	disruption	NOUN
fnp-4365	221	21	,	,	PUNCT
fnp-4365	221	22	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	221	23	and	and	CCONJ
fnp-4365	221	24	microglial	microglial	ADJ
fnp-4365	221	25	activation8	activation8	PROPN
fnp-4365	221	26	.	.	PUNCT
fnp-4365	222	1	the	the	DET
fnp-4365	222	2	findings	finding	NOUN
fnp-4365	222	3	in	in	ADP
fnp-4365	222	4	the	the	DET
fnp-4365	222	5	autopsy	autopsy	NOUN
fnp-4365	222	6	of	of	ADP
fnp-4365	222	7	another	another	DET
fnp-4365	222	8	patient	patient	NOUN
fnp-4365	222	9	who	who	PRON
fnp-4365	222	10	died	die	VERB
fnp-4365	222	11	from	from	ADP
fnp-4365	222	12	progressive	progressive	ADJ
fnp-4365	222	13	neurologic	neurologic	ADJ
fnp-4365	222	14	deterioration	deterioration	NOUN
fnp-4365	222	15	were	be	AUX
fnp-4365	222	16	diffuse	diffuse	ADJ
fnp-4365	222	17	gliosis	gliosis	NOUN
fnp-4365	222	18	with	with	ADP
fnp-4365	222	19	severe	severe	ADJ
fnp-4365	222	20	neuronal	neuronal	ADJ
fnp-4365	222	21	loss	loss	NOUN
fnp-4365	222	22	and	and	CCONJ
fnp-4365	222	23	degeneration	degeneration	NOUN
fnp-4365	222	24	of	of	ADP
fnp-4365	222	25	white	white	ADJ
fnp-4365	222	26	matter	matter	NOUN
fnp-4365	222	27	,	,	PUNCT
fnp-4365	222	28	dense	dense	ADJ
fnp-4365	222	29	infiltration	infiltration	NOUN
fnp-4365	222	30	of	of	ADP
fnp-4365	222	31	macrophages	macrophage	NOUN
fnp-4365	222	32	with	with	ADP
fnp-4365	222	33	numerous	numerous	ADJ
fnp-4365	222	34	microglial	microglial	ADJ
fnp-4365	222	35	cells	cell	NOUN
fnp-4365	222	36	,	,	PUNCT
fnp-4365	222	37	as	as	ADV
fnp-4365	222	38	well	well	ADV
fnp-4365	222	39	as	as	ADP
fnp-4365	222	40	a	a	DET
fnp-4365	222	41	cd8	cd8	PROPN
fnp-4365	222	42	+	+	NOUN
fnp-4365	222	43	infiltrate	infiltrate	VERB
fnp-4365	222	44	.	.	PUNCT
fnp-4365	223	1	it	it	PRON
fnp-4365	223	2	is	be	AUX
fnp-4365	223	3	worth	worth	ADJ
fnp-4365	223	4	noting	note	VERB
fnp-4365	223	5	that	that	SCONJ
fnp-4365	223	6	before	before	ADP
fnp-4365	223	7	the	the	DET
fnp-4365	223	8	hematologic	hematologic	NOUN
fnp-4365	223	9	malignancy	malignancy	NOUN
fnp-4365	223	10	,	,	PUNCT
fnp-4365	223	11	he	he	PRON
fnp-4365	223	12	had	have	VERB
fnp-4365	223	13	the	the	DET
fnp-4365	223	14	diagnosis	diagnosis	NOUN
fnp-4365	223	15	of	of	ADP
fnp-4365	223	16	optic	optic	ADJ
fnp-4365	223	17	atrophy	atrophy	NOUN
fnp-4365	223	18	,	,	PUNCT
fnp-4365	223	19	which	which	PRON
fnp-4365	223	20	could	could	AUX
fnp-4365	223	21	alter	alter	VERB
fnp-4365	223	22	the	the	DET
fnp-4365	223	23	findings10	findings10	NOUN
fnp-4365	223	24	.	.	PUNCT
fnp-4365	224	1	the	the	DET
fnp-4365	224	2	autopsy	autopsy	ADJ
fnp-4365	224	3	findings	finding	NOUN
fnp-4365	224	4	of	of	ADP
fnp-4365	224	5	another	another	DET
fnp-4365	224	6	2	2	NUM
fnp-4365	224	7	patients	patient	NOUN
fnp-4365	224	8	were	be	AUX
fnp-4365	224	9	vascular	vascular	ADJ
fnp-4365	224	10	in	in	ADP
fnp-4365	224	11	nature	nature	NOUN
fnp-4365	224	12	,	,	PUNCT
fnp-4365	224	13	with	with	ADP
fnp-4365	224	14	multifocal	multifocal	ADJ
fnp-4365	224	15	microhemorrhages	microhemorrhage	NOUN
fnp-4365	224	16	,	,	PUNCT
fnp-4365	224	17	perivascular	perivascular	ADJ
fnp-4365	224	18	infiltration	infiltration	NOUN
fnp-4365	224	19	of	of	ADP
fnp-4365	224	20	cd8	cd8	PROPN
fnp-4365	224	21	+	+	PROPN
fnp-4365	224	22	cells	cell	NOUN
fnp-4365	224	23	,	,	PUNCT
fnp-4365	224	24	intravascular	intravascular	ADJ
fnp-4365	224	25	von	von	PROPN
fnp-4365	224	26	willebrand	willebrand	NOUN
fnp-4365	224	27	factor	factor	NOUN
fnp-4365	224	28	(	(	PUNCT
fnp-4365	224	29	vwf	vwf	NOUN
fnp-4365	224	30	)	)	PUNCT
fnp-4365	224	31	binding	bind	VERB
fnp-4365	224	32	,	,	PUNCT
fnp-4365	224	33	and	and	CCONJ
fnp-4365	224	34	platelet	platelet	NOUN
fnp-4365	224	35	microthrombi	microthrombi	NOUN
fnp-4365	224	36	,	,	PUNCT
fnp-4365	224	37	along	along	ADP
fnp-4365	224	38	with	with	ADP
fnp-4365	224	39	more	more	ADV
fnp-4365	224	40	severe	severe	ADJ
fnp-4365	224	41	vascular	vascular	ADJ
fnp-4365	224	42	findings	finding	NOUN
fnp-4365	224	43	,	,	PUNCT
fnp-4365	224	44	such	such	ADJ
fnp-4365	224	45	as	as	ADP
fnp-4365	224	46	karyorrhexis	karyorrhexis	ADJ
fnp-4365	224	47	and	and	CCONJ
fnp-4365	224	48	fibrinoid	fibrinoid	ADJ
fnp-4365	224	49	vessel	vessel	NOUN
fnp-4365	224	50	wall	wall	PROPN
fnp-4365	224	51	necrosis	necrosis	PROPN
fnp-4365	224	52	.	.	PUNCT
fnp-4365	225	1	reactive	reactive	ADJ
fnp-4365	225	2	microglia	microglia	NOUN
fnp-4365	225	3	was	be	AUX
fnp-4365	225	4	also	also	ADV
fnp-4365	225	5	noted	note	VERB
fnp-4365	225	6	,	,	PUNCT
fnp-4365	225	7	the	the	DET
fnp-4365	225	8	percentage	percentage	NOUN
fnp-4365	225	9	of	of	ADP
fnp-4365	225	10	t	t	NOUN
fnp-4365	225	11	-	-	PUNCT
fnp-4365	225	12	cells	cell	NOUN
fnp-4365	225	13	in	in	ADP
fnp-4365	225	14	the	the	DET
fnp-4365	225	15	parenchyma	parenchyma	NOUN
fnp-4365	225	16	mirrored	mirror	VERB
fnp-4365	225	17	the	the	DET
fnp-4365	225	18	percentage	percentage	NOUN
fnp-4365	225	19	of	of	ADP
fnp-4365	225	20	those	those	DET
fnp-4365	225	21	cells	cell	NOUN
fnp-4365	225	22	in	in	ADP
fnp-4365	225	23	the	the	DET
fnp-4365	225	24	csf9	csf9	NOUN
fnp-4365	225	25	.	.	PUNCT
fnp-4365	226	1	it	it	PRON
fnp-4365	226	2	is	be	AUX
fnp-4365	226	3	worth	worth	ADJ
fnp-4365	226	4	highlighting	highlight	VERB
fnp-4365	226	5	that	that	SCONJ
fnp-4365	226	6	the	the	DET
fnp-4365	226	7	clinical	clinical	ADJ
fnp-4365	226	8	setting	setting	NOUN
fnp-4365	226	9	of	of	ADP
fnp-4365	226	10	patients	patient	NOUN
fnp-4365	226	11	undergoing	undergo	VERB
fnp-4365	226	12	car	car	NOUN
fnp-4365	226	13	t	t	NOUN
fnp-4365	226	14	-	-	PUNCT
fnp-4365	226	15	cell	cell	NOUN
fnp-4365	226	16	therapy	therapy	NOUN
fnp-4365	226	17	makes	make	VERB
fnp-4365	226	18	it	it	PRON
fnp-4365	226	19	difficult	difficult	ADJ
fnp-4365	226	20	to	to	PART
fnp-4365	226	21	determine	determine	VERB
fnp-4365	226	22	the	the	DET
fnp-4365	226	23	cause	cause	NOUN
fnp-4365	226	24	of	of	ADP
fnp-4365	226	25	the	the	DET
fnp-4365	226	26	observed	observed	ADJ
fnp-4365	226	27	neurological	neurological	ADJ
fnp-4365	226	28	symptoms	symptom	NOUN
fnp-4365	226	29	.	.	PUNCT
fnp-4365	227	1	while	while	SCONJ
fnp-4365	227	2	crs	crs	PROPN
fnp-4365	227	3	is	be	AUX
fnp-4365	227	4	widely	widely	ADV
fnp-4365	227	5	studied	study	VERB
fnp-4365	227	6	,	,	PUNCT
fnp-4365	227	7	neurological	neurological	ADJ
fnp-4365	227	8	toxicity	toxicity	NOUN
fnp-4365	227	9	itself	itself	PRON
fnp-4365	227	10	remains	remain	VERB
fnp-4365	227	11	less	less	ADV
fnp-4365	227	12	understood	understand	VERB
fnp-4365	227	13	.	.	PUNCT
fnp-4365	228	1	neurological	neurological	ADJ
fnp-4365	228	2	damage	damage	NOUN
fnp-4365	228	3	due	due	ADP
fnp-4365	228	4	to	to	ADP
fnp-4365	228	5	the	the	DET
fnp-4365	228	6	underlying	underlie	VERB
fnp-4365	228	7	hematological	hematological	ADJ
fnp-4365	228	8	disease	disease	NOUN
fnp-4365	228	9	,	,	PUNCT
fnp-4365	228	10	opportunistic	opportunistic	ADJ
fnp-4365	228	11	infections	infection	NOUN
fnp-4365	228	12	in	in	ADP
fnp-4365	228	13	a	a	DET
fnp-4365	228	14	setting	setting	NOUN
fnp-4365	228	15	of	of	ADP
fnp-4365	228	16	severe	severe	ADJ
fnp-4365	228	17	immunosuppression	immunosuppression	NOUN
fnp-4365	228	18	,	,	PUNCT
fnp-4365	228	19	and	and	CCONJ
fnp-4365	228	20	pharmacological	pharmacological	ADJ
fnp-4365	228	21	toxicity	toxicity	NOUN
fnp-4365	228	22	of	of	ADP
fnp-4365	228	23	accompanying	accompany	VERB
fnp-4365	228	24	chemotherapy	chemotherapy	NOUN
fnp-4365	228	25	drugs	drug	NOUN
fnp-4365	228	26	are	be	AUX
fnp-4365	228	27	conditions	condition	NOUN
fnp-4365	228	28	that	that	PRON
fnp-4365	228	29	should	should	AUX
fnp-4365	228	30	be	be	AUX
fnp-4365	228	31	taken	take	VERB
fnp-4365	228	32	into	into	ADP
fnp-4365	228	33	consideration	consideration	NOUN
fnp-4365	228	34	when	when	SCONJ
fnp-4365	228	35	evaluating	evaluate	VERB
fnp-4365	228	36	the	the	DET
fnp-4365	228	37	possible	possible	ADJ
fnp-4365	228	38	effects	effect	NOUN
fnp-4365	228	39	of	of	ADP
fnp-4365	228	40	car	car	NOUN
fnp-4365	228	41	t	t	NOUN
fnp-4365	228	42	-	-	PUNCT
fnp-4365	228	43	cell	cell	NOUN
fnp-4365	228	44	therapy	therapy	NOUN
fnp-4365	228	45	.	.	PUNCT
fnp-4365	229	1	fludarabine	fludarabine	PROPN
fnp-4365	229	2	,	,	PUNCT
fnp-4365	229	3	a	a	DET
fnp-4365	229	4	drug	drug	NOUN
fnp-4365	229	5	used	use	VERB
fnp-4365	229	6	for	for	ADP
fnp-4365	229	7	the	the	DET
fnp-4365	229	8	conditioning	conditioning	NOUN
fnp-4365	229	9	with	with	ADP
fnp-4365	229	10	cyclophosphamide	cyclophosphamide	NOUN
fnp-4365	229	11	in	in	ADP
fnp-4365	229	12	all	all	DET
fnp-4365	229	13	our	our	PRON
fnp-4365	229	14	cases	case	NOUN
fnp-4365	229	15	,	,	PUNCT
fnp-4365	229	16	seems	seem	VERB
fnp-4365	229	17	to	to	PART
fnp-4365	229	18	promote	promote	VERB
fnp-4365	229	19	a	a	DET
fnp-4365	229	20	discernible	discernible	ADJ
fnp-4365	229	21	form	form	NOUN
fnp-4365	229	22	of	of	ADP
fnp-4365	229	23	neurotoxicity	neurotoxicity	NOUN
fnp-4365	229	24	,	,	PUNCT
fnp-4365	229	25	with	with	ADP
fnp-4365	229	26	unspecific	unspecific	ADJ
fnp-4365	229	27	but	but	CCONJ
fnp-4365	229	28	distinctive	distinctive	ADJ
fnp-4365	229	29	gliosis	gliosis	NOUN
fnp-4365	229	30	and	and	CCONJ
fnp-4365	229	31	white	white	ADJ
fnp-4365	229	32	matter	matter	NOUN
fnp-4365	229	33	involvement11	involvement11	NOUN
fnp-4365	229	34	.	.	PUNCT
fnp-4365	230	1	basic	basic	ADJ
fnp-4365	230	2	neuropathologic	neuropathologic	ADJ
fnp-4365	230	3	assessment	assessment	NOUN
fnp-4365	230	4	allows	allow	VERB
fnp-4365	230	5	reliably	reliably	ADV
fnp-4365	230	6	detecting	detect	VERB
fnp-4365	230	7	or	or	CCONJ
fnp-4365	230	8	discarding	discard	VERB
fnp-4365	230	9	malignant	malignant	ADJ
fnp-4365	230	10	cell	cell	NOUN
fnp-4365	230	11	infiltration	infiltration	NOUN
fnp-4365	230	12	in	in	ADP
fnp-4365	230	13	the	the	DET
fnp-4365	230	14	central	central	ADJ
fnp-4365	230	15	nervous	nervous	ADJ
fnp-4365	230	16	system	system	NOUN
fnp-4365	230	17	.	.	PUNCT
fnp-4365	231	1	it	it	PRON
fnp-4365	231	2	also	also	ADV
fnp-4365	231	3	enables	enable	VERB
fnp-4365	231	4	to	to	PART
fnp-4365	231	5	demonstrate	demonstrate	VERB
fnp-4365	231	6	the	the	DET
fnp-4365	231	7	presence	presence	NOUN
fnp-4365	231	8	of	of	ADP
fnp-4365	231	9	inflammation	inflammation	NOUN
fnp-4365	231	10	with	with	ADP
fnp-4365	231	11	or	or	CCONJ
fnp-4365	231	12	without	without	ADP
fnp-4365	231	13	infectious	infectious	ADJ
fnp-4365	231	14	agents	agent	NOUN
fnp-4365	231	15	in	in	ADP
fnp-4365	231	16	neurological	neurological	ADJ
fnp-4365	231	17	tissue	tissue	NOUN
fnp-4365	231	18	,	,	PUNCT
fnp-4365	231	19	although	although	SCONJ
fnp-4365	231	20	their	their	PRON
fnp-4365	231	21	absence	absence	NOUN
fnp-4365	231	22	does	do	AUX
fnp-4365	231	23	not	not	PART
fnp-4365	231	24	completely	completely	ADV
fnp-4365	231	25	rule	rule	VERB
fnp-4365	231	26	out	out	ADP
fnp-4365	231	27	infection	infection	NOUN
fnp-4365	231	28	as	as	ADP
fnp-4365	231	29	in	in	ADP
fnp-4365	231	30	our	our	PRON
fnp-4365	231	31	fifth	fifth	ADJ
fnp-4365	231	32	case	case	NOUN
fnp-4365	231	33	.	.	PUNCT
fnp-4365	232	1	alterations	alteration	NOUN
fnp-4365	232	2	of	of	ADP
fnp-4365	232	3	the	the	DET
fnp-4365	232	4	bbb	bbb	NOUN
fnp-4365	232	5	can	can	AUX
fnp-4365	232	6	not	not	PART
fnp-4365	232	7	be	be	AUX
fnp-4365	232	8	reliably	reliably	ADV
fnp-4365	232	9	studied	study	VERB
fnp-4365	232	10	in	in	ADP
fnp-4365	232	11	he	he	PRON
fnp-4365	232	12	alone	alone	ADJ
fnp-4365	232	13	and	and	CCONJ
fnp-4365	232	14	specially	specially	ADV
fnp-4365	232	15	without	without	ADP
fnp-4365	232	16	a	a	DET
fnp-4365	232	17	prior	prior	ADJ
fnp-4365	232	18	technical	technical	ADJ
fnp-4365	232	19	background	background	NOUN
fnp-4365	232	20	.	.	PUNCT
fnp-4365	233	1	nevertheless	nevertheless	ADV
fnp-4365	233	2	,	,	PUNCT
fnp-4365	233	3	without	without	ADP
fnp-4365	233	4	clear	clear	ADJ
fnp-4365	233	5	evidence	evidence	NOUN
fnp-4365	233	6	of	of	ADP
fnp-4365	233	7	brain	brain	NOUN
fnp-4365	233	8	weight	weight	NOUN
fnp-4365	233	9	gain	gain	NOUN
fnp-4365	233	10	,	,	PUNCT
fnp-4365	233	11	oedema	oedema	NOUN
fnp-4365	233	12	,	,	PUNCT
fnp-4365	233	13	and	and	CCONJ
fnp-4365	233	14	white	white	ADJ
fnp-4365	233	15	matter	matter	NOUN
fnp-4365	233	16	changes	change	NOUN
fnp-4365	233	17	,	,	PUNCT
fnp-4365	233	18	nor	nor	CCONJ
fnp-4365	233	19	minimal	minimal	ADJ
fnp-4365	233	20	vascular	vascular	ADJ
fnp-4365	233	21	damage	damage	NOUN
fnp-4365	233	22	and	and	CCONJ
fnp-4365	233	23	perivascular	perivascular	ADJ
fnp-4365	233	24	cellular	cellular	ADJ
fnp-4365	233	25	reactions	reaction	NOUN
fnp-4365	233	26	,	,	PUNCT
fnp-4365	233	27	bbb	bbb	NOUN
fnp-4365	233	28	disruption	disruption	NOUN
fnp-4365	233	29	may	may	AUX
fnp-4365	233	30	be	be	AUX
fnp-4365	233	31	at	at	ADP
fnp-4365	233	32	best	well	ADV
fnp-4365	233	33	limited	limit	VERB
fnp-4365	233	34	in	in	ADP
fnp-4365	233	35	cases	case	NOUN
fnp-4365	233	36	without	without	ADP
fnp-4365	233	37	neurological	neurological	ADJ
fnp-4365	233	38	involvement	involvement	NOUN
fnp-4365	233	39	in	in	ADP
fnp-4365	233	40	life	life	NOUN
fnp-4365	233	41	.	.	PUNCT
fnp-4365	234	1	on	on	ADP
fnp-4365	234	2	the	the	DET
fnp-4365	234	3	other	other	ADJ
fnp-4365	234	4	hand	hand	NOUN
fnp-4365	234	5	,	,	PUNCT
fnp-4365	234	6	astrocyte	astrocyte	NOUN
fnp-4365	234	7	injury	injury	NOUN
fnp-4365	234	8	can	can	AUX
fnp-4365	234	9	be	be	AUX
fnp-4365	234	10	highlighted	highlight	VERB
fnp-4365	234	11	with	with	ADP
fnp-4365	234	12	ihc	ihc	PROPN
fnp-4365	234	13	showing	show	VERB
fnp-4365	234	14	gfap	gfap	ADJ
fnp-4365	234	15	aberrant	aberrant	ADJ
fnp-4365	234	16	beading	beading	NOUN
fnp-4365	234	17	and	and	CCONJ
fnp-4365	234	18	fragmentation	fragmentation	NOUN
fnp-4365	234	19	,	,	PUNCT
fnp-4365	234	20	a	a	DET
fnp-4365	234	21	phenomenon	phenomenon	NOUN
fnp-4365	234	22	called	call	VERB
fnp-4365	234	23	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	234	24	,	,	PUNCT
fnp-4365	234	25	that	that	PRON
fnp-4365	234	26	relates	relate	VERB
fnp-4365	234	27	to	to	ADP
fnp-4365	234	28	blood	blood	NOUN
fnp-4365	234	29	barrier	barrier	NOUN
fnp-4365	234	30	dysfunction8,15	dysfunction8,15	PROPN
fnp-4365	234	31	.	.	PUNCT
fnp-4365	235	1	we	we	PRON
fnp-4365	235	2	reexamined	reexamine	VERB
fnp-4365	235	3	our	our	PRON
fnp-4365	235	4	cases	case	NOUN
fnp-4365	235	5	with	with	ADP
fnp-4365	235	6	gfap	gfap	ADJ
fnp-4365	235	7	,	,	PUNCT
fnp-4365	235	8	and	and	CCONJ
fnp-4365	235	9	only	only	ADV
fnp-4365	235	10	saw	see	VERB
fnp-4365	235	11	scattered	scatter	VERB
fnp-4365	235	12	foci	focus	NOUN
fnp-4365	235	13	of	of	ADP
fnp-4365	235	14	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	235	15	in	in	ADP
fnp-4365	235	16	2	2	NUM
fnp-4365	235	17	cases	case	NOUN
fnp-4365	235	18	,	,	PUNCT
fnp-4365	235	19	one	one	NUM
fnp-4365	235	20	with	with	ADP
fnp-4365	235	21	hypoxic	hypoxic	ADJ
fnp-4365	235	22	-	-	PUNCT
fnp-4365	235	23	ischemic	ischemic	ADJ
fnp-4365	235	24	changes	change	NOUN
fnp-4365	235	25	in	in	ADP
fnp-4365	235	26	the	the	DET
fnp-4365	235	27	context	context	NOUN
fnp-4365	235	28	of	of	ADP
fnp-4365	235	29	nosocomial	nosocomial	ADJ
fnp-4365	235	30	pneumonia	pneumonia	NOUN
fnp-4365	235	31	and	and	CCONJ
fnp-4365	235	32	one	one	NUM
fnp-4365	235	33	with	with	ADP
fnp-4365	235	34	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	235	35	.	.	PUNCT
fnp-4365	236	1	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	236	2	has	have	AUX
fnp-4365	236	3	been	be	AUX
fnp-4365	236	4	related	relate	VERB
fnp-4365	236	5	to	to	ADP
fnp-4365	236	6	acute	acute	VERB
fnp-4365	236	7	metabolic	metabolic	NOUN
fnp-4365	236	8	disturbances	disturbance	NOUN
fnp-4365	236	9	in	in	ADP
fnp-4365	236	10	astrocytes	astrocyte	NOUN
fnp-4365	236	11	(	(	PUNCT
fnp-4365	236	12	hypoxia	hypoxia	NOUN
fnp-4365	236	13	,	,	PUNCT
fnp-4365	236	14	ischemia	ischemia	NOUN
fnp-4365	236	15	,	,	PUNCT
fnp-4365	236	16	hypoglycemia	hypoglycemia	NOUN
fnp-4365	236	17	…	…	PUNCT
fnp-4365	236	18	)15	)15	PUNCT
fnp-4365	236	19	,	,	PUNCT
fnp-4365	236	20	and	and	CCONJ
fnp-4365	236	21	as	as	ADP
fnp-4365	236	22	such	such	ADJ
fnp-4365	236	23	may	may	AUX
fnp-4365	236	24	not	not	PART
fnp-4365	236	25	be	be	AUX
fnp-4365	236	26	pathognomonic	pathognomonic	ADJ
fnp-4365	236	27	of	of	ADP
fnp-4365	236	28	crs	crs	PROPN
fnp-4365	236	29	brain	brain	NOUN
fnp-4365	236	30	pathology	pathology	NOUN
fnp-4365	236	31	or	or	CCONJ
fnp-4365	236	32	fludarabine	fludarabine	VERB
fnp-4365	236	33	neurotoxicity	neurotoxicity	NOUN
fnp-4365	236	34	,	,	PUNCT
fnp-4365	236	35	for	for	ADP
fnp-4365	236	36	example	example	NOUN
fnp-4365	236	37	,	,	PUNCT
fnp-4365	236	38	especially	especially	ADV
fnp-4365	236	39	when	when	SCONJ
fnp-4365	236	40	is	be	AUX
fnp-4365	236	41	mild	mild	ADJ
fnp-4365	236	42	and	and	CCONJ
fnp-4365	236	43	focal	focal	ADJ
fnp-4365	236	44	and	and	CCONJ
fnp-4365	236	45	may	may	AUX
fnp-4365	236	46	have	have	VERB
fnp-4365	236	47	alternative	alternative	ADJ
fnp-4365	236	48	causes	cause	NOUN
fnp-4365	236	49	.	.	PUNCT
fnp-4365	237	1	the	the	DET
fnp-4365	237	2	relative	relative	ADJ
fnp-4365	237	3	lack	lack	NOUN
fnp-4365	237	4	of	of	ADP
fnp-4365	237	5	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	237	6	as	as	ADV
fnp-4365	237	7	well	well	ADV
fnp-4365	237	8	as	as	ADP
fnp-4365	237	9	overall	overall	ADJ
fnp-4365	237	10	gliosis	gliosis	NOUN
fnp-4365	237	11	in	in	ADP
fnp-4365	237	12	most	most	ADJ
fnp-4365	237	13	of	of	ADP
fnp-4365	237	14	our	our	PRON
fnp-4365	237	15	cases	case	NOUN
fnp-4365	237	16	would	would	AUX
fnp-4365	237	17	support	support	VERB
fnp-4365	237	18	the	the	DET
fnp-4365	237	19	notion	notion	NOUN
fnp-4365	237	20	that	that	SCONJ
fnp-4365	237	21	bbb	bbb	PROPN
fnp-4365	237	22	dysfunction	dysfunction	NOUN
fnp-4365	237	23	is	be	AUX
fnp-4365	237	24	not	not	PART
fnp-4365	237	25	a	a	DET
fnp-4365	237	26	systematic	systematic	ADJ
fnp-4365	237	27	feature	feature	NOUN
fnp-4365	237	28	in	in	ADP
fnp-4365	237	29	car	car	NOUN
fnp-4365	237	30	t	t	NOUN
fnp-4365	237	31	-	-	PUNCT
fnp-4365	237	32	cell	cell	NOUN
fnp-4365	237	33	treated	treat	VERB
fnp-4365	237	34	critical	critical	ADJ
fnp-4365	237	35	patients	patient	NOUN
fnp-4365	237	36	when	when	SCONJ
fnp-4365	237	37	they	they	PRON
fnp-4365	237	38	do	do	AUX
fnp-4365	237	39	not	not	PART
fnp-4365	237	40	have	have	VERB
fnp-4365	237	41	specific	specific	ADJ
fnp-4365	237	42	and	and	CCONJ
fnp-4365	237	43	severe	severe	ADJ
fnp-4365	237	44	neurological	neurological	ADJ
fnp-4365	237	45	symptomatology	symptomatology	NOUN
fnp-4365	237	46	.	.	PUNCT
fnp-4365	238	1	we	we	PRON
fnp-4365	238	2	present	present	VERB
fnp-4365	238	3	6	6	NUM
fnp-4365	238	4	patients	patient	NOUN
fnp-4365	238	5	who	who	PRON
fnp-4365	238	6	died	die	VERB
fnp-4365	238	7	after	after	ADP
fnp-4365	238	8	car	car	NOUN
fnp-4365	238	9	t	t	NOUN
fnp-4365	238	10	-	-	PUNCT
fnp-4365	238	11	cell	cell	NOUN
fnp-4365	238	12	therapy	therapy	NOUN
fnp-4365	238	13	,	,	PUNCT
fnp-4365	238	14	2	2	NUM
fnp-4365	238	15	of	of	ADP
fnp-4365	238	16	whom	whom	PRON
fnp-4365	238	17	displayed	display	VERB
fnp-4365	238	18	neurologic	neurologic	ADJ
fnp-4365	238	19	clinical	clinical	ADJ
fnp-4365	238	20	manifestations	manifestation	NOUN
fnp-4365	238	21	with	with	ADP
fnp-4365	238	22	only	only	ADV
fnp-4365	238	23	one	one	NUM
fnp-4365	238	24	showing	show	VERB
fnp-4365	238	25	significant	significant	ADJ
fnp-4365	238	26	neuropathological	neuropathological	ADJ
fnp-4365	238	27	findings	finding	NOUN
fnp-4365	238	28	.	.	PUNCT
fnp-4365	239	1	this	this	DET
fnp-4365	239	2	case	case	NOUN
fnp-4365	239	3	had	have	VERB
fnp-4365	239	4	an	an	DET
fnp-4365	239	5	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	239	6	of	of	ADP
fnp-4365	239	7	immune	immune	NOUN
fnp-4365	239	8	-	-	PUNCT
fnp-4365	239	9	toxic	toxic	ADJ
fnp-4365	239	10	versus	versus	ADP
fnp-4365	239	11	infectious	infectious	ADJ
fnp-4365	239	12	origin	origin	NOUN
fnp-4365	239	13	,	,	PUNCT
fnp-4365	239	14	being	be	AUX
fnp-4365	239	15	the	the	DET
fnp-4365	239	16	findings	finding	NOUN
fnp-4365	239	17	in	in	ADP
fnp-4365	239	18	the	the	DET
fnp-4365	239	19	rest	rest	NOUN
fnp-4365	239	20	of	of	ADP
fnp-4365	239	21	the	the	DET
fnp-4365	239	22	patients	patient	NOUN
fnp-4365	239	23	unspecific	unspecific	ADJ
fnp-4365	239	24	and	and	CCONJ
fnp-4365	239	25	minimal	minimal	ADJ
fnp-4365	239	26	,	,	PUNCT
fnp-4365	239	27	with	with	ADP
fnp-4365	239	28	mild	mild	ADJ
fnp-4365	239	29	chronic	chronic	ADJ
fnp-4365	239	30	vascular	vascular	NOUN
fnp-4365	239	31	disease	disease	NOUN
fnp-4365	239	32	and	and	CCONJ
fnp-4365	239	33	changes	change	NOUN
fnp-4365	239	34	suggestive	suggestive	ADJ
fnp-4365	239	35	of	of	ADP
fnp-4365	239	36	terminal	terminal	ADJ
fnp-4365	239	37	hypoxic	hypoxic	ADJ
fnp-4365	239	38	-	-	PUNCT
fnp-4365	239	39	ischemic	ischemic	ADJ
fnp-4365	239	40	etiology	etiology	NOUN
fnp-4365	239	41	.	.	PUNCT
fnp-4365	240	1	interestingly	interestingly	ADV
fnp-4365	240	2	,	,	PUNCT
fnp-4365	240	3	the	the	DET
fnp-4365	240	4	encephalomyelitis	encephalomyelitis	NOUN
fnp-4365	240	5	changes	change	NOUN
fnp-4365	240	6	could	could	AUX
fnp-4365	240	7	not	not	PART
fnp-4365	240	8	be	be	AUX
fnp-4365	240	9	related	relate	VERB
fnp-4365	240	10	to	to	ADP
fnp-4365	240	11	the	the	DET
fnp-4365	240	12	presence	presence	NOUN
fnp-4365	240	13	of	of	ADP
fnp-4365	240	14	car	car	NOUN
fnp-4365	240	15	t	t	NOUN
fnp-4365	240	16	-	-	PUNCT
fnp-4365	240	17	cells	cell	NOUN
fnp-4365	240	18	in	in	ADP
fnp-4365	240	19	brain	brain	NOUN
fnp-4365	240	20	tissue	tissue	NOUN
fnp-4365	240	21	,	,	PUNCT
fnp-4365	240	22	while	while	SCONJ
fnp-4365	240	23	we	we	PRON
fnp-4365	240	24	were	be	AUX
fnp-4365	240	25	able	able	ADJ
fnp-4365	240	26	to	to	PART
fnp-4365	240	27	demonstrate	demonstrate	VERB
fnp-4365	240	28	car	car	NOUN
fnp-4365	240	29	t	t	NOUN
fnp-4365	240	30	-	-	PUNCT
fnp-4365	240	31	cells	cell	NOUN
fnp-4365	240	32	in	in	ADP
fnp-4365	240	33	brain	brain	NOUN
fnp-4365	240	34	tissue	tissue	NOUN
fnp-4365	240	35	of	of	ADP
fnp-4365	240	36	one	one	NUM
fnp-4365	240	37	patient	patient	NOUN
fnp-4365	240	38	without	without	ADP
fnp-4365	240	39	relevant	relevant	ADJ
fnp-4365	240	40	histological	histological	ADJ
fnp-4365	240	41	changes	change	NOUN
fnp-4365	240	42	nor	nor	CCONJ
fnp-4365	240	43	neurological	neurological	ADJ
fnp-4365	240	44	symptoms	symptom	NOUN
fnp-4365	240	45	.	.	PUNCT
fnp-4365	241	1	in	in	ADP
fnp-4365	241	2	conclusion	conclusion	NOUN
fnp-4365	241	3	,	,	PUNCT
fnp-4365	241	4	patients	patient	NOUN
fnp-4365	241	5	that	that	PRON
fnp-4365	241	6	die	die	VERB
fnp-4365	241	7	after	after	ADP
fnp-4365	241	8	car	car	NOUN
fnp-4365	241	9	t	t	NOUN
fnp-4365	241	10	-	-	PUNCT
fnp-4365	241	11	cell	cell	NOUN
fnp-4365	241	12	therapy	therapy	NOUN
fnp-4365	241	13	show	show	VERB
fnp-4365	241	14	non	non	ADJ
fnp-4365	241	15	-	-	ADJ
fnp-4365	241	16	specific	specific	ADJ
fnp-4365	241	17	or	or	CCONJ
fnp-4365	241	18	minimal	minimal	ADJ
fnp-4365	241	19	neuropathological	neuropathological	ADJ
fnp-4365	241	20	changes	change	NOUN
fnp-4365	241	21	,	,	PUNCT
fnp-4365	241	22	especially	especially	ADV
fnp-4365	241	23	when	when	SCONJ
fnp-4365	241	24	they	they	PRON
fnp-4365	241	25	lack	lack	VERB
fnp-4365	241	26	evident	evident	ADJ
fnp-4365	241	27	neurological	neurological	ADJ
fnp-4365	241	28	symptoms	symptom	NOUN
fnp-4365	241	29	and	and	CCONJ
fnp-4365	241	30	these	these	PRON
fnp-4365	241	31	do	do	AUX
fnp-4365	241	32	not	not	PART
fnp-4365	241	33	contribute	contribute	VERB
fnp-4365	241	34	in	in	ADP
fnp-4365	241	35	patient	patient	ADJ
fnp-4365	241	36	death	death	NOUN
fnp-4365	241	37	.	.	PUNCT
fnp-4365	242	1	car	car	NOUN
fnp-4365	242	2	t	t	NOUN
fnp-4365	242	3	-	-	PUNCT
fnp-4365	242	4	cell	cell	NOUN
fnp-4365	242	5	related	relate	VERB
fnp-4365	242	6	direct	direct	ADJ
fnp-4365	242	7	toxicity	toxicity	NOUN
fnp-4365	242	8	may	may	AUX
fnp-4365	242	9	not	not	PART
fnp-4365	242	10	be	be	AUX
fnp-4365	242	11	the	the	DET
fnp-4365	242	12	only	only	ADJ
fnp-4365	242	13	cause	cause	NOUN
fnp-4365	242	14	for	for	ADP
fnp-4365	242	15	neurological	neurological	ADJ
fnp-4365	242	16	symptoms	symptom	NOUN
fnp-4365	242	17	,	,	PUNCT
fnp-4365	242	18	and	and	CCONJ
fnp-4365	242	19	autopsy	autopsy	ADJ
fnp-4365	242	20	may	may	AUX
fnp-4365	242	21	detect	detect	VERB
fnp-4365	242	22	other	other	ADJ
fnp-4365	242	23	pathological	pathological	ADJ
fnp-4365	242	24	processes	process	NOUN
fnp-4365	242	25	,	,	PUNCT
fnp-4365	242	26	such	such	ADJ
fnp-4365	242	27	as	as	ADP
fnp-4365	242	28	disease	disease	NOUN
fnp-4365	242	29	progression	progression	NOUN
fnp-4365	242	30	.	.	PUNCT
fnp-4365	243	1	car	car	NOUN
fnp-4365	243	2	t	t	NOUN
fnp-4365	243	3	-	-	PUNCT
fnp-4365	243	4	cell	cell	NOUN
fnp-4365	243	5	therapy	therapy	NOUN
fnp-4365	243	6	is	be	AUX
fnp-4365	243	7	a	a	DET
fnp-4365	243	8	new	new	ADJ
fnp-4365	243	9	therapeutic	therapeutic	ADJ
fnp-4365	243	10	approach	approach	NOUN
fnp-4365	243	11	that	that	PRON
fnp-4365	243	12	needs	need	VERB
fnp-4365	243	13	further	further	ADJ
fnp-4365	243	14	research	research	NOUN
fnp-4365	243	15	to	to	PART
fnp-4365	243	16	elucidate	elucidate	VERB
fnp-4365	243	17	its	its	PRON
fnp-4365	243	18	potential	potential	ADJ
fnp-4365	243	19	adverse	adverse	ADJ
fnp-4365	243	20	effects	effect	NOUN
fnp-4365	243	21	and	and	CCONJ
fnp-4365	243	22	the	the	DET
fnp-4365	243	23	underlying	underlying	ADJ
fnp-4365	243	24	pathological	pathological	ADJ
fnp-4365	243	25	mechanisms	mechanism	NOUN
fnp-4365	243	26	behind	behind	ADP
fnp-4365	243	27	them	they	PRON
fnp-4365	243	28	.	.	PUNCT
fnp-4365	244	1	conflicts	conflict	NOUN
fnp-4365	244	2	of	of	ADP
fnp-4365	244	3	interest	interest	NOUN
fnp-4365	244	4	the	the	DET
fnp-4365	244	5	authors	author	NOUN
fnp-4365	244	6	have	have	VERB
fnp-4365	244	7	no	no	DET
fnp-4365	244	8	conflicts	conflict	NOUN
fnp-4365	244	9	of	of	ADP
fnp-4365	244	10	interest	interest	NOUN
fnp-4365	244	11	that	that	PRON
fnp-4365	244	12	relate	relate	VERB
fnp-4365	244	13	to	to	ADP
fnp-4365	244	14	the	the	DET
fnp-4365	244	15	content	content	NOUN
fnp-4365	244	16	of	of	ADP
fnp-4365	244	17	this	this	DET
fnp-4365	244	18	article	article	NOUN
fnp-4365	244	19	.	.	PUNCT
fnp-4365	245	1	acknowledgments	acknowledgment	NOUN
fnp-4365	245	2	we	we	PRON
fnp-4365	245	3	are	be	AUX
fnp-4365	245	4	thankful	thankful	ADJ
fnp-4365	245	5	to	to	ADP
fnp-4365	245	6	the	the	DET
fnp-4365	245	7	pathology	pathology	NOUN
fnp-4365	245	8	technicians	technician	NOUN
fnp-4365	245	9	in	in	ADP
fnp-4365	245	10	the	the	DET
fnp-4365	245	11	immunohistochemistry	immunohistochemistry	NOUN
fnp-4365	245	12	and	and	CCONJ
fnp-4365	245	13	molecular	molecular	ADJ
fnp-4365	245	14	sections	section	NOUN
fnp-4365	245	15	of	of	ADP
fnp-4365	245	16	the	the	DET
fnp-4365	245	17	pathology	pathology	NOUN
fnp-4365	245	18	department	department	NOUN
fnp-4365	245	19	for	for	ADP
fnp-4365	245	20	the	the	DET
fnp-4365	245	21	performed	perform	VERB
fnp-4365	245	22	studies	study	NOUN
fnp-4365	245	23	.	.	PUNCT
fnp-4365	246	1	funding	fund	VERB
fnp-4365	246	2	the	the	DET
fnp-4365	246	3	authors	author	NOUN
fnp-4365	246	4	have	have	AUX
fnp-4365	246	5	not	not	PART
fnp-4365	246	6	received	receive	VERB
fnp-4365	246	7	specific	specific	ADJ
fnp-4365	246	8	funding	funding	NOUN
fnp-4365	246	9	for	for	ADP
fnp-4365	246	10	this	this	DET
fnp-4365	246	11	study	study	NOUN
fnp-4365	246	12	.	.	PUNCT
fnp-4365	247	1	cfl	cfl	NOUN
fnp-4365	247	2	thanks	thank	NOUN
fnp-4365	247	3	the	the	DET
fnp-4365	247	4	spanish	spanish	PROPN
fnp-4365	247	5	institute	institute	PROPN
fnp-4365	247	6	of	of	ADP
fnp-4365	247	7	health	health	PROPN
fnp-4365	247	8	carlos	carlos	PROPN
fnp-4365	247	9	iii	iii	PROPN
fnp-4365	247	10	(	(	PUNCT
fnp-4365	247	11	projects	project	VERB
fnp-4365	247	12	pi19/00669	pi19/00669	PROPN
fnp-4365	247	13	and	and	CCONJ
fnp-4365	247	14	ici19/00025	ici19/00025	PROPN
fnp-4365	247	15	;	;	PUNCT
fnp-4365	247	16	co	co	VERB
fnp-4365	247	17	-	-	VERB
fnp-4365	247	18	funded	fund	VERB
fnp-4365	247	19	by	by	ADP
fnp-4365	247	20	the	the	DET
fnp-4365	247	21	european	european	PROPN
fnp-4365	247	22	union	union	PROPN
fnp-4365	247	23	)	)	PUNCT
fnp-4365	247	24	.	.	PUNCT
fnp-4365	248	1	references	reference	NOUN
fnp-4365	248	2	1	1	NUM
fnp-4365	248	3	.	.	PUNCT
fnp-4365	248	4	kochenderfer	kochenderfer	NOUN
fnp-4365	248	5	,	,	PUNCT
fnp-4365	248	6	j.	j.	PROPN
fnp-4365	248	7	n.	n.	PROPN
fnp-4365	248	8	et	et	PROPN
fnp-4365	248	9	al	al	PROPN
fnp-4365	248	10	.	.	PUNCT
fnp-4365	249	1	chemotherapy	chemotherapy	NOUN
fnp-4365	249	2	-	-	PUNCT
fnp-4365	249	3	refractory	refractory	NOUN
fnp-4365	249	4	diffuse	diffuse	VERB
fnp-4365	249	5	large	large	ADJ
fnp-4365	249	6	b	b	NUM
fnp-4365	249	7	-	-	PUNCT
fnp-4365	249	8	cell	cell	NOUN
fnp-4365	249	9	lymphoma	lymphoma	NOUN
fnp-4365	249	10	and	and	CCONJ
fnp-4365	249	11	indolent	indolent	ADJ
fnp-4365	249	12	b	b	NOUN
fnp-4365	249	13	-	-	PUNCT
fnp-4365	249	14	cell	cell	NOUN
fnp-4365	249	15	malignancies	malignancy	NOUN
fnp-4365	249	16	can	can	AUX
fnp-4365	249	17	be	be	AUX
fnp-4365	249	18	effectively	effectively	ADV
fnp-4365	249	19	treated	treat	VERB
fnp-4365	249	20	with	with	ADP
fnp-4365	249	21	autologous	autologous	ADJ
fnp-4365	249	22	t	t	NOUN
fnp-4365	249	23	cells	cell	NOUN
fnp-4365	249	24	expressing	express	VERB
fnp-4365	249	25	an	an	DET
fnp-4365	249	26	anti	anti	ADJ
fnp-4365	249	27	-	-	ADJ
fnp-4365	249	28	cd19	cd19	ADJ
fnp-4365	249	29	chimeric	chimeric	ADJ
fnp-4365	249	30	antigen	antigen	ADJ
fnp-4365	249	31	receptor	receptor	NOUN
fnp-4365	249	32	.	.	PUNCT
fnp-4365	250	1	j.	j.	PROPN
fnp-4365	250	2	clin	clin	PROPN
fnp-4365	250	3	.	.	PUNCT
fnp-4365	251	1	oncol	oncol	ADJ
fnp-4365	251	2	.	.	PUNCT
fnp-4365	252	1	33	33	NUM
fnp-4365	252	2	,	,	PUNCT
fnp-4365	252	3	540–549	540–549	NUM
fnp-4365	252	4	(	(	PUNCT
fnp-4365	252	5	2015	2015	NUM
fnp-4365	252	6	)	)	PUNCT
fnp-4365	252	7	.	.	PUNCT
fnp-4365	253	1	pmid	pmid	NOUN
fnp-4365	253	2	:	:	PUNCT
fnp-4365	253	3	25154820	25154820	NUM
fnp-4365	253	4	.	.	PUNCT
fnp-4365	254	1	https://doi.org/10.1200/jco.2014.56.2025	https://doi.org/10.1200/jco.2014.56.2025	NOUN
fnp-4365	254	2	2	2	NUM
fnp-4365	254	3	.	.	PUNCT
fnp-4365	254	4	turtle	turtle	NOUN
fnp-4365	254	5	,	,	PUNCT
fnp-4365	254	6	c.	c.	PROPN
fnp-4365	254	7	j.	j.	PROPN
fnp-4365	254	8	et	et	PROPN
fnp-4365	254	9	al	al	PROPN
fnp-4365	254	10	.	.	PUNCT
fnp-4365	255	1	cd19	cd19	PROPN
fnp-4365	255	2	car	car	NOUN
fnp-4365	255	3	-	-	PUNCT
fnp-4365	255	4	t	t	NOUN
fnp-4365	255	5	cells	cell	NOUN
fnp-4365	255	6	of	of	ADP
fnp-4365	255	7	defined	define	VERB
fnp-4365	255	8	cd4+:cd8	cd4+:cd8	NOUN
fnp-4365	255	9	+	+	NOUN
fnp-4365	255	10	composition	composition	NOUN
fnp-4365	255	11	in	in	ADP
fnp-4365	255	12	adult	adult	NOUN
fnp-4365	255	13	b	b	NOUN
fnp-4365	255	14	cell	cell	NOUN
fnp-4365	255	15	all	all	DET
fnp-4365	255	16	patients	patient	NOUN
fnp-4365	255	17	.	.	PUNCT
fnp-4365	256	1	j.	j.	PROPN
fnp-4365	256	2	clin	clin	PROPN
fnp-4365	256	3	.	.	PUNCT
fnp-4365	257	1	invest	invest	VERB
fnp-4365	257	2	.	.	PUNCT
fnp-4365	258	1	126	126	NUM
fnp-4365	258	2	,	,	PUNCT
fnp-4365	258	3	2123–2138	2123–2138	NUM
fnp-4365	258	4	(	(	PUNCT
fnp-4365	258	5	2016	2016	NUM
fnp-4365	258	6	)	)	PUNCT
fnp-4365	258	7	.	.	PUNCT
fnp-4365	259	1	pmid	pmid	NOUN
fnp-4365	259	2	:	:	PUNCT
fnp-4365	259	3	27111235	27111235	NUM
fnp-4365	259	4	.	.	PUNCT
fnp-4365	260	1	pmcid	pmcid	NOUN
fnp-4365	260	2	:	:	PUNCT
fnp-4365	260	3	pmc4887159	pmc4887159	PROPN
fnp-4365	260	4	.	.	PUNCT
fnp-4365	261	1	https://doi.org/10.1172/jci85309	https://doi.org/10.1172/jci85309	PROPN
fnp-4365	261	2	3	3	NUM
fnp-4365	261	3	.	.	PUNCT
fnp-4365	262	1	maude	maude	PROPN
fnp-4365	262	2	,	,	PUNCT
fnp-4365	262	3	s.	s.	PROPN
fnp-4365	262	4	l.	l.	PROPN
fnp-4365	262	5	et	et	PROPN
fnp-4365	262	6	al	al	PROPN
fnp-4365	262	7	.	.	PROPN
fnp-4365	262	8	chimeric	chimeric	ADJ
fnp-4365	262	9	antigen	antigen	ADJ
fnp-4365	262	10	receptor	receptor	NOUN
fnp-4365	262	11	t	t	NOUN
fnp-4365	262	12	cells	cell	NOUN
fnp-4365	262	13	for	for	ADP
fnp-4365	262	14	sustained	sustained	ADJ
fnp-4365	262	15	remissions	remission	NOUN
fnp-4365	262	16	in	in	ADP
fnp-4365	262	17	leukemia	leukemia	NOUN
fnp-4365	262	18	.	.	PUNCT
fnp-4365	263	1	n.	n.	PROPN
fnp-4365	263	2	engl	engl	PROPN
fnp-4365	263	3	.	.	PUNCT
fnp-4365	264	1	j.	j.	PROPN
fnp-4365	264	2	med	med	PROPN
fnp-4365	264	3	.	.	PROPN
fnp-4365	264	4	371	371	NUM
fnp-4365	264	5	,	,	PUNCT
fnp-4365	264	6	1507–1517	1507–1517	NUM
fnp-4365	264	7	(	(	PUNCT
fnp-4365	264	8	2014	2014	NUM
fnp-4365	264	9	)	)	PUNCT
fnp-4365	264	10	.	.	PUNCT
fnp-4365	265	1	pmid	pmid	NOUN
fnp-4365	265	2	:	:	PUNCT
fnp-4365	265	3	25317870	25317870	NUM
fnp-4365	265	4	.	.	PUNCT
fnp-4365	266	1	pmcid	pmcid	NOUN
fnp-4365	266	2	:	:	PUNCT
fnp-4365	266	3	pmc4267531	pmc4267531	PROPN
fnp-4365	266	4	.	.	PUNCT
fnp-4365	267	1	https://doi.org/10.1056/nejmoa1407222	https://doi.org/10.1056/nejmoa1407222	PROPN
fnp-4365	267	2	4	4	NUM
fnp-4365	267	3	.	.	PUNCT
fnp-4365	267	4	turtle	turtle	NOUN
fnp-4365	267	5	,	,	PUNCT
fnp-4365	267	6	c.	c.	PROPN
fnp-4365	267	7	j.	j.	PROPN
fnp-4365	267	8	,	,	PUNCT
fnp-4365	267	9	riddell	riddell	PROPN
fnp-4365	267	10	,	,	PUNCT
fnp-4365	267	11	s.	s.	PROPN
fnp-4365	267	12	r.	r.	PROPN
fnp-4365	267	13	&	&	CCONJ
fnp-4365	267	14	maloney	maloney	PROPN
fnp-4365	267	15	,	,	PUNCT
fnp-4365	267	16	d.	d.	PROPN
fnp-4365	267	17	g.	g.	PROPN
fnp-4365	267	18	cd19	cd19	PROPN
fnp-4365	267	19	-	-	PUNCT
fnp-4365	267	20	targeted	target	VERB
fnp-4365	267	21	chimeric	chimeric	ADJ
fnp-4365	267	22	antigen	antigen	ADJ
fnp-4365	267	23	receptor	receptor	NOUN
fnp-4365	267	24	-	-	PUNCT
fnp-4365	267	25	modified	modify	VERB
fnp-4365	267	26	t	t	NOUN
fnp-4365	267	27	-	-	PUNCT
fnp-4365	267	28	cell	cell	NOUN
fnp-4365	267	29	immunotherapy	immunotherapy	NOUN
fnp-4365	267	30	for	for	ADP
fnp-4365	267	31	b	b	NOUN
fnp-4365	267	32	-	-	PUNCT
fnp-4365	267	33	cell	cell	NOUN
fnp-4365	267	34	malignancies	malignancy	NOUN
fnp-4365	267	35	.	.	PUNCT
fnp-4365	268	1	clin	clin	PROPN
fnp-4365	268	2	.	.	PUNCT
fnp-4365	269	1	pharmacol	pharmacol	PROPN
fnp-4365	269	2	.	.	PUNCT
fnp-4365	270	1	ther	ther	PROPN
fnp-4365	270	2	.	.	PUNCT
fnp-4365	271	1	100	100	NUM
fnp-4365	271	2	,	,	PUNCT
fnp-4365	271	3	252–258	252–258	NUM
fnp-4365	271	4	(	(	PUNCT
fnp-4365	271	5	2016	2016	NUM
fnp-4365	271	6	)	)	PUNCT
fnp-4365	271	7	.	.	PUNCT
fnp-4365	272	1	pmid	pmid	NOUN
fnp-4365	272	2	:	:	PUNCT
fnp-4365	272	3	27170467	27170467	NUM
fnp-4365	272	4	.	.	PUNCT
fnp-4365	273	1	https://doi.org/10.1002/cpt.392	https://doi.org/10.1002/cpt.392	PROPN
fnp-4365	273	2	5	5	NUM
fnp-4365	273	3	.	.	PUNCT
fnp-4365	273	4	turtle	turtle	NOUN
fnp-4365	273	5	,	,	PUNCT
fnp-4365	273	6	c.	c.	PROPN
fnp-4365	273	7	j.	j.	PROPN
fnp-4365	273	8	et	et	PROPN
fnp-4365	273	9	al	al	PROPN
fnp-4365	273	10	.	.	PUNCT
fnp-4365	274	1	immunotherapy	immunotherapy	NOUN
fnp-4365	274	2	of	of	ADP
fnp-4365	274	3	non	non	ADJ
fnp-4365	274	4	-	-	ADJ
fnp-4365	274	5	hodgkin	hodgkin	ADJ
fnp-4365	274	6	’s	’s	PART
fnp-4365	274	7	lymphoma	lymphoma	NOUN
fnp-4365	274	8	with	with	ADP
fnp-4365	274	9	a	a	DET
fnp-4365	274	10	defined	define	VERB
fnp-4365	274	11	ratio	ratio	NOUN
fnp-4365	274	12	of	of	ADP
fnp-4365	274	13	cd8	cd8	PROPN
fnp-4365	274	14	+	+	PROPN
fnp-4365	274	15	and	and	CCONJ
fnp-4365	274	16	cd4	cd4	PROPN
fnp-4365	274	17	+	+	PROPN
fnp-4365	274	18	cd19	cd19	PROPN
fnp-4365	274	19	-	-	PUNCT
fnp-4365	274	20	specific	specific	ADJ
fnp-4365	274	21	chimeric	chimeric	ADJ
fnp-4365	274	22	antigen	antigen	ADJ
fnp-4365	274	23	receptor	receptor	NOUN
fnp-4365	274	24	-	-	PUNCT
fnp-4365	274	25	modified	modify	VERB
fnp-4365	274	26	t	t	NOUN
fnp-4365	274	27	cells	cell	NOUN
fnp-4365	274	28	.	.	PUNCT
fnp-4365	275	1	sci	sci	PROPN
fnp-4365	275	2	.	.	PROPN
fnp-4365	275	3	transl	transl	PROPN
fnp-4365	275	4	.	.	PUNCT
fnp-4365	276	1	med	med	PROPN
fnp-4365	276	2	.	.	PROPN
fnp-4365	276	3	8	8	NUM
fnp-4365	276	4	,	,	PUNCT
fnp-4365	276	5	355ra116	355ra116	NUM
fnp-4365	276	6	(	(	PUNCT
fnp-4365	276	7	2016	2016	NUM
fnp-4365	276	8	)	)	PUNCT
fnp-4365	276	9	.	.	PUNCT
fnp-4365	277	1	pmid	pmid	NOUN
fnp-4365	277	2	:	:	PUNCT
fnp-4365	277	3	27605551	27605551	NUM
fnp-4365	277	4	.	.	PUNCT
fnp-4365	278	1	pmcid	pmcid	NOUN
fnp-4365	278	2	:	:	PUNCT
fnp-4365	278	3	pmc5045301	pmc5045301	NOUN
fnp-4365	278	4	.	.	PUNCT
fnp-4365	279	1	https://doi.org/10.1126/scitranslmed.aaf8621	https://doi.org/10.1126/scitranslmed.aaf8621	PROPN
fnp-4365	279	2	6	6	NUM
fnp-4365	279	3	.	.	X
fnp-4365	279	4	oliver	oliver	PROPN
fnp-4365	279	5	-	-	PUNCT
fnp-4365	279	6	caldes	calde	NOUN
fnp-4365	279	7	,	,	PUNCT
fnp-4365	279	8	a.	a.	NOUN
fnp-4365	279	9	et	et	PROPN
fnp-4365	279	10	al	al	PROPN
fnp-4365	279	11	.	.	PUNCT
fnp-4365	280	1	first	first	ADJ
fnp-4365	280	2	report	report	NOUN
fnp-4365	280	3	of	of	ADP
fnp-4365	280	4	cart	cart	NOUN
fnp-4365	280	5	treatment	treatment	NOUN
fnp-4365	280	6	in	in	ADP
fnp-4365	280	7	al	al	PROPN
fnp-4365	280	8	amyloidosis	amyloidosis	NOUN
fnp-4365	280	9	and	and	CCONJ
fnp-4365	280	10	relapsed	relapse	VERB
fnp-4365	280	11	/	/	SYM
fnp-4365	280	12	refractory	refractory	NOUN
fnp-4365	280	13	multiple	multiple	ADJ
fnp-4365	280	14	myeloma	myeloma	NOUN
fnp-4365	280	15	.	.	PUNCT
fnp-4365	281	1	j.	j.	PROPN
fnp-4365	281	2	immunother	immunother	PROPN
fnp-4365	281	3	.	.	PUNCT
fnp-4365	282	1	cancer	cancer	NOUN
fnp-4365	282	2	9	9	NUM
fnp-4365	282	3	,	,	PUNCT
fnp-4365	282	4	e003783	e003783	NOUN
fnp-4365	282	5	(	(	PUNCT
fnp-4365	282	6	2021	2021	NUM
fnp-4365	282	7	)	)	PUNCT
fnp-4365	282	8	.	.	PUNCT
fnp-4365	283	1	pmid	pmid	NOUN
fnp-4365	283	2	:	:	PUNCT
fnp-4365	283	3	34876408	34876408	NUM
fnp-4365	283	4	.	.	PUNCT
fnp-4365	284	1	pmcid	pmcid	NOUN
fnp-4365	284	2	:	:	PUNCT
fnp-4365	284	3	pmc8655576	pmc8655576	NOUN
fnp-4365	284	4	.	.	PUNCT
fnp-4365	285	1	https://doi.org/10.1136/jitc-2021-003783	https://doi.org/10.1136/jitc-2021-003783	NOUN
fnp-4365	285	2	7	7	NUM
fnp-4365	285	3	.	.	PUNCT
fnp-4365	285	4	hunter	hunter	NOUN
fnp-4365	285	5	,	,	PUNCT
fnp-4365	285	6	b.	b.	PROPN
fnp-4365	285	7	d.	d.	PROPN
fnp-4365	285	8	&	&	CCONJ
fnp-4365	285	9	jacobson	jacobson	PROPN
fnp-4365	285	10	,	,	PUNCT
fnp-4365	285	11	c.	c.	PROPN
fnp-4365	285	12	a.	a.	PROPN
fnp-4365	285	13	car	car	PROPN
fnp-4365	285	14	t	t	PROPN
fnp-4365	285	15	-	-	PUNCT
fnp-4365	285	16	cell	cell	NOUN
fnp-4365	285	17	associated	associate	VERB
fnp-4365	285	18	neurotoxicity	neurotoxicity	NOUN
fnp-4365	285	19	:	:	PUNCT
fnp-4365	285	20	mechanisms	mechanism	NOUN
fnp-4365	285	21	,	,	PUNCT
fnp-4365	285	22	clinicopathologic	clinicopathologic	NOUN
fnp-4365	285	23	correlates	correlate	VERB
fnp-4365	285	24	,	,	PUNCT
fnp-4365	285	25	and	and	CCONJ
fnp-4365	285	26	future	future	ADJ
fnp-4365	285	27	directions	direction	NOUN
fnp-4365	285	28	.	.	PUNCT
fnp-4365	286	1	j.	j.	PROPN
fnp-4365	286	2	natl	natl	PROPN
fnp-4365	286	3	.	.	PUNCT
fnp-4365	286	4	cancer	cancer	NOUN
fnp-4365	286	5	inst	inst	PROPN
fnp-4365	286	6	.	.	PROPN
fnp-4365	286	7	111	111	NUM
fnp-4365	286	8	,	,	PUNCT
fnp-4365	286	9	646–654	646–654	NUM
fnp-4365	286	10	(	(	PUNCT
fnp-4365	286	11	2019	2019	NUM
fnp-4365	286	12	)	)	PUNCT
fnp-4365	286	13	.	.	PUNCT
fnp-4365	287	1	pmid	pmid	NOUN
fnp-4365	287	2	:	:	PUNCT
fnp-4365	287	3	30753567	30753567	NUM
fnp-4365	287	4	.	.	PUNCT
fnp-4365	288	1	https://doi.org/10.1093/jnci/djz017	https://doi.org/10.1093/jnci/djz017	ADP
fnp-4365	288	2	8	8	NUM
fnp-4365	288	3	.	.	PUNCT
fnp-4365	289	1	torre	torre	PROPN
fnp-4365	289	2	,	,	PUNCT
fnp-4365	289	3	m.	m.	NOUN
fnp-4365	289	4	et	et	PROPN
fnp-4365	289	5	al	al	PROPN
fnp-4365	289	6	.	.	PROPN
fnp-4365	289	7	neuropathology	neuropathology	NOUN
fnp-4365	289	8	of	of	ADP
fnp-4365	289	9	a	a	DET
fnp-4365	289	10	case	case	NOUN
fnp-4365	289	11	with	with	ADP
fnp-4365	289	12	fatal	fatal	ADJ
fnp-4365	289	13	car	car	NOUN
fnp-4365	289	14	t	t	NOUN
fnp-4365	289	15	-	-	PUNCT
fnp-4365	289	16	cell	cell	NOUN
fnp-4365	289	17	-	-	PUNCT
fnp-4365	289	18	associated	associate	VERB
fnp-4365	289	19	cerebral	cerebral	ADJ
fnp-4365	289	20	edema	edema	NOUN
fnp-4365	289	21	.	.	PUNCT
fnp-4365	290	1	j.	j.	PROPN
fnp-4365	290	2	neuropathol	neuropathol	PROPN
fnp-4365	290	3	.	.	PUNCT
fnp-4365	291	1	exp	exp	PROPN
fnp-4365	291	2	.	.	PUNCT
fnp-4365	292	1	neurol	neurol	PROPN
fnp-4365	292	2	.	.	PUNCT
fnp-4365	293	1	77	77	NUM
fnp-4365	293	2	,	,	PUNCT
fnp-4365	293	3	877–882	877–882	NUM
fnp-4365	293	4	(	(	PUNCT
fnp-4365	293	5	2018	2018	NUM
fnp-4365	293	6	)	)	PUNCT
fnp-4365	293	7	.	.	PUNCT
fnp-4365	294	1	pmid	pmid	NOUN
fnp-4365	294	2	:	:	PUNCT
fnp-4365	294	3	30060228	30060228	NUM
fnp-4365	294	4	.	.	PUNCT
fnp-4365	295	1	https://doi.org/10.1093/jnen/nly064	https://doi.org/10.1093/jnen/nly064	NOUN
fnp-4365	295	2	9	9	NUM
fnp-4365	295	3	.	.	PUNCT
fnp-4365	295	4	gust	gust	PROPN
fnp-4365	295	5	,	,	PUNCT
fnp-4365	295	6	j.	j.	PROPN
fnp-4365	295	7	et	et	PROPN
fnp-4365	295	8	al	al	PROPN
fnp-4365	295	9	.	.	PUNCT
fnp-4365	295	10	endothelial	endothelial	ADJ
fnp-4365	295	11	activation	activation	NOUN
fnp-4365	295	12	and	and	CCONJ
fnp-4365	295	13	blood	blood	NOUN
fnp-4365	295	14	–	–	PUNCT
fnp-4365	295	15	brain	brain	NOUN
fnp-4365	295	16	barrier	barrier	NOUN
fnp-4365	295	17	disruption	disruption	NOUN
fnp-4365	295	18	in	in	ADP
fnp-4365	295	19	neurotoxicity	neurotoxicity	NOUN
fnp-4365	295	20	after	after	ADP
fnp-4365	295	21	adoptive	adoptive	ADJ
fnp-4365	295	22	immunotherapy	immunotherapy	NOUN
fnp-4365	295	23	with	with	ADP
fnp-4365	295	24	cd19	cd19	PROPN
fnp-4365	295	25	car	car	NOUN
fnp-4365	295	26	-	-	PUNCT
fnp-4365	295	27	t	t	NOUN
fnp-4365	295	28	cells	cell	NOUN
fnp-4365	295	29	.	.	PUNCT
fnp-4365	296	1	cancer	cancer	NOUN
fnp-4365	296	2	discov	discov	NOUN
fnp-4365	296	3	.	.	PUNCT
fnp-4365	297	1	7	7	NUM
fnp-4365	297	2	,	,	PUNCT
fnp-4365	297	3	1404–1419	1404–1419	NUM
fnp-4365	297	4	(	(	PUNCT
fnp-4365	297	5	2017	2017	NUM
fnp-4365	297	6	)	)	PUNCT
fnp-4365	297	7	.	.	PUNCT
fnp-4365	298	1	pmcid	pmcid	NOUN
fnp-4365	298	2	:	:	PUNCT
fnp-4365	298	3	pmc5718945	pmc5718945	X
fnp-4365	298	4	.	.	PUNCT
fnp-4365	299	1	https://doi.org/10.1158/2159-8290.cd-17-0698	https://doi.org/10.1158/2159-8290.cd-17-0698	PROPN
fnp-4365	299	2	10	10	NUM
fnp-4365	299	3	.	.	PUNCT
fnp-4365	300	1	schuster	schuster	PROPN
fnp-4365	300	2	,	,	PUNCT
fnp-4365	300	3	s.	s.	PROPN
fnp-4365	300	4	j.	j.	PROPN
fnp-4365	300	5	et	et	PROPN
fnp-4365	300	6	al	al	PROPN
fnp-4365	300	7	.	.	PROPN
fnp-4365	300	8	chimeric	chimeric	ADJ
fnp-4365	300	9	antigen	antigen	ADJ
fnp-4365	300	10	receptor	receptor	NOUN
fnp-4365	300	11	t	t	NOUN
fnp-4365	300	12	cells	cell	NOUN
fnp-4365	300	13	in	in	ADP
fnp-4365	300	14	refractory	refractory	PROPN
fnp-4365	300	15	b	b	NOUN
fnp-4365	300	16	-	-	PUNCT
fnp-4365	300	17	cell	cell	NOUN
fnp-4365	300	18	lymphomas	lymphoma	NOUN
fnp-4365	300	19	.	.	PUNCT
fnp-4365	301	1	n.	n.	PROPN
fnp-4365	301	2	engl	engl	PROPN
fnp-4365	301	3	.	.	PUNCT
fnp-4365	302	1	j.	j.	PROPN
fnp-4365	302	2	med	med	PROPN
fnp-4365	302	3	.	.	PROPN
fnp-4365	303	1	377	377	NUM
fnp-4365	303	2	,	,	PUNCT
fnp-4365	303	3	2545–2554	2545–2554	NUM
fnp-4365	303	4	(	(	PUNCT
fnp-4365	303	5	2017	2017	NUM
fnp-4365	303	6	)	)	PUNCT
fnp-4365	303	7	.	.	PUNCT
fnp-4365	304	1	pmid	pmid	NOUN
fnp-4365	304	2	:	:	PUNCT
fnp-4365	304	3	29226764	29226764	NUM
fnp-4365	304	4	.	.	PUNCT
fnp-4365	305	1	pmcid	pmcid	NOUN
fnp-4365	305	2	:	:	PUNCT
fnp-4365	305	3	pmc5788566	pmc5788566	PROPN
fnp-4365	305	4	.	.	PUNCT
fnp-4365	306	1	https://doi.org/10.1056/nejmoa1708566	https://doi.org/10.1056/nejmoa1708566	PROPN
fnp-4365	306	2	11	11	NUM
fnp-4365	306	3	.	.	PUNCT
fnp-4365	307	1	lowe	lowe	PROPN
fnp-4365	307	2	,	,	PUNCT
fnp-4365	307	3	k.	k.	PROPN
fnp-4365	307	4	l.	l.	PROPN
fnp-4365	307	5	et	et	PROPN
fnp-4365	307	6	al	al	PROPN
fnp-4365	307	7	.	.	PROPN
fnp-4365	307	8	fludarabine	fludarabine	PROPN
fnp-4365	307	9	and	and	CCONJ
fnp-4365	307	10	neurotoxicity	neurotoxicity	NOUN
fnp-4365	307	11	in	in	ADP
fnp-4365	307	12	engineered	engineer	VERB
fnp-4365	307	13	t	t	NOUN
fnp-4365	307	14	-	-	PUNCT
fnp-4365	307	15	cell	cell	NOUN
fnp-4365	307	16	therapy	therapy	NOUN
fnp-4365	307	17	.	.	PUNCT
fnp-4365	308	1	gene	gene	NOUN
fnp-4365	308	2	therapy	therapy	NOUN
fnp-4365	308	3	.	.	PUNCT
fnp-4365	309	1	25	25	NUM
fnp-4365	309	2	,	,	PUNCT
fnp-4365	309	3	176–191	176–191	NUM
fnp-4365	309	4	(	(	PUNCT
fnp-4365	309	5	2018	2018	NUM
fnp-4365	309	6	)	)	PUNCT
fnp-4365	309	7	.	.	PUNCT
fnp-4365	310	1	pmid	pmid	NOUN
fnp-4365	310	2	:	:	PUNCT
fnp-4365	310	3	29789639	29789639	NUM
fnp-4365	310	4	.	.	PUNCT
fnp-4365	311	1	https://doi.org/10.1038/s41434-018-0019-6	https://doi.org/10.1038/s41434-018-0019-6	NUM
fnp-4365	311	2	12	12	NUM
fnp-4365	311	3	.	.	PUNCT
fnp-4365	311	4	ortíz	ortíz	PROPN
fnp-4365	311	5	-	-	PUNCT
fnp-4365	311	6	maldonado	maldonado	NOUN
fnp-4365	311	7	,	,	PUNCT
fnp-4365	311	8	v.	v.	ADP
fnp-4365	311	9	et	et	PROPN
fnp-4365	311	10	al	al	PROPN
fnp-4365	311	11	.	.	PROPN
fnp-4365	311	12	cart19	cart19	NOUN
fnp-4365	311	13	-	-	PUNCT
fnp-4365	311	14	be-01	be-01	NUM
fnp-4365	311	15	:	:	PUNCT
fnp-4365	311	16	a	a	DET
fnp-4365	311	17	multicenter	multicenter	ADJ
fnp-4365	311	18	trial	trial	NOUN
fnp-4365	311	19	of	of	ADP
fnp-4365	311	20	ari-0001	ari-0001	NOUN
fnp-4365	311	21	cell	cell	NOUN
fnp-4365	311	22	therapy	therapy	NOUN
fnp-4365	311	23	in	in	ADP
fnp-4365	311	24	patients	patient	NOUN
fnp-4365	311	25	with	with	ADP
fnp-4365	311	26	cd19	cd19	PROPN
fnp-4365	311	27	+	+	CCONJ
fnp-4365	311	28	relapsed	relapsed	ADJ
fnp-4365	311	29	/	/	SYM
fnp-4365	311	30	refractory	refractory	NOUN
fnp-4365	311	31	malignancies	malignancy	NOUN
fnp-4365	311	32	.	.	PUNCT
fnp-4365	312	1	mol	mol	PROPN
fnp-4365	312	2	.	.	PROPN
fnp-4365	313	1	ther	ther	PROPN
fnp-4365	313	2	.	.	PUNCT
fnp-4365	314	1	29	29	NUM
fnp-4365	314	2	,	,	PUNCT
fnp-4365	314	3	636–644	636–644	NUM
fnp-4365	314	4	(	(	PUNCT
fnp-4365	314	5	2021	2021	NUM
fnp-4365	314	6	)	)	PUNCT
fnp-4365	314	7	.	.	PUNCT
fnp-4365	315	1	pmid	pmid	NOUN
fnp-4365	315	2	:	:	PUNCT
fnp-4365	315	3	33010231	33010231	NUM
fnp-4365	315	4	.	.	PUNCT
fnp-4365	316	1	pmcid	pmcid	ADJ
fnp-4365	316	2	:	:	PUNCT
fnp-4365	316	3	pmc7854276	pmc7854276	NOUN
fnp-4365	316	4	.	.	PUNCT
fnp-4365	317	1	https://doi.org/10.1016/j.ymthe.2020.09.027	https://doi.org/10.1016/j.ymthe.2020.09.027	PROPN
fnp-4365	317	2	13	13	NUM
fnp-4365	317	3	.	.	PUNCT
fnp-4365	318	1	castella	castella	NOUN
fnp-4365	318	2	,	,	PUNCT
fnp-4365	318	3	m.	m.	NOUN
fnp-4365	318	4	et	et	PROPN
fnp-4365	318	5	al	al	PROPN
fnp-4365	318	6	.	.	PROPN
fnp-4365	318	7	development	development	NOUN
fnp-4365	318	8	of	of	ADP
fnp-4365	318	9	a	a	DET
fnp-4365	318	10	novel	novel	ADJ
fnp-4365	318	11	anti	anti	ADJ
fnp-4365	318	12	-	-	ADJ
fnp-4365	318	13	cd19	cd19	ADJ
fnp-4365	318	14	chimeric	chimeric	ADJ
fnp-4365	318	15	antigen	antigen	ADJ
fnp-4365	318	16	receptor	receptor	NOUN
fnp-4365	318	17	:	:	PUNCT
fnp-4365	318	18	a	a	DET
fnp-4365	318	19	paradigm	paradigm	NOUN
fnp-4365	318	20	for	for	ADP
fnp-4365	318	21	an	an	DET
fnp-4365	318	22	affordable	affordable	ADJ
fnp-4365	318	23	car	car	NOUN
fnp-4365	318	24	t	t	NOUN
fnp-4365	318	25	cell	cell	NOUN
fnp-4365	318	26	production	production	NOUN
fnp-4365	318	27	at	at	ADP
fnp-4365	318	28	academic	academic	ADJ
fnp-4365	318	29	institutions	institution	NOUN
fnp-4365	318	30	.	.	PUNCT
fnp-4365	319	1	mol	mol	PROPN
fnp-4365	319	2	.	.	PROPN
fnp-4365	320	1	ther	ther	PROPN
fnp-4365	320	2	.	.	PUNCT
fnp-4365	321	1	methods	method	NOUN
fnp-4365	321	2	clin	clin	PROPN
fnp-4365	321	3	.	.	PUNCT
fnp-4365	322	1	dev	dev	PROPN
fnp-4365	322	2	.	.	PROPN
fnp-4365	323	1	12	12	NUM
fnp-4365	323	2	,	,	PUNCT
fnp-4365	323	3	134–144	134–144	NUM
fnp-4365	323	4	(	(	PUNCT
fnp-4365	323	5	2019	2019	NUM
fnp-4365	323	6	)	)	PUNCT
fnp-4365	323	7	.	.	PUNCT
fnp-4365	324	1	pmid	pmid	NOUN
fnp-4365	324	2	:	:	PUNCT
fnp-4365	324	3	30623002	30623002	NUM
fnp-4365	324	4	.	.	PUNCT
fnp-4365	325	1	pmcid	pmcid	NOUN
fnp-4365	325	2	:	:	PUNCT
fnp-4365	325	3	pmc6319086	pmc6319086	NOUN
fnp-4365	325	4	.	.	PUNCT
fnp-4365	326	1	https://doi.org/10.1016/j.omtm.2018.11.010	https://doi.org/10.1016/j.omtm.2018.11.010	ADJ
fnp-4365	326	2	14	14	NUM
fnp-4365	326	3	.	.	PUNCT
fnp-4365	327	1	castella	castella	NOUN
fnp-4365	327	2	,	,	PUNCT
fnp-4365	327	3	m.	m.	NOUN
fnp-4365	327	4	et	et	PROPN
fnp-4365	327	5	al	al	PROPN
fnp-4365	327	6	.	.	PROPN
fnp-4365	327	7	point	point	PROPN
fnp-4365	327	8	-	-	PUNCT
fnp-4365	327	9	of	of	ADP
fnp-4365	327	10	-	-	PUNCT
fnp-4365	327	11	care	care	NOUN
fnp-4365	327	12	car	car	NOUN
fnp-4365	327	13	t	t	NOUN
fnp-4365	327	14	-	-	PUNCT
fnp-4365	327	15	cell	cell	NOUN
fnp-4365	327	16	production	production	NOUN
fnp-4365	327	17	(	(	PUNCT
fnp-4365	327	18	ari-0001	ari-0001	NOUN
fnp-4365	327	19	)	)	PUNCT
fnp-4365	327	20	using	use	VERB
fnp-4365	327	21	a	a	DET
fnp-4365	327	22	closed	closed	ADJ
fnp-4365	327	23	semi	semi	ADJ
fnp-4365	327	24	-	-	ADJ
fnp-4365	327	25	automatic	automatic	ADJ
fnp-4365	327	26	bioreactor	bioreactor	NOUN
fnp-4365	327	27	:	:	PUNCT
fnp-4365	327	28	experience	experience	NOUN
fnp-4365	327	29	from	from	ADP
fnp-4365	327	30	an	an	DET
fnp-4365	327	31	academic	academic	ADJ
fnp-4365	327	32	phase	phase	NOUN
fnp-4365	327	33	i	i	PRON
fnp-4365	327	34	clinical	clinical	ADJ
fnp-4365	327	35	trial	trial	NOUN
fnp-4365	327	36	.	.	PUNCT
fnp-4365	328	1	front	front	ADJ
fnp-4365	328	2	.	.	PUNCT
fnp-4365	329	1	immunol	immunol	NOUN
fnp-4365	329	2	.	.	PUNCT
fnp-4365	330	1	11	11	NUM
fnp-4365	330	2	,	,	PUNCT
fnp-4365	330	3	482	482	NUM
fnp-4365	330	4	(	(	PUNCT
fnp-4365	330	5	2020	2020	NUM
fnp-4365	330	6	)	)	PUNCT
fnp-4365	330	7	.	.	PUNCT
fnp-4365	331	1	pmid	pmid	NOUN
fnp-4365	331	2	:	:	PUNCT
fnp-4365	331	3	32528460	32528460	NUM
fnp-4365	331	4	.	.	PUNCT
fnp-4365	332	1	pmcid	pmcid	NOUN
fnp-4365	332	2	:	:	PUNCT
fnp-4365	332	3	pmc7259426	pmc7259426	VERB
fnp-4365	332	4	.	.	PUNCT
fnp-4365	333	1	https://doi.org/10.3389/fimmu.2020.00482	https://doi.org/10.3389/fimmu.2020.00482	PROPN
fnp-4365	333	2	15	15	NUM
fnp-4365	333	3	.	.	PUNCT
fnp-4365	334	1	balaban	balaban	PROPN
fnp-4365	334	2	,	,	PUNCT
fnp-4365	334	3	d.	d.	PROPN
fnp-4365	334	4	,	,	PUNCT
fnp-4365	334	5	miyawaki	miyawaki	PROPN
fnp-4365	334	6	,	,	PUNCT
fnp-4365	334	7	e.	e.	PROPN
fnp-4365	334	8	k.	k.	PROPN
fnp-4365	334	9	,	,	PUNCT
fnp-4365	334	10	bhattacharyya	bhattacharyya	PROPN
fnp-4365	334	11	,	,	PUNCT
fnp-4365	334	12	s.	s.	PROPN
fnp-4365	334	13	&	&	CCONJ
fnp-4365	334	14	torre	torre	PROPN
fnp-4365	334	15	,	,	PUNCT
fnp-4365	334	16	m.	m.	NOUN
fnp-4365	334	17	the	the	DET
fnp-4365	334	18	phenomenon	phenomenon	NOUN
fnp-4365	334	19	of	of	ADP
fnp-4365	334	20	clasmatodendrosis	clasmatodendrosis	NOUN
fnp-4365	334	21	.	.	PUNCT
fnp-4365	335	1	heliyon	heliyon	NOUN
fnp-4365	335	2	7	7	NUM
fnp-4365	335	3	,	,	PUNCT
fnp-4365	335	4	e07605	e07605	X
fnp-4365	335	5	(	(	PUNCT
fnp-4365	335	6	2021	2021	NUM
fnp-4365	335	7	)	)	PUNCT
fnp-4365	335	8	.	.	PUNCT
fnp-4365	336	1	pmid	pmid	NOUN
fnp-4365	336	2	:	:	PUNCT
fnp-4365	336	3	34368479	34368479	NUM
fnp-4365	336	4	.	.	PUNCT
fnp-4365	337	1	pmcid	pmcid	NOUN
fnp-4365	337	2	:	:	PUNCT
fnp-4365	337	3	pmc8326353	pmc8326353	PROPN
fnp-4365	337	4	.	.	PUNCT
fnp-4365	338	1	https://doi.org/10.1016/j.heliyon.2021.e07605	https://doi.org/10.1016/j.heliyon.2021.e07605	VERB
fnp-4365	338	2	copyright	copyright	NOUN
fnp-4365	338	3	:	:	PUNCT
fnp-4365	338	4	©	©	PROPN
fnp-4365	338	5	2022	2022	NUM
fnp-4365	338	6	the	the	DET
fnp-4365	338	7	author(s	author(s	NOUN
fnp-4365	338	8	)	)	PUNCT
fnp-4365	338	9	.	.	PUNCT
fnp-4365	339	1	this	this	PRON
fnp-4365	339	2	is	be	AUX
fnp-4365	339	3	an	an	DET
fnp-4365	339	4	open	open	ADJ
fnp-4365	339	5	access	access	NOUN
fnp-4365	339	6	article	article	NOUN
fnp-4365	339	7	distributed	distribute	VERB
fnp-4365	339	8	under	under	ADP
fnp-4365	339	9	the	the	DET
fnp-4365	339	10	terms	term	NOUN
fnp-4365	339	11	of	of	ADP
fnp-4365	339	12	the	the	DET
fnp-4365	339	13	creative	creative	ADJ
fnp-4365	339	14	commons	common	NOUN
fnp-4365	339	15	attribution	attribution	NOUN
fnp-4365	339	16	4.0	4.0	NUM
fnp-4365	339	17	international	international	ADJ
fnp-4365	339	18	license	license	NOUN
fnp-4365	339	19	(	(	PUNCT
fnp-4365	339	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-4365	339	21	)	)	PUNCT
fnp-4365	339	22	,	,	PUNCT
fnp-4365	339	23	which	which	PRON
fnp-4365	339	24	permits	permit	VERB
fnp-4365	339	25	unrestricted	unrestricted	ADJ
fnp-4365	339	26	use	use	NOUN
fnp-4365	339	27	,	,	PUNCT
fnp-4365	339	28	distribution	distribution	NOUN
fnp-4365	339	29	,	,	PUNCT
fnp-4365	339	30	and	and	CCONJ
fnp-4365	339	31	reproduction	reproduction	NOUN
fnp-4365	339	32	in	in	ADP
fnp-4365	339	33	any	any	DET
fnp-4365	339	34	medium	medium	NOUN
fnp-4365	339	35	,	,	PUNCT
fnp-4365	339	36	provided	provide	VERB
fnp-4365	339	37	the	the	DET
fnp-4365	339	38	original	original	ADJ
fnp-4365	339	39	author	author	NOUN
fnp-4365	339	40	and	and	CCONJ
fnp-4365	339	41	source	source	NOUN
fnp-4365	339	42	are	be	AUX
fnp-4365	339	43	credited	credit	VERB
fnp-4365	339	44	,	,	PUNCT
fnp-4365	339	45	a	a	DET
fnp-4365	339	46	link	link	NOUN
fnp-4365	339	47	to	to	ADP
fnp-4365	339	48	the	the	DET
fnp-4365	339	49	creative	creative	ADJ
fnp-4365	339	50	commons	common	NOUN
fnp-4365	339	51	license	license	NOUN
fnp-4365	339	52	is	be	AUX
fnp-4365	339	53	provided	provide	VERB
fnp-4365	339	54	,	,	PUNCT
fnp-4365	339	55	and	and	CCONJ
fnp-4365	339	56	any	any	DET
fnp-4365	339	57	changes	change	NOUN
fnp-4365	339	58	are	be	AUX
fnp-4365	339	59	indicated	indicate	VERB
fnp-4365	339	60	.	.	PUNCT
fnp-4365	340	1	the	the	DET
fnp-4365	340	2	creative	creative	ADJ
fnp-4365	340	3	commons	common	NOUN
fnp-4365	340	4	public	public	ADJ
fnp-4365	340	5	domain	domain	NOUN
fnp-4365	340	6	dedication	dedication	NOUN
fnp-4365	340	7	waiver	waiver	NOUN
fnp-4365	340	8	(	(	PUNCT
fnp-4365	340	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-4365	340	10	)	)	PUNCT
fnp-4365	340	11	applies	apply	VERB
fnp-4365	340	12	to	to	ADP
fnp-4365	340	13	the	the	DET
fnp-4365	340	14	data	datum	NOUN
fnp-4365	340	15	made	make	VERB
fnp-4365	340	16	available	available	ADJ
fnp-4365	340	17	in	in	ADP
fnp-4365	340	18	this	this	DET
fnp-4365	340	19	article	article	NOUN
fnp-4365	340	20	,	,	PUNCT
fnp-4365	340	21	unless	unless	SCONJ
fnp-4365	340	22	otherwise	otherwise	ADV
fnp-4365	340	23	stated	state	VERB
fnp-4365	340	24	.	.	PUNCT